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You’ll need coffee shops and sunsets and road trips. Airplanes and passports and new 
songs and old songs, but people more than anything else. You will need other people and 
you will need to be that other person to someone else, a living breathing screaming 
invitation to believe better things.  
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Figure C-1 Illustration of the AP-DTIMS-Orbitrap MS instrument 
configuration. 
164 
Figure C-2 Illustration of the DTIMS dual-gate modes of operation for ion 
selection and filtering. The corresponding MS TIC traces for gate 
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#2 operations using gated mode and scan mode IM-MS acquisition 
schemes are shown. 
Figure C-3 (A) Faraday response for 4 ppm w/v citric acid in 80:20 
methanol/water for increasing DTIMS gate #1 pulse widths. (B) 
MS signal for 10 ppm w/v citric acid for increasing DTIMS gate 
#2 pulse widths over a 2.5 ms scan window. The gate #1 pulse 
width was 100 µs and the scan step was 25 µs. (C) MS signal for 
10 ppm w/v citric acid for increasing DTIMS gate #2 scan step 
ratios over a 2.5 ms scan window. Gate #1 and #2 pulse widths 
were set equal at 100 µs. The number of data points per peak is 
plotted with each curve trace. For (A-C), DTIMS operation 
potential was -7000 V, drift gas temperature was 200 ˚C, and drift 
gas flow rate and exhaust pump rate were 2.0 L min-1 and 0.5 L 
min-1, respectively. 
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Figure C-4 Scan mode averaged mass spectrum and Faraday response (inset) 
for 100 ppm w/v of mixture of [Ser-Asp-Gly-Arg-Gly] and [Gly-
Arg-Gly-Asp-Ser] peptide sequence isomers in 50:50 
acetonitrile/water with 0.1% formic acid (A). All ion fragmentation 
HCD of the separated peptide isomers using a normalized collision 
energy of 20 V, where individual [M+2H]+ species were isolated 
by ion mobility before fragmentation (B and C). Asterisks (*) 
denote identified sidechain fragments of serine, aspartic acid, and 
arginine. (DTIMS operation potential: 10,000 V, drift gas 
temperature: 220 ˚C, drift gas flow rate: 3.0 L min-1, exhaust pump 
rate: 1.5 L min-1; gate #1 and #2 pulse width: 150 µs; scan step: 50 
µs). 
174 
Figure C-5 AP-DTIMS-Orbitrap MS analysis for 100 ppm solution (w/v in 
50:50 methanol/water) of 3 saccharides: D-(+)-melibiose, D-(+)-
melezitose, and D-(+)-raffinose. Panels show the extracted mass 
spectra for each mixture component (A), the corresponding 
Faraday response (B), a map of the chemical space with m/z plotted 
as a function of drift time (C), and the extracted MS total ion 
chronograms (D). (gate #1 & #2: 200 µs, scan step: 50 µs; AGC: 
5.0E+06, IT: 1000 ms, Resolution: 35,000). 
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Figure D-1 a) The robot and laboratory environment integrated into the Actin 
GUI. The digitized object surface contour following the laser scan 
was also included (shown in red). (B) Laser scan start and end 
waypoints being programmed in Actin-MS to define the length of 
the scan. (C) A bell pepper being scanned by the laser. A block of 
foam was placed on the actual workbench to define a safety buffer 
zone. The scanned object contour appears to be “floating” in GUI 
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space because it was placed on this foam piece, which was not 
digitized. 
Figure D-2 (A) During RoSA-MS analysis, the robot docks the needle probe 
into an open port sampling interface (OPSI). (B) Schematic of the 
needle probe docked in the OPSI. Pressure from the spring-loaded 
probe against the annulus tubing maintains a sealed junction. The 
solvent flow between the annulus and the center capillary dissolves 
the material on the needle tip. The sealed fluidics system delivers 
the solubilized sample to the mass spectrometer. 
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Figure D-3 (A) To evaluate the precision of the robot controlled by Actin, a 
0.125 mm OD needle was programed to pierce the same location 
on a piece of paper after a random 3-waypoint arm movement. (B) 
For the first twenty cycles of piercing, the needle went through the 
paper creating a single hole 200 μm in diameter. From these 
measurements, the estimated deviation was calculated to be in the 
order of 200 μm -125 μm =75 μm, for an overall precision of 75 
μm/2=37.5 μm (~40 μm). Following this experiment, the RoSA 
system was restarted to test experiment-to-experiment positioning 
robustness. The system was programmed to pierce the same 
location as in the previous experiment for an additional 20 cycles. 
In this case, it was observed that the system showed a offset that 
created a new hole ~300 μm away from the original location. (C) 
Several objects scanned by the laser scanner, (D) the obtained point 
cloud data revealing the laser scanner’s precision in the x, y, z 
directions. 
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Figure D-4 (A) Digitized surface mesh for a coffee cup. The red dot indicates 
the selected sampling point. (B) Photo showing the needle probe 
contacting the sample surface. (C) Mass spectrum obtained for the 
material detached by the probe and injected into the OPSI. 
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Figure D-5 (A) Genuine artemether/lumefantrine antimalarial combination 
medicine blister pack being laser scanned. The relative abundances 
for artemether (m/z = 321, 619) (B) and various sugar-like 
compounds (m/z = 203, 205, and 365) (C) are plotted on the mesh 
surface. (D) Falsified antimalarial combination medicine blister 
pack being laser scanned, (E) and (F) show intensities for 
artemether (m/z = 321, 619) and various sugar ions (m/z = 203, 
205, and 365) ions. The corresponding survey mass spectra are 
shown in (G) and (H). 
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Figure D-6 (A) A hand that was sprayed with DEET holding a football. (B) 
Several locations on this football were analyzed by RoSA-MS. The 
summed peak area (m/z 192 + 214) for DEET ions was converted 
to a pseudo color scale for the specific coordinates sampled. The 
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dashed lines indicate the approximate boundary of the fingers when 
touching the football surface. (C) Full scan mass spectrum obtained 
from the coordinates where the thumb contacted the surface. 
Figure D-7 (A) A spot plate following a dry down condensation reaction 
involving amino acids and hydroxy acids to form mixed 
amide/ester-linked oligomers, known as depsipeptides. The surface 
of the wells was analyzed by RoSA-MS to detect product 
formation. The dashed line in the inset indicates the sampled 
transect. (B) Seven independent surface points were probed, and 
the abundances of the g′GAg′ depsipeptide, one of the reaction 
products, mapped on the mesh representation of the surface. (g′, 
glycolic acid; G, glycine; A, alanine.) (C) Surface abundance for 
leucine, one of the starting reagents. (D) Surface abundance ratio 
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SUMMARY 
The development of new chemical analysis tools and the assessment of current 
technologies help explore new realms of chemistry and ensure the quality of chemical 
products. Mass spectrometry is a powerful analytical tool that measures the mass-to-charge 
ratio of ionized analytes that can explore and ensure the quality of various chemistries. In 
Part 1 of this thesis, new tools were constructed for Vacuum-assisted Plasma Ionization 
(VaPI) for rapid ionization of analytes to measure aerosol chemistries and pyrolyzed 
polymers in real time. In Part 2 of this thesis, portable mass spectrometry was evaluated 
for the rapid screening of small molecule pharmaceuticals. Matrix assisted laser desorption 
ionization (MALDI) mass spectrometry was also developed to rapidly assess the quality of 
cellular therapies.  
Chapter 1 begins with introducing the major concepts behind ambient plasma 
ionization. The advantages and disadvantages of various plasma ionization sources are 
discussed. Many of the drawbacks found in these plasma ionizations sources include the 
loss of ions due to the fluid dynamics of the plasma stream. VaPI was developed to combat 
these fluid dynamic problems and later chapters in this thesis will build upon the plasma 
source for new applications. One of the major upgrades to the VaPI source was coupling it 
to an ion mobility mass spectrometer. The second part of Chapter 1 introduces the 
fundamentals of ion mobility spectrometry. Ion mobility offers an orthogonal separation 
technique to mass spectrometry based upon an ion’s collisional cross section that can help 
separate isomers. Finally, the third part of Chapter 1 discusses the current challenges 
combating poor quality pharmaceuticals. The problems small molecule medicines 
 xxv 
currently face and how they are applicable to new treatments such as cellular therapies are 
summarized.  
In Part 1 of this thesis, Chapter 2 developed VaPI into a real time analysis tool for 
aerosol chemistries known as aero-VaPI. The aero-VaPI source was developed to analyze 
pre-biotic aerosol chemistries. The VaPI source was coupled to two key technologies. First, 
the VaPI source was coupled in parallel to a scanning mobility particle size analyzer to 
measure the diameters of aerosols key to understanding their underlying chemistries. 
Second, the VaPI source was built to connect to the ambient pressure interface of the 
Waters Synapt G2s, an ion mobility mass spectrometer. The main benefit of aero-VaPI 
over other commercial aerosol analyzers is the soft ionization source that allows for the 
analysis of intact analytes and the capability to separate intact isomers with different ion 
mobilities.  The capabilities of aero-VaPI were demonstrated with lipids and aerosolized 
dry-down reactions to simulate pre-biotic chemistries. Simultaneous acquisition of the 
aerosol diameter, ion mobility, and m/z illustrates the breadth of chemical information that 
can be acquired in real time for pre-biotic aerosolized chemical reactions using aero-VaPI.  
Chapter 3 details the construction of a pyrolysis device for VaPI (pyro-VaPI) used 
for the analysis of pyrolyzed polymers. Mechanistic insight into pyrolyzed polymers can 
lead to better identifications and property understandings for polymers. Other pyrolysis 
mass spectrometers on the market either harshly fragments the ions with electron 
ionization, have additional sample preparations steps, or do not have the capability to 
conduct ion mobility separations. A home-built pyrolysis device that could pyrolyze 
samples as high as 900°C was constructed and coupled to the VaPI-Synapt G2s platform. 
The ability to regulate the pyrolysis device’s temperature controls the analyte’s volatilities 
 xxvi 
which can be measured orthogonally to the ion mobility and m/z information collected by 
the Synapt G2s. Nylons were used to evaluate pyro-VaPI as it is a common well-studied 
polymer.  Unique isobaric species of pyrolyzed nylons were discovered in the ion mobility 
region once a certain temperature was reached. The separated isobars were fragmented 
post-mobility to confirm the species were nylons. Each nylon isobaric ion mobility peak 
fragmented differently under the same collision energy suggesting different bond strengths. 
The combination of measurements in volatilities, collision cross section, and m/z show 
how new potential molecular interactions of pyrolyzed species can be discovered with 
pyro-VaPI.  
Part 2 of this thesis begins with Chapter 4 that evaluates 12 portable screening 
devices alongside each other for small molecule pharmaceutical screening in a controlled 
laboratory setting. Middle to low income nations with poor regulation face illicit or poorly 
manufactured pharmaceuticals. These poor quality pharmaceuticals can include medicines 
with no active pharmaceutical ingredient (API), the wrong API, or inadequate amounts of 
API. Portable screening tools can assist inspectors to find poor quality medicines; however, 
there is little literature for regulators comparing more than one device side by side. In this 
study, 12 devices ranging from a single use colorimetric assay, to Raman spectrometers, 
and to a portable mass spectrometer such as the Waters QDa were evaluated together. Each 
device tested as many simulated and field collected medicines as they were capable of. 
Advantages and disadvantages for each device were detailed including setup, required 
consumables, ease of use, and performance. Overall, all 12 devices could detect medicines 
with none or the wrong API. Medicines with the correct but reduced concentrations of API 
were more difficult to detect. Spectroscopy tools and single use disposable assays had low 
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sensitivities towards reduced API concentration medicines. Quantitative devices such as 
the QDa had higher sensitivities for reduced API concentration medicines, but reduced 
specificities.  Although the QDa had one of the highest sensitivities in the study, further 
refinement of the consumables and instrument are required for resource limited field 
deployment.  
Chapter 5 explores the use of MALDI for the rapid screening of cellular therapies.  
These cellular therapies such as stem cells are increasingly becoming popular as they offer 
revolutionary treatments in regenerative medicine. Due to their popularity, many of the 
poor quality problems that impact small molecule medicines are affecting cellular therapies 
such as poor quality or illicit products. Regulators need rapid screening tools for the pre- 
and post-market surveillance of cellular therapies. MALDI is already clinically approved 
to rapidly speciate bacteria. The high throughput capabilities, simple consumables, and 
simple protocols of MALDI are ideal as a rapid screening tool. To accelerate the MALDI 
pipeline towards cellular therapy screening, the Accelerated Screening for the Protection 
and Efficacy of Cellular Therapies (ASPECT) workflow was developed to rapidly process 
samples and receive an automated easy to read output for the end user. Custom scripts were 
written to rapidly extract and process the MALDI data. A MALDI target plate map at the 
end of the script would indicate to the end user which samples passed and failed. In a 
preliminary data set, untreated and ethanol incubated mesenchymal stromal cells were 
compared using lipid, metabolite, and lipid profiling.  Overall, lipid profiling had the most 
sensitivity towards disruption of the cellular membrane through ethanol incubation. 
Although protein and metabolite profiling had less sensitivity toward ethanol incubated 
cells, ASPECT may be improved with better algorithms in the script.  
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Chapter 6 summarizes the conclusions drawn from the main chapters of this thesis 
work, with the impact and possible future work also discussed. 
The Appendices describe various projects that were in parallel with this thesis 
work. Appendix A evaluates a microplasma ionization source for air and water monitoring 
on environments like the International Space Station (ISS). The power consumption, gas 
consumption, and ionization potential were compared between various gases and a 
commercial plasma ionization source. Overall, the microplasma source is very resource 
efficient compared to the commercial plasma source. Argon or nitrogen gas would have 
sufficient ionization potential and is renewable onboard the ISS compared to helium. 
Appendix B summarizes the collection of projects that evaluated screening devices for 
poor quality small molecule medicines. A literature review was conducted on 41 devices, 
of which 12 were selected for the laboratory phase described in Chapter 4. A selection of 
6 devices from the laboratory phase were evaluated by pharmacy inspectors in Laos to 
determine their usability and required training. The devices in the field phase were then 
cost analyzed to estimate expenses compared to their overall effectiveness. Finally, an 
article summarized the lessons learnt and future steps for the research collection.  
Appendix C evaluates coupling atmospheric drift tube ion mobility to an Orbitrap high 
resolution mass spectrometer. Various settings such as ion mobility gating schemes and 
Orbitrap parameters were assessed to achieve maximum mobility resolution and signal 
intensity. Isobaric peptides and sugar isomers were successfully resolved and confirmed 
through high-energy collision dissociation experiments. Finally, Appendix D describes the 
construction of a robotic sampling platform to acquire 3D data for mass spectrometry. The 
robot would probe a surface, record the location of the probe, move the probe to the 
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sampling interface of the mass spectrometer, and finally the mass spectrum of the adhered 
compounds on the probe would be recorded. 3D chemical maps were created for several 






The development of new chemical analysis tools and the assessment of current 
technologies can help rapidly explore new realms of chemistry and quickly ensure the 
quality of chemical products. This chapter is divided into three parts. The first part provides 
an overview of ambient plasma ionization mass spectrometry. Ambient plasma ionization 
directly ionizes samples without the need for complex solvents or matrices, a desired trait 
for rapid screening applications. The second part summarizes ion mobility, a tool in mass 
spectrometry that can help rapidly separate isomers in the gas phase on the millisecond 
time scale. Ion mobility provides valuable orthogonal collisional cross section data in mass 
spectrometry compared to measuring the m/z alone. Chapters 2 and 3 in this dissertation 
will combine ambient plasma ionization and ion mobility for mass spectrometry in aerosol 
and polymer analysis. The third part of this chapter introduces a brief overview of poor 
quality medicines. Since the dawn of modern medicine, pharmaceuticals have been 
falsified or poorly manufactured impacting the health of patients. Chapters 4 and 5 of this 
dissertation go in depth into the evaluation and development of tools for the rapid quality 
screening of small molecule pharmaceuticals and biopharmaceuticals. 
1.2 Principles of Ambient Plasma Ionization Mass Spectrometry  
In mass spectrometry, softly ionizing analytes is most desired. Soft ionization 
allows for the analysis of simplified spectra so additional experiments can be conducted on 
the intact precursor ions for further identification of the analyte. The two most widely used 
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sources for soft ionization include electrospray ionization (ESI) and matrix-assisted laser 
desorption ionization (MALDI) [1–3]. ESI, MALDI, and many of their derivatives require 
significant sample preparation or solvents. ESI requires the analytes to be dissolved in 
solution and MALDI requires samples to be mixed with a matrix and dried prior to 
ionization [4]. Ambient plasma ionization is a soft ionization technique with little to no 
sample preparation required that can also minimize solvent use. 
The earliest publication using a plasma to softly ionize samples for ambient 
pressure mass spectrometry was in 2005 with the Direct Analysis in Real Time (DART) 
source [5]. DART operates similarly to many other ambient plasma ionization sources later 
developed (Figure 1-1). First, the plasma is generated within DART by flowing a gas such 
as helium through a direct current point to plane electrical discharge. Metastables of the 
gases are created as they interact with the electrical discharge. As these metastables exit 
the ion source, they interact with the ambient atmosphere to create a variety of reactive ion 
species. One of the most widely known reactive ion species in helium plasmas emerge from 
the Penning ionization of water in the ambient atmosphere to create protonated water 
clusters shown in the scheme below. 
𝐻𝑒∗  +  𝑛𝐻2𝑂 →  𝐻𝑒 +  (𝑛𝐻2𝑂)𝑛−1𝐻
+  +  𝑂𝐻− 
𝑀 + (𝑛𝐻2𝑂)𝑛−1𝐻
+  → [𝑀 + 𝐻]+ + 𝑛𝐻2𝑂 
These protonated water clusters interact with and ionize the analyte before entering the 
mass spectrometer [6]. Other reactive ion species are created in helium plasmas as it 
interacts with the ambient atmosphere such as N2
+, but to a lesser extent [7].  Changing the 
plasma gas from helium to nitrogen also creates some [M+H]+ ions through nitrogen 
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metastable Penning ionization, but the generation of [M+NH4]
+  through the scheme below 
is generally more prevalent [8].  
𝑁2
∗ 𝑁∗⁄ + 𝑁𝐻3 →  𝑁2 𝑁 + 𝑁𝐻3
+ + 𝑒− ⁄  
𝑁𝐻3
+ + 𝐻2𝑂 →  𝐻𝑂
− + 𝑁𝐻4
+ 
𝑀 +  𝑁𝐻4





Figure 1-1 Diagram of how DART operates and protonates volatilized analytes in positive 
ion mode. Helium gas is fed through a glow discharge that creates metastable species. 
These metastables interact with the ambient atmosphere as they exit the DART source to 
create a variety of reactive ion species. One of the reactive ion species created are 




One aspect of ambient plasma ionization that allows for minimal sample 
preparations is the ability to desorb analytes with the plasma. Gases and volatile chemicals 
can be immediately introduced in front of the plasma stream for ionization. Solid or less 
volatile samples introduced into the plasma stream can be desorbed through various means. 
Ion sources like DART can heat the plasma stream to further volatize the analytes on the 
surfaces with no need to extract or dilute the analyte [9]. Placing the sample on an external 
heater can help further vaporize or thermally desorb samples into DART’s plasma stream 
[9–12]. Laser ablation has also been coupled to DART to ablate samples into the plasma 
stream without the need of a matrix layer compared to ambient pressure MALDI [13, 14].  
DART is a widely used commercial ion source for ambient plasma ionization, but 
many others are available with different configurations. Dielectric barrier discharge (DBD) 
plasma ion sources operate using an alternating current to create the plasma. The first DBD 
source reported for mass spectrometry used a microscope slide with the sample mounted 
to the surface of the slide as the dielectric barrier between two electrodes [15]. The low 
temperature plasma (LTP) probe is an example of a DBD plasma source that acts as a 
plasma gun similarly to DART. The LTP probe can operate at significantly lower 
temperatures than DART, making it possible to analyze more thermally labile molecules 
[16].  LTP’s construction is simple and small enough to be coupled to a backpack mass 
spectrometer [17]. DBD sources have also been configured to maximize the sensitivity for 
volatile samples by pulling the analytes into an enclosed junction with the plasma stream 
directly connected to the ambient pressure interface of the mass spectrometer [18]. Other 
variants of DBD ion sources also exist. The plasma-assisted desorption ionization source 
is a low temperature AC plasma probe without the use of a dielectric barrier [19]. If a 
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higher temperature and higher density plasma stream is required, microwave-induced 
plasma desorption/ionization is another DBD like source that can be utilized [20].  
As widely used as the previously mentioned ambient plasma ionization sources are, 
high resource requirements and low sensitivity reduce rapid screening applications. For 
DART and similar sources, the fluid dynamics of a high-volume gas flow can push analytes 
away from the inlet of the mass spectrometer reducing sensitivity [21]. The high plasma 
gas volume can also overwhelm the vacuum on the ambient pressure interface of the mass 
spectrometer. Modifications to the ambient pressure interface of the mass spectrometer 
such as the VAPUR™ gas ion separator tube can help remove the excess plasma gas, but 
may inadvertently pull analytes away reducing sensitivity [22]. Wasting plasma gas that 
does not ionize analytes increase resource requirements and reduces the portability of 
plasma sources. Helium is the most widely used ambient plasma ionization gas due to its 
high ionization potential, but it is a scarce resource that further reduces portability [23].  
Several efforts have been made to minimize the resource requirements for ambient 
plasma ionization to make them more appealing for rapid low resource screening 
applications. Switching from resource limited helium to more plentiful gases like pure 
nitrogen, pure argon, and doping gases like argon with hydrogen to boost ionization 
efficiency have been made [16, 24, 25].  To reduce electrical and gas consumption, 
miniaturizing the plasma source to the micron level diameter outlet with a micro hollow 
cathode discharge (MHCD) has been built [26]. To minimize the loss of analytes due to 
the fluid dynamic of the plasma stream, the vacuum assisted plasma ionization (VaPI) 
source was developed. VaPI is configured similarly to the previously mentioned DBD 
source optimized for volatile analysis [18]; however the VaPI has a much larger and more 
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modular sampling junction allowing for the coupling of other ablation techniques such as 
with a laser [27]. In this thesis, the capabilities and applications of VaPI will be further 
expanded for aerosol and polymer analysis when coupled to ion mobility in Chapters 2 & 
3. The MHCD source will also be evaluated as a more resource efficient plasma ionization 
source for the International Space Station in Appendix A.  
1.3 Principles of Ion Mobility Spectrometry 
In mass spectrometry, separating different classes of analytes prior to the mass 
analyzer allows for the acquisition of multidimensional data.  Gas chromatography (GC) 
and liquid chromatography (LC) are well established pre-ionization separation techniques. 
These chromatographic techniques separate analytes based on their affinity towards a 
stationary phase versus the gas or liquid mobile phase. Analytes with higher affinities 
towards the stationary phase remain longer and are detected in later mass spectral scans 
than analytes with low affinities. These elution times off the stationary phase are a second 
dimension to the analyte’s mass-to-charge that may be critical for the detection of isomers 
that are inseparable in the mass analyzer alone. Although widely used, GC and LC require 
considerable consumables such as solvents and stationary phase columns or capillaries. 
Chromatography separations of a single sample can take on the order of minutes as well 
[28–30]. Although techniques like ultra-performance liquid chromatography have helped 
improve throughput, large consumable requirements are not ideal for rapid screening 
applications [31]. Capillary electrophoresis (CE) is an alternative pre-ionization separation 
technique that can be faster and simpler than GC and LC. CE separates analytes based on 
their size and charge through a buffer solution with an applied voltage. Larger analytes 
with fewer charges travel slower in CE than smaller and more charged species. Although 
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basic CE does not require a stationary phase, it still requires solvents and capillaries that 
need replacement [32, 33]. 
Ion mobility offers rapid post-ionization separation of analytes in a fraction of the 
time it takes for traditional chromatography or CE. The measure of the mobility of ions 
through the ambient atmosphere began as early as 1906 [34], with a drift tube similar to 
that of modern configurations being developed in 1928 [35]. The basic configuration for 
drift tube ion mobility as shown in Figure 1-2 has minimally changed. First, a packet of 
ions is injected into the entrance of the drift cell. An electric field suspends the ions in the 
central axis of the drift cell and drives them towards the end where the detector is located. 
The drift cell is held at ambient or low gas pressures. As the ions travel through the drift 
cell, the analytes collide with neutral gases. Ions with more collisions travel slower in the 
drift cell. Isomers can be separated if their molecular arrangement changes the surface area 
of the molecule. Larger surface area molecules measured in terms of a collisional cross 
section encounter more collisions than smaller molecules and travel slower in the drift tube. 





Figure 1-2 Diagram of a standalone drift tube. As the Bradbury-Nielson ion gate opens 
and closes, the electric field gradient pushes a packet of ions through a reduced or ambient 
pressure drift cell. The ions collide with neutral gases in the drift cell. Ions with larger 
collisional cross sections collide with more drift gases and travel slower in the drift tube. 
As a result, ions are separated based on their collisional cross sections. At the end of the 
drift tube, the ion collides with a detector such as a Faraday plate. The change in time 
between the detection event and when the ion gate was opened is the ion’s drift time. The 
drift time is correlated to the ion’s collisional cross section. 
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To best describe the factors that contribute to an analyte’s ion mobility, one of the 










In this equation: K is the analyte’s ion mobility, µ is the reduced mass of the ion and neutral 
molecule mass, k is the Boltzmann constant, T is the gas temperature, Q is the charge, n is 
the density of drift gas molecules which is directly proportional to gas pressure, and Ω is 
the average collisional cross section. After an analyte’s mobility is measured, the 
collisional cross section can be calculated from the known conditions of the drift tube and 
be an identifier for the molecule [37].  
One of the simplest is a standalone drift tube described above with a Faraday plate 
as the detector (Figure 1-2). This standalone configuration is commonly used for portable 
explosives detection at security checkpoints such as airports [34]. Limited chemical 
information can be gathered with a standalone ion mobility spectrometer and analytes may 
be unresolved. Replacing the Faraday plate with a mass spectrometer can give orthogonal 
collisional cross section and mass to charge information about an analyte. The first reported 
ion mobility mass spectrometer was developed at Georgia Tech in 1962 by E.W. McDaniel 
[38]. Since then, many variants of ion mobility mass spectrometers have been developed 
and commercialized [39]. 
The Synapt series of mass spectrometers from Waters utilizes traveling wave ion 
mobility spectrometry (TWIMS) [40]. Unlike a traditional drift cell with a static electric 
field gradient, TWIMS pulses the voltages across the drift cell to create an electric field 
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wave from one end of the cell to the other. The ions are pushed by the electric field waves 
and collide with neutral gases in the reduced pressure drift cell. Smaller ions travel with 
the electric field wave better than larger ions that resists the wave’s force. This separates 
isomers with different collisional cross sections before entering the time of flight mass 
analyzer. Although having TWIMS at the center of the mass spectrometer lowers the 
possible mobility resolution due to gas pressure limits set by the other high vacuum 
chambers of the instrument, this configuration offers many other capabilities. The addition 
of a quadrupole mass filter before the TWIMS drift cell allows for isolation of a single 
mass to charge feature for further investigation. The Synapt can also fragment ions before 
or after ion mobility separations.  Pre-mobility fragmentation can help gather collisional 
cross section measurements about different fragments of the precursor ion. Post-mobility 
separations can help confirm if species with various drift times are arranged in different 
structures [41, 42].  
The capabilities of a TWIMS mass spectrometer can help gather rich datasets for 
rapid sampling platforms. Due to the difficulty of pre-ionization separation for ambient 
plasma sources, the addition of ion mobility can help gather additional orthogonal 
collisional cross section data to distinguish isomers. With the added capabilities of 
fragmenting ions before or after the mobility region, higher confidence identifications can 
be achieved compared to a mass analyzer alone. In chapters 2 and 3 of this thesis, I show 
how by combining the capabilities of TWIMS with VaPI one can provide rapid and 
sensitive data collection to discover new potential chemistries. 
1.4 Current Quality Problems with Pharmaceuticals 
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To maintain the safety and efficacy of pharmaceuticals, good manufacturing 
practices (GMP) dictate constant inspection of the ingredients and final product. GMP are 
empowered by thorough standardization and enforcement. Monographs established by 
agencies such as the United States Pharmacopeia ensure the accurate quality assessment of 
pharmaceuticals [43]. Enforcement agencies such as the Food and Drug Administration 
help police the market for poor quality medications created from poor GMP or illicit sales 
[44]. When the resources for these organizations are limited, patients face the chance of 
receiving poor quality medicines. These poor quality medicines can hurt patients by 
providing little to no treatment for their disease, creating distrust with the health system, 
and increasing anti-microbial resistance for anti-infectives with low active ingredient 
concentrations [45]. Low to middle income nations face the brunt of poor quality medicines 
due to the lack of resources available for standardized equipment and enforcement. Thirty 
percent of the world’s medicine regulatory authorities have no drug regulation or a capacity 
that hardly functions. As a result, The World Health Organization estimates that 1 in 10 
medicines is poor quality in low to middle income nations [46]. New portable and rapid 
screening tools are required to make GMP and market surveillance more feasible in 
resource-stricken nations.  
Market surveillance is a key tool to prevent the sale of poor quality medicines to 
patients. Pharmacy inspections help ensure proper storage and distribution of medicines; 
however, simple paperwork and visual inspections of the medicines may miss various poor 
quality medicines. Substandard medicines may contain low active ingredient 
concentrations that the human eye alone cannot distinguish. Illicit manufacturers can 
replicate key complicated packaging designs such as holographic stickers to elude simple 
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visual inspections. Sugar pills with acetaminophen have been sold by illicit manufacturers 
to even elude the patients themselves into thinking they are getting treated for the disease 
[47]. To compliment visual pharmacy inspections, many tools including mass spectrometry 
have been developed to detect poor quality medicines. Chapters 4 and Appendix B of this 
thesis details a multiphase international project to test out various portable technologies, 
including portable mass spectrometry, to assess the quality of small molecule medicines 
such as anti-biotics and anti-malarials.  Chapter 5 of this thesis explores using MALDI 
mass spectrometry for the rapid screening of poor quality cellular therapies, the next 
generation of pharmaceuticals. 
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 AEROSOL VACUUM-ASSISSTED PLASMA 
IONIZATION (AERO-VAPI) COUPLED TO ION MOBILITY-
MASS SPECTROMTRY 
Adapted with permission from: 
Blair, S.L., Ng, N.L., Zambrzycki, S.C., Li, A., Fernández, F.M.: Aerosol Vacuum-
Assisted Plasma Ionization (Aero-VaPI) Coupled to Ion Mobility-Mass Spectrometry. J. 
Am. Soc. Mass Spectrom. 29, 635–639 (2018). https://doi.org/10.1007/s13361-017-1872z.     
Copyright 2018 American Chemical Society. 
Blair S.L. optimized the aerosol generation and particle sizer. Zambrzycki S.C. built and 
optimized the VaPI source coupled to the mass spectrometer.  
2.1 Abstract 
 We report on the real-time analysis of organic aerosol particles by Vacuum-assisted 
Plasma Ionization-Mass Spectrometry (Aero-VaPI-MS) using a home-built VaPI ion 
source coupled to a Synapt G2-S HDMS ion mobility-mass spectrometry (IM-MS) system. 
Standards of organic molecules of interest in prebiotic chemistry were used to generate 
aerosols. Monocaprin and decanoic acid aerosol particles were successfully detected in 
both the positive and negative ion modes, respectively. A complex aerosol mixture of 
different sizes of polymers of L-malic acid was also examined through ion mobility (IM) 
separations, resulting in the detection of polymers of up to eight monomeric units. This 
noncommercial plasma ion source is proposed as a low-cost alternative to other plasma 
ionization platforms used for aerosol analysis, and a higher-performance alternative to 
more traditional aerosol mass spectrometers. VaPI provides robust online ionization of 
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organics in aerosols without extensive ion activation, with the coupling to IM-MS 




Few mass spectrometry (MS) platforms are available for aerosol particle analysis 
that have both high temporal and high mass resolution [1]. Current online analysis methods 
suffer from limitations such as insufficient peak capacity, limited mass accuracy, 
unpredictable adduct formation, extensive ion activation, and slow response [2–8]. 
Developing soft aerosol ion sources that can be coupled to most high resolution mass 
spectrometers would thus enable more robust molecular identification of organics from 
aerosol particles, yielding more easily interpretable insights into aerosol chemistry 
mechanisms and composition. 
One of the most commonly used mass spectrometers in the aerosol field is the high-
resolution time-of-flight aerosol mass spectrometer (aerosol HR-ToF-AMS) [3]. It utilizes 
electron ionization, yielding complex fragment mass spectra absent of molecular ions, 
hindering the ability to easily track intact species [1]. Later, a Filter Inlet for Gases and 
AEROsols (FIGAERO) was developed and coupled to a high-resolution time-of-flight 
chemical ionization-mass spectrometer (aerosol HRToF-CIMS) [6], which relies on filter 
collection of particles followed by thermodesorption prior to ionization. Because of the 
finite filter collection time, aerosol particle measurements with the FIGAERO-HRToF-
CIMS lack high temporal resolution, and are susceptible to on-filter reactions causing 
artifacts during sampling and measurement [9]. Ambient ionization techniques such as 
extractive electrospray ionization [8], direct analysis in real time (DART) [4], flowing 
atmospheric-pressure afterglow (FAPA) [2], and droplet assisted inlet ionization [5] have 
also been used for improving aerosol analysis. However, these MS techniques can still 
suffer from extraction efficiency limitations, ion suppression, incomplete aerosol sampling, 
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high background, or oxidation reactions. More recently, an aerosol flowing atmospheric-
pressure afterglow (AeroFAPA) ion source was developed to detect organic compounds in 
aerosols [10]. Also, Zenobi et al. developed a dielectric barrier discharge plasma technique 
[11] used for studying offline-vaporized liquid or solid samples [12], and for real-time 
breath analysis [13]. Further enhancements to aerosol MS analysis have been achieved 
through the coupling of MS to ion mobility (IM), enabling the separation of isobaric species 
in aerosol mixtures [14]. 
In this work, we present a home-built Vacuum-assisted Plasma Ionization (VaPI) ion 
source for aerosols (Aero-VaPI) coupled to a Waters Synapt G2-S HDMS Ion Mobility-
Mass Spectrometry (IM-MS) system. The Aero-VaPI ion source is an atmospheric pressure 
glow discharge plasma that is interconnected with the inlet of an IM-mass spectrometer. 
The vacuum pull from the mass spectrometer induces a Venturi effect at a sampling tee, 
enabling the capture and entrainment of the sample aerosol into the metastable atom 
population of the plasma before going into the mass spectrometer. This arrangement offers 
advantages such as a cost effective and simple assembly, efficient ionization, aerodynamic 
Venturi sample entrainment, and more straightforward molecular identification [15, 16]. 
The applicability of the Aero-VaPI-MS system to particle analysis in a prebiotic chemistry 
context is presented. 
2.3 Experimental 
2.3.1 Materials 
Chemical standards of monocaprin (1-monodecanoylglycerol) and decanoic acid 
(each ≥99%) were purchased from Sigma Aldrich, and L-malic acid (99%) from Chem-
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Impex International. Aerosol samples of monocaprin and decanoic acid were separately 
generated from aqueous and methanolic ~2 mM solutions with a TSI 3076 Constant Output 
Atomizer at 2 standard liters per minute (SLM) and measured with Aero-VaPI-MS in the 
positive and negative ion modes, respectively. Poly-L-malic acid was synthesized via 
heated dry-down reactions previously described by Forsythe et al. (2015) [17], without any 
purification. An L-malic acid-equivalent 0.50 mM solution of poly-L-malic acid was 
analyzed with ESI-IM-MS in the negative mode. A nebulizer (SLT8900H, Salter Labs® 
8900 Series Small Volume Jet Nebulizer from Medline Inc.) was used to generate aerosols 
at 6 SLM of the same poly-L-malic acid solution and was measured with Aero-VaPI-IM-
MS in the negative ion mode. The nebulizer offered an air jet of lower pressure (10 psi 
versus 34 psi of N2), producing a more stable signal for L-malic acid polymers during 
particle generation. Aerosols were not size-selected prior to mass spectrometry analysis. 
2.3.2 Instrumentation 
The Aero-VaPI ion source (Figure 2-1) consists of an enclosed system with an AC-
powered point-to-plane glow discharge operating at near atmospheric pressure that 
intersects an aerosol sample stream suctioned by a Venturi sampling tee. Ions are 
transferred from the Venturi sampling tee into a Synapt G2-S HDMS (Waters, IMS-TOF) 
mass spectrometer. The power is supplied by a high voltage plasma generator with a sine 
waveform (T&C Power Conversion Inc.; Model AG 0201-HV, Rochester, NY) with a 
frequency adjustment of 6.68 and a rf adjustment of 1.34. The discharge frequency and 
voltage were 370 kHz at 2.9 kV peak to peak, respectively. The VaPI source is mounted 
on a VAPUR DART interface that had its vacuum port blocked, serving only as a 
mechanical support for the source, but not providing additional pumping. Analytes within 
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aerosol particles are desorbed by collisions with heated plasma gas within the sampling tee 
and chemically-ionized through proton transfer reactions with reactive ion species 
generated by the plasma. The He (UHP300 Airgas) flow, AC power, and temperature of 
the VaPI sampling tee were optimized to 0.40 SLM in order to maximize the metastable 
population without putting too much strain on the turbo pumps, 10.0 W forward and 0 W 
reverse applied to a tungsten needle, and 40 °C, to achieve thermal equilibrium while 
maintaining the lowest temperature possible to minimize fragmentation and potential z 
reactions, respectively. The electrode gap from the point of the tungsten tip to the inside of 
the grounded sampling tee (where the metal is first exposed) is 3 cm. Flows were measured 
with an Allicat Scientific mass flow meter (M-5SLPM-D, Tucson, AZ). The Venturi 
sampling tee was heated by heating tape (BriskHeat heating cord Model HTC451006) that 




Figure 2-1 Cross-sectional view of the home-built Aero-VaPI ion source coupled to 
IM-MS via a VAPUR® interface that had its side vacuum port blocked, serving only 
as a mechanical adapter. 
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2.4 Results and Discussion 
Our interest in aerosols stems from our research in the prebiotic de novo synthesis of 
proto-biopolymers in an origins of life scenario. It has been shown that aerosols can act as 
chemical reactors in the prebiotic formation of such polymeric species [18–21]. Dobson et 
al., for example, have proposed that by their ability to concentrate molecules, aerosols 
could have served as efficient prebiotic chemical reactors for the first protocelullar 
structures [19]. Condensation reactions are important in prebiotic chemistry, and include 
formation of lipids [18] and far-from-equilibrium polymers [22]. These reactions can be 
favored in aerosols, where water loss is driven by evaporation. Trainer et al. have 
hypothesized that organic species that have functionalities of interest to prebiotic chemistry 
are more likely to exist in the aerosol phase [23]. Previous studies have focused on amino 
acid or tholin formation [24, 25], but only few have investigated the molecular composition 
of products generated via aerosols [26]. 
As a first experiment, Aero-VaPI-MS was tested for aerosol composition 
determination in the positive and negative modes with monocaprin and decanoic acid 
aerosols (Figures 2-2 A & B), respectively. Bulk condensation reactions of glycerol and 
decanoic acid to form monocaprin have been studied by Apel and Deamer as a route for 
the production of a more evolved amphiphile leading to proto-cellular membranous 
structures [18]. In the positive mode monocaprin was detected as the [M + H]+, as well as 
[M – H2O + H]
+ resulting from protonation-induced water loss (Figure 2-2 C). The 
deprotonated ion of decanoic acid, [M – H]-, was observed in the negative mode, as seen 
in Figure 2-2 D. In these experiments, the atomizer was sequentially turned on and off to 
verify that signal returned to baseline following introduction of the analyte. The rise time 
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of the signals for these aerosols was a function of the aerosol equilibration time in the 
tubing lines. It is expected that during application of this instrumentation to an aerosol 
reaction system, lines would be equilibrated at the start of the experiment and would 
continuously sample from the aerosol system, so no subsequent re-equilibration would be 
needed. It was observed that the signal dipped slightly below the original baseline 
following each injection event, likely due to a temporary pressure imbalance. Once the 







Figure 2-2 Relative mass-weighted particle size distributions for (A) 2 mM 
methanolic solution of monocaprin and (B) 2 mM aqueous solution of decanoic acid. 
Aero-VaPI-MS signals for aerosol particles consisting of (C) monocaprin in (+)-
mode; [M – H2O + H]
+ monitored at m/z 229, from protonation-induced water loss 
(D) decanoic acid in (–)-mode; [M – H]- monitored at m/z 171 
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Another molecule of interest in prebiotic chemistry is malic acid, being part of both 
the Calvin and citric acid cycles. Mamajanov et al. have studied the esterification of malic 
acid under wet/dry batch cycling conditions, proposing a ratcheting mechanism for the 
formation of far-from-equilibrium polymers [22]. Malic acid has also been proposed as an 
intermediate in the formation of proto-peptides [27]. Here, we used poly-L-malic acid 
aerosol as a test for Aero-VaPI-MS detection of products of prebiotic condensation 
polymerization reactions in aerosols. To this purpose, a solution of poly-L-malic acid was 
first analyzed by electrospray (ESI) IM-MS (Figure 2-3 A & B). All oligomers were well 
separated with IM and detected within a drift time of 8 ms. The average ESI IM-MS mass 
spectrum (Figure 2-3 A) showed [M – H]- ions for oligomers with chain lengths ranging 
from 1 to 8, together with their corresponding water loss (∆m/z = 18) species. The single 
water loss ion species, denoted as [Mˊ – H]-, contributed significantly to the total ion count, 
as seen in the ion mobility arrival time distribution (Figure 2-3 B). These neutral water 
losses are common in ESI-MS of acids, occurring by alcohol dehydration or cyclic 
anhydride formation between adjacent carboxyl groups [28]. 
Aero-VaPI-IM-MS spectral data for poly-L-malic acid aerosols (Figure 2-3 C & D) 
were very similar to that obtained by ESI IM-MS, with the interesting difference that the 
water loss signals were much less abundant than with ESI. It was necessary to multiply the 
[Mˊ – H]- ion signals by a factor of 10 in order to better observe their IM distribution 




Figure 2-3  Negative ion mode of poly-L-
malic acid (A) ESI IM-MS averaged mass 
spectrum, (B) ESI IM-MS ion mobility 
arrival time distribution, (C) Aero-VaPI IM-
MS averaged mass spectrum and (D) Aero-
VaPI IM-MS ion mobility arrival time 
distribution. Oligomer [M-H]- (solid circles) 
and [M’-H]- (open circles) signals are 
denoted by markers colored by the number of 
monomer units. The ion mobility arrival time 
distribution signals are colored similarly. (E) 
Poly-L-malic acid aerosol relative mass-
weighted particle size distribution. Particles 
were generated from a 0.5 mM aqueous 
solution of poly-L-malic acid.  
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Oligomers did not represent the majority of the total ion signal in some drift time 
regions, such as the region between 1–2 ms and the shoulder at 5.5 ms. The first arrival 
time distribution region (1–2 ms) was broad and populated mostly by small ions such as 
water loss ions C4H1O3- and C4H3O4- at m/z 97 and 115, which may be dehydrated forms 
of malic acid such as maleic anhydride and maleic acid, respectively (Figure 2-4). Oxidized 
species possibly arising from these ions, such as C4H5O6-, C4H6O6-, C4H5O7-, and 
C4H7O8-, were also observed with corresponding m/z values of 149, 150, 165, and 183. 
The presence of these smaller ionic species suggests that oligomer ion-molecule reactions 
do occur within the Aero-VaPI source due to the higher reactivity of plasma sources 
relative to ESI [29]. VaPI plasma ionization is expected to have an abundance of high 
energy charge transfer species, as there is no grid electrode to filter them out from the 
plasma, as in DART [30]. Further experiments are required to investigate these and other 





Figure 2-4 Negative ion mode Aero-VaPI-IM-MS ion mobility arrival time 
distribution  in the 1-2 ms time range for a poly-L-malic acid aerosol. Particles 
were generated from a 0.5 mM aqueous solution of poly-L-malic acid. Observed 
fragment and oxidized species ions are plotted by color and line style with m/z of 
each ion listed in the legend. Unidentified peaks are labeled as “UN”. 
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2.5 Conclusions 
The Aero-VaPI ion source is cost effective, has minimal assembly, provides softer 
ionization than with standard aerosol mass spectrometers, and, when coupled to IM-MS, 
can rapidly separate species in aerosol mixtures for the molecular detection of organic 
analytes in particles. Although organics may undergo a small amount of activation in the 
VaPI source, no sample handling is required with the Aero-VaPI-MS system, avoiding 
solvent-dependent extraction efficiency limitations. Initial results suggest that this 
technique can be applied to monitor aerosol chemistry in real-time, including prebiotic 
condensation reactions. Future studies of new prebiotic aerosol chemistry with Aero-VaPI-
MS are expected to provide insight into the mechanisms of de novo proto-biopolymer 
formation. 
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 PYROLYSIS VACUUM-ASSISTED PLASMA 
IONIZATION (PYRO-VAPI) ION MOBILITY-MASS 
SPECTROMETRY FOR INSOLUBLE POLYMER ANALYSIS  
Adapted with permission from: 
Zambrzycki, S., Bernier, M., Bradshaw, J., Fernandez, F.: Pyrolysis Vacuum-Assisted 
Plasma Ionization Ion Mobility–Mass Spectrometry for Insoluble Polymer Analysis. J. 
Am. Soc. Mass Spectrom. 32, 1388–1392 (2021). https://doi.org/10.1021/jasms.1c00109 
3.1 Abstract 
This work describes a new thermal desorption/pyrolysis vacuum-assisted plasma 
ionization (pyro-VaPI) ion source coupled to ion mobility-mass spectrometry (IM-MS) for 
insoluble polymer analysis. Pyro-VaPI combines a pyrolysis device, soft ambient plasma 
ionization, IM, and MS into a single platform for polymer analysis with minimal sample 
preparation. Nylons, a widely used and well-studied thermoplastic, were chosen to evaluate 
pyro-VaPI performance. Six different nylon polymers were studied and characterized. 
With the application of IM-MS, two different isobars for the protonated cyclic dimers of 
6-6, 6-9, 6-10, and 6-12 nylon and two isobars for the cyclic tetramer of nylon 6 were 
detected at 200 °C. These isobars were observed at different heating times, with the species 
drifting faster in the IM cell appearing several minutes after the slower drifting species. To 
the best of our knowledge, these isobaric dimers and tetramers have not been previously 
reported, indicating pyro-VaPI IM-MS is a useful tool for the structural characterization of 
heated or pyrolyzed polymers. 
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3.2 Introduction 
Thermoplastics, such as nylons, play an integral role in many commonly used fibers, 
films and structural components due to their high strength and malleability when heated. 
Chemically-resistant thermoplastics offer enhanced durability in harsh conditions, but 
limited solubility can make their mass spectrometric analysis challenging. Correct 
identification of insoluble polymers, however, is critical for forensics investigations 
attempting to link evidence sources [1]. Mechanistic insights into thermal degradation of 
insoluble polymers can also be useful for developing new materials such as non-
halogenated anti-flammable polymers [2]. 
Pyrolysis gas chromatography-mass spectrometry (Py-GC-MS) is well-established 
for characterizing insoluble polymers, as it does not require sample dissolution [3]. 
However, the use of electron ionization in Py-GC-MS produces complicated spectra, thus 
requiring GC separations and appropriate databases. The use of chemical ionization (CI) 
instead of EI somewhat simplifies mass spectra, and can even eliminate the need for GC 
[4, 5]. Electrospray ionization is softer than CI, but has been generally limited to 
contaminants or extractable dyes without breaking down polymers chemically [6, 7]. 
Matrix-assisted laser desorption ionization (MALDI) can analyze insoluble polymers 
without dissolution, but requires crushing the analyte together with the matrix in a highly 
homogeneous fashion [8, 9]. 
As alternatives to ESI and MALDI, a variety of ambient plasma ionization sources 
have been developed [10]. The atmospheric solids analysis probe (ASAP) is the most 
notable example for insoluble polymer analysis. In ASAP, a stream of heated nitrogen gas 
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is flowed over the sample to vaporize it into a corona discharge for atmospheric pressure 
CI [11], followed by MS or ion mobility mass spectrometry (IM-MS) analysis. Although 
many reports of polymer analysis with ASAP exist, they require the sample to be melted 
and re-solidified onto the probe, which may lead to unwanted changes [12–15]. The 
coupling of a thermal desorption cell such as in the ionRocket to direct analysis in real-
time (DART) is an alternative to avoid the melting and re-solidifying steps required in 
ASAP [16, 17]. In this approach, the polymer sample is loaded into the ionRocket cup, the 
cup is heated, the analyte vapors merge with the DART plasma stream for ionization, and 
the ionized compounds are transported into the inlet of a mass spectrometer for analysis 
[18, 19]. Both ASAP and ionRocket/DART can conduct thermal gradient experiments that 
separate species with different volatilities.  
In this communication, we describe a new platform that combines a home-built 
thermal desorption/pyrolysis unit with a vacuum-assisted plasma ionization ion source [20, 
21], and IM-MS detection (Pyro-VaPI IM-MS). This technique offers a highly modular 
design that boosts sensitivity by enhanced sample plume entrainment compared to open air 
approaches such as DART. Pyro-VaPI enjoys the IM-MS capabilities of ASAP 
experiments and the simplicity of sample preparation of ionRocket/DART. Nylons were 
used to characterize pyro-VaPI performance as they are very common, well-studied 




Nylon polymers were sourced from the Nylon Polymer Kit (Cat# 2054) by 
Scientific Polymer Products Inc. (Ontario, NY). The following nylon polymers were tested: 
nylon 6 poly(caprolactam), nylon 6-6 poly(hexamethylene adipamide), nylon 6-9 
poly(hexamethylene azelamide), nylon 6-10 poly(hexamethylene sebacamide), nylon 6-12 
poly(hexamethylene dodecanediamide), nylon 11 poly(undecanoamide), and nylon 12 
poly(laurolactam).  
3.3.2 Pyrolysis/Heating Unit 
A pyrolysis device that reached temperatures up to 900°C and currents of 5.5 A 
without failure was built. For polymer pyro-VaPI analysis, an intact single plastic pellet 
was placed into a stainless-steel cup, and the power supply was ramped to 200°C (2.5 A).  
3.3.3 Instrumentation 
A schematic of the pyro-VaPI IM-MS platform is shown in Figure 3-1. The VaPI 
system was coupled to a Waters Synapt G2-S IM-MS platform (Milford, MA). Manual 
controls were disabled for the traveling wave IM portion and the following parameters 
were utilized: wave height 40.0 V, wave velocity 650 m s-1, gas flow 90.00 mL min-1, and 
pressure 3.15 mbar. Briefly, a VaPI source was modified to connect to an IonSense 
VAPUR interface for Waters instruments (Saugus, MA) [21]. The gas used for sustaining 
the VaPI plasma was ultra-high purity helium from Airgas (Atlanta, GA). The He flow rate 
was set at 0.4 L min-1, measured by an Alicat Scientific model M-5SLPM-D mass flow 
meter (Tucson, AZ). The plasma was created by a tungsten needle powered with a T&C 
Power Conversion Inc. model AG 0201-HV radio frequency high voltage generator 
(Rochester, NY). For plasma ignition, the radio frequency generator was set to a power of 
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10 W and frequency of 370 kHz, resulting in a peak to peak voltage of 2.9 kV.  All samples 
were tested in positive ion mode in the 200 to 1200 m/z range. A polytetrafluoroethylene 
(PTFE) tube extended from the VaPI ion source and hovered at about 1 cm over the 
pyrolysis device cup, which was placed in a fume hood. This tube was cleaned with acetone 
after each experiment to avoid cross-talk between sample runs. The sampling tee 
connecting the VaPI plasma chamber with the sampling tube from the pyrolysis unit was 
held at 200 °C using a BriskHeat heating cord and controller, models HTC451006 and 




Figure 3-1 Diagram of the pyro-VaPI IM-MS platform 
(not to scale). The pyrolysis unit was placed in a fume 
hood together with the heating power supply unit to 
minimize fire hazards and to prevent fumes from the 
pyrolysis experiments from reaching the user. A PTFE 
tube extended from the pyrolysis unit to the VaPI ion 
source, which was directly connected to a Waters Synapt 
G2-S ion mobility-mass spectrometer via the IonSense 
VAPUR interface. 
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3.4 Results and Discussion 
Pyro-VaPI IM-MS analysis of various common nylons showed ions with m/z 
corresponding to that of a cyclized monomer unit (Figure 3-2 A). Ions with m/z values 
corresponding to the cyclic ion resulting from two linked repeat units were also readily 
observed (Figure 3-2 B), with alternating polymers such as nylon 6-6, 6-9, 6-10, and 6-12 
showing two isobaric species with different IM arrival times.  Nylons 6, 6-6, 11, & 12, 
produced ions that matched the elemental formula of the cyclic trimers (Figures 3-2 C). 
Nylons 6 & 11 were the only nylons that yielded detectable gas phase species matching the 
cyclic tetramers, and two isobaric species of the cyclic tetramer of nylon 6 were also 





Figure 3-2 Extracted arrival time distributions for various pyrolyzed nylon polymers 
matching the (A) cyclic monomer ions with m/z 114.09, 184.17, 198.19, 227.18, 269.22, 
283.24, and 311.27 for nylon 6, nylon 11, nylon 12, nylon 6-6, nylon 6-9, nylon 6-10, 
and nylon 6-12, respectively; (B) cyclic dimer ions with m/z 227.18, 367.33, 395.36, 
453.34, 537.44, 565.47,and 621.53 for nylon 6, nylon 11, nylon 12, nylon 6-6, nylon 6-
9, nylon 6-10, and nylon 6-12, respectively; (C) cyclic trimer ions with m/z 340.26, 
550.49, 592.54, and 679.51 for nylon 6, nylon 11, nylon 12, and nylon 6-6, respectively; 
and (D) cyclic tetramer ions with m/z 453.34 and 733.66 for nylon 6 and nylon 11, 
respectively. 
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The identity of the two mobility-resolved cyclic species originating from the cyclic 
tetramer of nylon 6 and cyclic dimer of nylons 6-6, 6-9, 6-10, and 6-12 was confirmed by 
tandem MS experiments. The precursor ions for these species were mass selected in the 
IM-MS quadrupole mass analyzer, ion mobility-separated, and then fragmented post-
mobility in the transfer cell. An example of results for these experiments is shown in 
Figures 3-3 for nylon 6-6, confirming that both mobility peaks observed resulted from 




Figure 3-3 Pyro-VaPI analysis of nylon 6-6 (polyhexamethylene adipamide). 
(A) Extracted drift time for the cyclic dimer at m/z 453.36 showing potentially 
two different isomers/conformers of nylon 6-6. These species were fragmented 
in the transfer cell (post-mobility) at 13 eV collision energy. The MS/MS 
spectra for the fragmented cyclic dimer species at (B) 4.24 ms and (C) 4.67 ms 
peak are presented. M refers to a repeat unit of nylon 6-6 in the cyclic species. 
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In these experiments, we also observed that each of the two distinct IM features 
showed unique fragment ion abundances in their mobility-resolved MS/MS spectra. For 
the cyclic tetramer of nylon 6 and cyclic dimer of nylons 6-6, 6-9, 6-10, and 6-12, the 
shorter drift time species showed the highest abundance of the precursor ion. Conversely, 
the species with the longer drift time systematically showed the highest abundance for the 
smaller unit species upon fragmentation (Figures 3-3 B-C). The difference in drift time and 
fragmentation ion abundance in the two distinct IM features are likely due to the formation 
of different pyrolyzed nylons.  
Examination of the IM arrival times for isobaric species of some of the investigated 
nylons showed that they were not resolvable in the ion mobility domain.  For example, the 
cyclic species formed by a cyclic monomer of nylon 6-6 had a drift time of 2.28 ms (Figure 
3-2 A). This species is isomeric with the cyclic dimer unit species of nylon 6 that had a 
drift time of 2.33 ms (Figure 3-2 B). A similar effect was observed between the cyclic 
dimer species of nylon 6-6 (4.34 ms, Figure 3-2 B) and the cyclic tetramer species of nylon 
6 (4.23 ms, Figure 3-2 D). The lack of resolution between these species was disappointing 
but not completely unexpected due to the high structural similarity of the ions generated 
by pyrolysis, despite originating from different nylon polymers. 
Next, it was investigated if the pyrolysis data contained any temperature-dependent 
trends in the arrival time distributions for nylons 6, 6-6, 6-9, 6-10, & 6-12. To this end, the 
experimental pyrolysis time, IM drift time, and feature abundance were plotted along 
various dimensions using DriftScope. Figure 3-4 shows some of the results of such 
analysis, indicating that the faster drifting species for nylon 6-6 did not appear until ~4 
minutes into the pyrolysis process, which corresponded to a pyrolysis temperature 50 °C 
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hotter than for the slower drifting species. Similarly, faster drifting species were also 
detected for nylons 6, 6-9, 6-10, & 6-12 starting after ~4, ~4, ~2, and ~6 minutes into the 
pyrolysis process, respectively. This finding suggests that the faster-mobility species were 
not generated until the higher temperature was reached, or that they did not form until 
extended heating was applied to the sample. Sub-minute oscillations were seen in the 
DriftScope data in Figure 3-4 B. These oscillations are the likely result of the melted nylon 
bubbling during heating, releasing pyrolyzed nylon species after each bubble collapsed on 
the surface of the melted plastic. Overall, the multidimensional data presented in Figure 3-
4 illustrates the power of combining information gathered from the thermal 
desorption/pyrolysis unit in real time with the ion mobility-mass spectral data collection. 
This generates a dataset with comprehensive chemical information that enables improved 




Figure 3-4 Investigation of pyro-VaPI ion abundances for nylon 6-6 (polyhexamethylene 
adipamide) at various time-points of a temperature gradient. (A) The cumulative arrival 
time distribution, the arrival time distribution between 2 and 4 minutes of the temperature 
gradient, and the arrival time distribution between 12 and 14 minutes of the gradient for 
the cyclic dimer ion extracted at m/z 453.36 showing two different species for nylon 6-6. 
(B) IM drift time vs. temperature gradient time for m/z 453.36. The intensity was log 
scaled. The minimum intensity threshold was set at 54 %. (C) Temperature profile of the 
shallow cup pyrolysis experiment measured with a thermocouple. 
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3.5 Conclusions 
We have coupled a pyrolysis device to a VaPI ion source to combine the capabilities 
of thermal desorption/pyrolysis, soft ambient plasma ionization, ion mobility, and MS/MS 
into one platform. In addition, we have discovered unique isobaric species that nylons 6, 
6-6, 6-9, 6-10, and 6-12 can release once a certain pyrolysis temperature is reached. With 
pyro-VaPI, improved identification and new potential mechanistic discoveries of 
pyrolyzed polymer molecular interactions can be achieved by combining the information 
gathered from volatilities, collisional cross sections, and m/z values.  
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4.1 Abstract 
4.1.1 Background: 
 Post-market surveillance is a key regulatory function to prevent substandard and 
falsified (SF) medicines from being consumed by patients. Field deployable technologies 
offer the potential for rapid objective screening for SF medicines. 
4.1.2 Methods and Findings: 
 We evaluated twelve devices: three near infrared spectrometers (MicroPHAZIR 
RX, NIR-S-G1, Neospectra 2.5), two Raman spectrometers (Progeny, TruScan RM), one 
mid-infrared spectrometer (4500a), one disposable colorimetric assay (Paper Analytical 
Devices, PAD), one disposable immunoassay (Rapid Diagnostic Test, RDT), one portable 
liquid chromatograph (C-Vue), one microfluidic system (PharmaChk), one mass 
spectrometer (QDa), and one thin layer chromatography kit (GPHF-Minilab). Each device 
was tested with a series of field collected medicines (FCM) along with simulated medicines 
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(SIM) formulated in a laboratory. The FCM and SIM ranged from samples with good 
quality active pharmaceutical ingredient (API) concentrations, reduced concentrations of 
API (80% and 50% of the API), no API, and the wrong API. All the devices had high 
sensitivities (91.5 to 100.0%) detecting medicines with no API or the wrong API. However, 
the sensitivities of each device towards samples with 50% and 80% API varied greatly, 
from 0% to 100%. The infrared and Raman spectrometers had variable sensitivities for 
detecting samples with 50% and 80% API (from 5.6% to 50.0%). The devices with the 
ability to quantitate API (C-Vue, PharmaChk, QDa) had sensitivities ranging from 91.7 % 
to 100 % to detect all poor quality samples. The specificity was lower for the quantitative 
C-Vue, PharmaChk, & QDa (50.0% to 91.7%) than for all the other devices in this study 
(95.5% to 100%). 
4.1.3 Conclusions: 
The twelve devices evaluated could detect medicines with the wrong or none of the APIs, 
consistent with falsified medicines, with high accuracy. However, API quantitation to 
detect formulations similar to those commonly found in substandards proved more 
difficult, requiring further technological innovation. 
4.2 Introduction 
Poor quality medicines are classified by the World Health Organization (WHO) as 
substandard or falsified (SF)[1]. Falsified medicines purport to be real, authorized 
medicines, but they ‘deliberately/fraudulently misrepresent their identity, composition or 
source'[1]. Falsified medicines are the result of criminal activity and usually have 
packaging that is a copy of a genuine product. They may contain the incorrect amount of 
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the correct active pharmaceutical ingredient (API), wrong API(s), or more commonly, no 
API at all. Substandard medicines are those authorized medical products ‘that fail to meet 
either their quality standards or their specifications, or both’ [1]. They negate the benefits 
of modern medicines, failed treatments, increased antimicrobial resistance, and distrust in 
the health system [2]. 
The recent expansion of the diversity of portable devices for medicine quality 
screening holds great hope for empowering inspectors in the field, making their work more 
cost-effective and actionable, improving MRA capacity, and protecting patients from the 
harms of SF medicines. However, significant knowledge gaps exist regarding the optimal 
choice of device, or combination of devices. These gaps impede decisions on how to best 
use these portable devices [3, 4]. 
We undertook a multi-phase collaborative project to evaluate diverse devices for 
SF medicine detection, producing key information required for deciding which of these 
technologies may be the most appropriate for field medicine quality screening. In this study 
we present the results for the evaluation of 12 portable screening technologies for 
distinguishing between genuine good quality, 50% and 80% API medicines (mimicking 
substandard medicines), and 0% and wrong API medicines (mimicking falsified products) 
under controlled laboratory conditions. We close with suggestions of which devices were 




 Following a detailed literature review [5] and further discussions with experts, 
twelve devices were chosen for evaluation (Table 1). These included single-use Paper 
Analytical Devices (PAD), Rapid Diagnostic Tests (RDT), a portable liquid 
chromatograph, a single quadrupole benchtop mass spectrometer, the PharmaChk 
microfluidic device, an attenuated total reflectance mid-IR (MIR) spectrometer, three 
different near-infrared (NIR) spectrometers, two Raman spectrometers, and the Minilab 
thin layer chromatography kit.  
These 12 devices were chosen to represent a variety of different technologies within 
the project’s budget and time constraints. The ideal device should be portable, battery 
powered, durable, and require minimal training, consumables, sample preparation, and test 
the APIs included in this study. The two Raman spectrometers (TruScan RM and Progeny) 
were chosen for their different laser excitation sources. The infrared spectrometers (4500a, 
MicroPHAZIR RX, Neospectra 2.5, NIR-S-G1) were selected because they each had 
different testing modalities along with sampling in different infrared spectral ranges. The 
remaining devices were selected because they are representative of key technologies used 
in the screening of small molecule medicines.  
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Table 4-1 List of instruments and devices evaluated, including their underlying technology and basic instrument specifications. 
Technology Device Name (Manufacturer) Basic Instrument Specifications APIs Tested 
Market Status at the 
Time of this Study 
Colorimetric 
Assay 
Paper Analytical Devices (PAD, 
Notre Dame University). 
12 colorimetric chemical tests on a 
single-use paper card. 
A, AZITH, P, 





Rapid Diagnostic Tests, (RDT, China Agricultural 
University of Beijing and University of 
Pennsylvania). 
Single-use disposable dipsticks, 
concentration specific. 
Artemether, 






Mercury lamp (≈254 nm) detector; 
Millipore Chromolith 
RP18e 25 x 4.6 mm column. 






Selected ion monitoring mode per 
API; flow injection analysis. 
All Marketed [13] 
Microfluidics PharmaChk (Boston University). 
Luminescence detection, 






4500a FTIR Single Reflection† (Agilent) 
Attenuated Total Reflectance. 
Spectral range: 2,500-15,384 nm. 
All Marketed [15] 
Near-Infrared 
Spectroscopy 
NeoSpectra 2.5* (Si-Ware). Spectral range: 1,350-2,500 nm. All Marketed [16] 
MicroPHAZIR RX*† (Thermo Fisher Scientific). Spectral range: 1,600-2,400 nm. All Marketed [17] 




Excitation Laser: 1,064 nm, 
Spectral range 200-2,500 cm-1. 
All Marketed [20] 
TruScan RM*† (Thermo Fisher Scientific). 
Excitation Laser: 785 nm, 
Spectral range 250-2,875 cm-1. 
All Marketed [21] 
Thin Layer 
Chromatography 
Minilab‡ (Global Pharma Health Fund E.V.). 
Detection by chemical staining and 
UV light exposure. 
All Marketed [22] 
A: Amoxicillin; API, Active pharmaceutical ingredient; ART: Artesunate; AZITH: Azithromycin; CA: Clavulanic Acid; DHA: Dihydroartemisinin; FTIR: Fourier Transform Infrared, OLFO: Ofloxacin; 
P: Piperaquine; SM: Sulfamethoxazole; TM: Trimethoprim.   
*Instrument/device could also scan samples through transparent packaging. 
†Automatic spectral reference library comparison capabilities. 
‡Only TLC portion of the Minilab was used in this study, but not the dissolution and weighing tests. 
°Also referred to in this study as, “NIRscan”, the beta version used in this study 
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4.3.2 Samples: 
 Antibiotic and antimalarial formulations represent a majority of the total number of 
SF medicines reported to the WHO Global Surveillance and Monitoring System between 
2013-2017 [23]. Seven key antibiotics and antimalarials used in South-East Asia were 
chosen for device evaluation: AL=Artemether-Lumefantrine; ART=Artesunate; 
AZITH=Azithromycin; ACA= Amoxicillin-Clavulanic Acid; DHAP=Dihydroartemisinin-
Piperaquine; OLFO=Ofloxacin; and SMTM=Sulfamethoxazole-Trimethoprim. 
Field-collected medicines (FCM) and simulated medicines (SIM) were used to test 
the devices. FCM included good quality, falsified, and “look-alike” medicines. All FCM 
samples were tested with ultra-performance liquid chromatography (UPLC) or mass 
spectrometry (MS) to ensure quality. Good quality FCM were purchased from reliable 
wholesalers in the Greater Mekong Sub-Region or donated by manufacturers. Falsified 
FCM were collected during  earlier studies (see [24] and references therein). Look-alike 
FCM were visually indistinguishable from genuine medicines, and contained APIs not 
evaluated in this study [25]. Five brands of FCM were sold in transparent packaging such 
as clear plastic blister packs or clear glass vials. Five devices tested claimed to be capable 
of performing nondestructive testing through transparent barriers (Table 1). Whenever 
feasible, FCM were also evaluated while sealed in their original packaging. Field-collected 
parenteral artesunate (Artesun) powder was removed from the vial and transferred to a 
plastic re-sealable bag for testing with Raman instruments because the powder was too 
dispersed in the original vial for one of the spectrometers to yield a stable signal and a 
consistent result. Device operators were not blinded to the identity of the samples being 
tested. 
 60 
 Most portable devices are only stated as able to check the presence/absence of the 
API or whole formulation spectra. Therefore, we did not examine dissolution rates, 
homogeneity of the API distribution within tablets, or tablet coating thicknesses. SIM were 
produced in the laboratory to mimic good quality, 80% and 50% API concentration tablets, 
mimicking substandard medicines, and no API and wrong API tablets, mimicking falsified 
medicines. All SIM were prepared as 100 mg 6 mm-diameter tablets, except for ART 
which was tested as a loose powder to simulate Artesun. ART, AZITH, OLFO, and SMTM 
powders (>98% purity) were purchased from TCI Chemical (Portland, OR). The simulated 
ACA, AL, and DHAP medicines, were produced from good quality FCM (AMK 1000 mg 
for ACA, Coartem for AL, and D-Artepp for DHAP) that were crushed, mixed, and re-
pressed into SIM tablets. The excipients included cellulose, lactose, or starch as the bulking 
agents, and magnesium stearate as the lubricant, all sourced from Sigma Aldrich (St. Louis, 
MO). The only ingredient in FCM genuine artesunate intravenous vials was artesunate. 
Magnesium stearate was thus excluded from the ART SIM formulation to simulate a loose 
powder intravenous artesunate. To mimic 80% and 50% substandards, the excipients listed 
above were added to dilute the API. Acetaminophen was used as the wrong API for 
falsified SIM and was sourced from Sigma Aldrich (St. Louis, MO).  
4.3.3 Data Analysis: 
 When testing medicine samples, devices generated results that were either 
qualitative or quantitative. Qualitative results were based upon pattern comparison between 
a known good quality medicine reference and the test medicine sample data. PAD 
chemically reacted with the medicine ingredients generating a color pattern, that was then 
visually compared to a reference photograph to determine the presence of an API. The 
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4500a, MicroPHAZIR RX, NIR-S-G1, Progeny, and TruScan RM spectrometers 
computationally compared experimentally-collected spectra to reference spectra of good 
quality medicines stored in the device’s database. Each sample spectrum acquired was 
given a score by the device software resulting from the comparison with the good quality 
reference medicine spectrum. Such scores had to meet a given threshold to determine if a 
medicine passed (Figure 4-1 A). For the NIR-S-G1 spectrometer, reference samples were 
sent to the developer who prepared the reference libraries. The passing threshold values for 
the correlation coefficient or p-value testing initially set as default by the developer in the 
MicroPHAZIR RX, NIR-S-G1, Progeny, and TruScan RM spectrometers were utilized. 
These devices would directly tell the user ‘pass’ or ‘fail’, which were recorded. The pass 
threshold for the 4500a MIR spectrometer’s correlation coefficient was set by us at >0.9 
because the device would not output a direct pass/fail result, but rather give a list of matches 
with their associated correlation coefficients. The Neospectra 2.5 spectrometer did not 
include software to compare the experimentally-collected spectra to reference spectra. 
Therefore, experimental Neospectra 2.5 spectra were overlaid with reference spectra and 
visually compared by an analyst blinded to sample identity for determining the final 




Figure 4-1 Illustration of the basic processes for qualitative spectral comparison and 
quantitative analysis. (A) Process for reference library creation and spectral comparison 
analysis. From top to bottom: (i) spectra are collected from different batches of the same 
medicine and compiled into a mean spectrum representative of that medicine. (ii) This 
mean spectrum is used to build a “library” or database that serves as the comparator against 
which test samples are compared. (iii) Test samples are scanned and then (iv) the test 
sample spectra are overlaid with the reference spectrum for visual or computational 
comparison to determine a pass or fail. (B) Illustration of a basic quantitative experiment. 
From left to right and top to bottom. (i) A set of standard calibration samples with 
increasing API concentration is prepared along with a solution of the test sample that 
should fit in the concentration range of those standards. (ii) All solutions are then tested on 
the instrument and (iii) the data collected. (iv) The data obtained is then used to build a 
calibration curve via linear least-squares regression. Interpolation of the peak area of the 
questioned sample into this curve yields the estimated API concentration.   
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To estimate the amount of API with quantitative instruments (C-Vue, PharmaChk 
and QDa) a calibration curve approach was used (Figure 4-1 B). After sample preparation 
and data acquisition with the instruments, the calculated API amount had to be within ± 10 
% of the stated API amount for the sample to be classified as good quality, for both single 
and combination API medicines. We considered that medicines with %API outside the 90-
110% range of the manufacturer’s stated amount of API(s) were out of specification for 
any API included. For co-formulations, the entire medicine was deemed out of 
specification if at least one of the API was not within the 90-110% range.  
Both the RDT and the Minilab-TLC are semi-quantitative devices. RDT rely on the 
color density of control and test lines to confirm the presence of an API at a specific 
concentration. The TLC portion of the Minilab kit relies on the size and migration distance 
of a spot that is formed by a small sample deposited on the TLC plate, compared to a good 
quality reference standard on the same plate.  
When a sample failed the first test, we operated a ‘best of three’ system for overall 
sample classification (out of the three tests performed on the failing samples, the most 
frequently occurring of ‘pass’ or ‘fail’ would then be the overall sample classification), in 
the absence of devices manufacturer’s guidelines. For the single-use RDT the failing 
samples were rerun only once due to a limited number of tests available. For the PAD, the 
failing samples were rerun once, as recommended by the developer. For both the RDT and 
PAD a third run was conducted when the first two test results were discordant, and the 2/3 
majority result was retained.  
4.3.4 Statistical Analysis: 
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The overall sample binary classification (‘pass’ or ‘fail’) was used to calculate the 
sensitivity and specificity for each instrument. Sensitivity was defined as the percentage of 
true positives over the total of true positives and false negatives, and specificity as the 
percentage of true negatives over the total of true negatives and false positives. A true 
positive was defined as the sample being poor quality with the device correctly giving a 
fail result. Sensitivity and specificity were expressed as percentages with their 95% 
confidence intervals (95% CI). The exact confidence interval was based on Jeffreys’ 
confidence interval formula [26]. Sensitivities and specificities were compared by device 
pairs using McNemar tests. Data analysis was carried out using Microsoft Excel 2013 and 
STATA 14.2. The level of significance was set at p=0.05 (two-sided). 
To gauge whether the passing correlation coefficient or p-value threshold values 
initially set in the 4500a, MicroPHAZIR RX, Progeny, and TruScan RM spectrometers 
were optimal, receiver operating characteristic (ROC) curves were created. Only 
substandard and good quality SIM were used in the ROC curve analysis because these 
samples were shown to be the most challenging for the devices to distinguish. A variety of 
thresholds were tested to best visualize the curve and optimize the sensitivity and false 
positive rate (1-specificity). ROC curve analysis was also applied to the C-Vue, 
PharmaChk, and QDA, but the correlation coefficient or p-value thresholds were replaced 
with percent concentration thresholds. 
4.4 Results 
All devices showed 100% sensitivity to correctly identify tablets with 0% or wrong 
API after removal from their packaging, except for the NIR-S-G1 that showed a sensitivity 
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(95% CI) of 91.5% (79.6-97.6%,). Specificities of 100% were observed for most of the 
devices, except the C-Vue [60.0% (32.3-83.7%)], PharmaChk [50.0% (1.3-98.7%)], 
Progeny [95.5% (77.2-99.9%)] and the QDa [91.7% (73.0-99.0%)] (Table 2). The 




Table 4-2 Sensitivity and specificity to correctly determine quality of medicine samples 
for the 12 tested devices. 
*With substantial and upfront work, optical spectrometers could theoretically perform API quantitation. Parameters could be adjusted 
for better analysis of medicines containing lower-than-stated amount of API(s). However, in this study, only default parameters provided 
by the manufacturer were used. It is believed, however, that potential enhancements in sensitivity and specificity could be made by 
optimizing threshold values and experimental settings for specific medicines. 
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4.4.1 Thin Layer Chromatography: Minilab 
 The Minilab TLC kit consisted of a hard-shell case containing all the chemical 
analysis equipment necessary to perform TLC experiments. It correctly characterized all 
good quality, no-API falsified, and wrong-API falsified FCM and SIM. Only 1 out of 21 
of the SIM 50% API substandards were misidentified as good quality. A majority (16/21) 
of SIM 80% API substandards were misidentified as good quality as differences between 
the 100% and 80% reference spots on the TLC plates were difficult to distinguish visually. 
The Minilab is designed to detect samples with API below 80% API. The primary 
limitation identified was the higher requirements in terms of resources needed to conduct 
experiments, and the difficulties associated with visual interpretation of the results. Its 
primary strength was the wide variety of APIs covered and its detailed instructions. 
4.4.2 Single Use Devices: PAD and RDT 
 The PAD are paper card colorimetric assays with 12 testing lanes. Test samples 
were applied by rubbing them onto the testing lanes. The bottom of the cards are placed in 
water, where they develop to generate a color pattern that confirms the presence (or not) of 
a given API. They correctly characterized all good quality, no-API falsified, and wrong-
API falsified FCM and SIM.  The PAD were not designed to detect substandard medicines 
containing lower API amounts than stated and all 50% and 80% API substandards samples 
were incorrectly classified as good quality. The primary limitation of PAD was that the 
colors were difficult to interpret for weakly colored reaction products. Their primary 
strengths were that the experiments required minimal effort and consumables. 
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 RDT are lateral flow immunoassays that typically target a single API. They have 
the stated capability of distinguishing between substandard and falsified antimalarials. A 
subset of the RDT tested claimed to be able to detect artemether in artemether-lumefantrine 
co-formulated medicines. These RDT, however, were defective and not considered further. 
RDT specific for DHA and ART had a sensitivity of 16.7% in detecting substandards. RDT 
correctly characterized all the remaining good quality, no-API falsified, and wrong-API 
FCM and SIM. The primary limitations of RDT were the additional consumables required 
for their operation and the relatively extensive sample preparation needed compared to 
PAD. In a few cases it was difficult to read the RDT control lines on the cartridges due to 
inconsistent colors observed between RDT units. One advantage of RDT over PAD was 
their ability to detect some substandards. 
4.4.3 MIR Spectrometer: 4500a 
 The 4500a is a MIR spectrometer that performs attenuated total reflection 
experiments on powdered samples. It is controlled through a computer or Windows-based 
smartphone. With a correlation coefficient threshold of >0.9 for pass/fail analysis, the 
4500a MIR spectrometer correctly characterized all good quality, no-API falsified, and 
wrong-API falsified FCM and SIM. None of the 80% API substandard SIM were correctly 
classified as poor quality; however, over half (12/21) of the 50% API substandard SIM 
were correctly classified as poor quality. Primary weaknesses were its inability to test 
through transparent packaging because many plastics completely absorb MIR radiation, 
and the need to crush samples into powders.  A major strength of the 4500a MIR 
spectrometer software was the step-by-step instructions provided to aid in correcting 
background, cleaning the unit, and labeling IR spectra.  
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4.4.4 NIR Spectrometers: Neospectra 2.5, NIR-S-G1, & MicroPHAZIR RX 
 The Neospectra 2.5 Fourier transform NIR detector module can be used to build a 
device that fits a user’s custom needs. It correctly characterized all good quality, no-API 
falsified, and wrong-API falsified FCM and SIM. All the 80% API substandards and 16 
out of 21 of the 50% API substandards were misidentified as good quality samples. The 
primary limitation was the inability to conduct automated spectral library matching. 
Although users can extract the raw spectra using third-party library comparison tools, this 
feature was not evaluated as it was outside the study scope. Its modularity was its primary 
strength, allowing to configure the system for sampling both solids and liquids. Its detector 
had the widest NIR wavelength range in this study, allowing for more spectral information 
to be collected. 
 The NIR-S-G1 NIR spectrometer is controlled by a smartphone via Bluetooth. 
Although this instrument correctly characterized all good quality medicines, it had 
difficulties in the analysis of the OFLO SIM. The no-API falsified, 50% substandard, and 
80% substandard OFLO SIM were all incorrectly deemed as being good quality. This may 
have been because the limited device spectral range (Figure 4-2) did not reveal a 
sufficiently large number of significant features when comparing against the reference 
library entry. The library processing software was not able to detect the relatively small 
spectral differences observed in the ~1500 nm region (Figure 4-2 B). Since this device was 
able to correctly determine that the wrong-API OFLO medicines were poor quality, the 
API itself may have had limited NIR spectral features distinguishable from the excipients. 
Additionally, one falsified SIM sample containing only starch was misidentified as good 
quality DHAP. The simulated DHAP sample used D-Artepp as the source of API. It is 
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possible that if D-Artepp contained starch, this excipient may have contributed to the 
misclassification. Cellulose and lactose-containing falsified tablets were correctly 
characterized as poor quality DHAP. All other falsified samples were correctly identified. 
Four out of 21 (19%) of the 80% API substandards, and 10 out of 21 (48%) of the 50% 
API substandards were correctly identified as poor quality. The limited spectral range and 
limited chain-of-custody capabilities, which included the inability to record tested sample 
information in the software at the time of testing, were key limitations. The primary 
strengths were the user interface simplicity and that the NIR-S-G1 was the most portable 




Figure 4-2 Comparison of NIR spectra obtained for ofloxacin-containing simulated 
medicines. Spectra were collected for ofloxacin-containing simulated medicines using the 
(A) Neospectra 2.5, (B) NIR-S-G1, and (C) MicroPHAZIR RX spectrometers. The black 
trace is of a falsified simulated medicine tablet containing only starch. The blue trace is of 
a simulated good quality ofloxacin sample that contained starch as the bulk excipient. 
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The MicroPHAZIR RX handheld NIR spectrometer contains the instrument and 
user interface in one module. It correctly characterized all good quality, 50% API 
substandard, no-API falsified, and wrong-API falsified FCM and SIM. Only 1 of the 21 
(4.8%) 80% API SIM substandards was correctly classified as poor quality. The primary 
limitation of the MicroPHAZIR RX were the instrument’s bulkiness and advanced skills 
necessary to process the spectra to generate reference libraries, but it had an easy-to-use 
interface. 
4.4.5 Raman Spectrometers: Progeny and TruScan RM 
 The Progeny is a handheld Raman spectrometer with a 1064 nm excitation laser, 
resulting in lower fluorescence than shorter wavelength lasers. It correctly characterized 
all the no-API falsified and wrong-API falsified FCM and SIM. All good quality samples 
were correctly characterized, except the FCM Augmentin (ACA), which was incorrectly 
determined as being Roxythroxyl (roxithromycin). The outer tablet coating of Augmentin 
may have been chemically similar to that of Roxythroxyl, a spectrum stored in the master 
Progeny reference library. None of the 80% SIM substandards and only 7 out of 21 (33%) 
of the 50% SIM substandards were correctly characterized as poor quality. The Progeny 
spectrometer was heavier than other units (1.6 kg) and risked burning samples with the 
laser if the instrument’s focal length was not properly set-up. The primary strengths were 
its simple to use touch screen interface, and the lack of fluorescence signals that could 
overwhelm the detector. 
The TruScan RM is a handheld Raman spectrometer with a 756 nm excitation laser 
that correctly classified all the good quality, no-API falsified, and wrong-API falsified 
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medicines in the FCM and SIM collections. The device only correctly classified 3 out of 
21 (14%) SIM 80% API, all three being DHAP samples. Seven out of 21 (33%) SIM 50 % 
API substandard were correctly classified. Limitations included the need for significant 
computer knowledge (e.g. setting up IP addresses, firewalls) to correctly complete the 
initial setup with the master computer and the excitation laser that caused significant 
fluorescence for ACA FCM and SIM samples when compared to the other non-destructive 
spectrometers tested. Sampling Artesun through the original sample glass vial yielded 
spectra that were indistinguishable from those of an empty glass vial, whereas this issue 
was not observed with the Progeny (Figure 4-3). The primary strengths of the TruScan RM 
were its relatively lower weight and bulkiness when compared with the Progeny and its 




Figure 4-3 Comparison of Raman spectra obtained for Artesun artesunate powder. Raman 
spectra were collected with the (A) Progeny and (B) TruScan RM spectrometers for 
Artesun artesunate powder for injection. Spectra are provided for 1) a scan of the bottom 
of the Artesun glass vial containing no artesunate (blue trace), 2) a sample containing 60 
mg of artesunate powder, scanned through the bottom of the glass vial (orange trace), and 
3) the artesunate powder transferred to a polypropylene bag and compacted into a more 
localized area to enable more focused analysis (green trace). 
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4.4.6 Quantitative Instruments: C-Vue, PharmaChk, & QDa 
 The C-Vue is a portable lightweight tabletop liquid chromatograph equipped with 
a manual syringe pump, a manual injector, a reverse-phase column, two detectors, and a 
control laptop. It was able to correctly characterize all the 80% API substandard, 50% API 
substandard, no-API, and wrong-API OFLO, SMTM, and ACA. The C-Vue specificity 
was one of the lowest in this study (60% good quality FCM and SIM misidentified as poor 
quality), potentially due to matrix effects from the excipients that were not used in the 
preparation of the calibration solutions. The lowest specificity was observed for medicines 
formulated with more than one API (0% and 40% for ACA and SMTM, respectively), but 
none of the single API good quality OFLO FCM and SIM were misclassified. Two notable 
limitations are its inability to detect artemisinin derivatives with the setup tested and the 
significant effort required to continuously ensure that the pump was pressurized by hand. 
Newer versions of this instrument include an upgraded mobile phase electric pump that 
simplifies operation. Its primary strength was the simplicity of its design, making it easy 
to transport, repair, or modify in the field. 
 The PharmaChk is a portable microfluidic system that uses luminol-based 
chemiluminescence detection, contained inside a hard-shell case. The system can 
automatically calibrate itself and assay samples in a single experiment. It was able to 
correctly characterize all the 50% API substandard, no-API falsified, and wrong-API 
falsified ART SIM. One of the three 80% API substandards was misclassified as good 
quality. The FCM good quality ART was correctly classified, while the SIM 100% ART 
sample was incorrectly classified in two trials as poor quality, with yields of 51.6 mg (86%) 
and 53.75 mg (89.5%) of the stated 60 mg amount. Its primary limitations were that the 
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prototype used could only test for ART and the reagents degraded within a few hours after 
being prepared. Its primary strengths were the automation of all API concentration 
calculations in the embedded computer system, the capability of simultaneously infusing 
reagent and samples, and the clear step by step instructions. 
 The QDa is a benchtop single quadrupole mass spectrometer with an electrospray 
ion source. All the 80% API substandards, 50% API substandards, no-API falsified, and 
wrong-API falsified medicines were correctly classified. Two good quality FCM were 
misclassified as poor quality, likely due to incomplete API extraction. Limitations of the 
QDa were that it required significantly more extensive sample preparation than the C-Vue 
or the PharmaChk because it required several dilutions for the tested sample for the extracts 
to fall within the linear range of the instrument and not overwhelm the detector. The 
requirements for additional consumables such as compressed nitrogen gas, and the higher 
mechanical complexity of the instrument could make portability and serviceability 
challenging. Its primary strength was its quantitative capabilities for a wide range of APIs, 
and the high sample throughput once sample preparation was complete.  
4.4.7 Device Comparison  
Pair-wise comparisons of the sensitivities showed that no device had statistically 
significantly lower or higher sensitivities to correctly identify 0% and wrong API samples 
than any other device.  
Specificity of the C-Vue was significantly lower than that of all other devices 
except the Progeny (p=0.0625) and the QDa (p=0.1250). The performances of the 
PharmaChk and RDT could not be compared with the C-Vue as this device was limited to 
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test ACA, OFLO and SMTM in the present study. Because only a few genuine medicine 
samples were available for specificity calculations, the interpretation of statistical 
comparisons is limited.  
The C-Vue and QDa performed better to correctly identify 50% and 80% API 
samples than other devices they could be compared to, except the PharmaChk (p<0.05) 
(Table 3); the Minilab showed higher sensitivity than other devices, except the C-Vue, 
QDa, PharmaChk and MicroPHAZIR RX (p<0.05). The MicroPHAZIR RX showed higher 
sensitivity than other spectrometers (p<0.05) to correctly identify 50% and 80% API 
samples except the NIR-S-G1 (p=0.0923); the Neospectra 2.5 had lower sensitivity than 
other spectrometers (p<0.05) except the Progeny (p=0.2188). The PAD showed 
significantly lower sensitivity to correctly identify 50% and 80% API samples than the 
other devices except the RDT (p=1.0) and the Neospectra 2.5 (p=0.50) but the number of 
samples for comparisons was limited. 
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Table 4-3 Pair-wise sensitivity comparisons of the devices used to test 50 % and 80 % API samples outside their packaging. Sensitivities 
expressed as 95% CI, in grey. The p-value of the McNemar test (n=number of 0%/wrong API medicines assessed by both devices in the 
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These results suggest that all tested devices are well-suited for detecting no API 
and wrong API medicines, these being common falsified medicines chemical 
compositions. Although detecting falsified medicines is of great public health importance, 
the co-detection of substandard medicines is also essential, especially as these will lead to 
cryptic therapeutic failure and engender antimicrobial resistance. Much needed 
technological improvements, as revealed by this study, are the ability to quantitate APIs 
via Raman/IR spectrometers or disposable devices, and improvement of the specificity of 
some of the quantitative devices. Although all substandards were successfully detected 
with quantitative devices, except two ART samples with the PharmaChk, their less-than-
optimal specificity is of concern. Reduced specificities increase the number of 
confirmatory testing required in quality control laboratories, resulting in increasing cost 
and loss of time and resources. Quarantine or withdrawal of the samples failing the 
screening technologies from the market due to device limitations can also negatively 
impact manufacturers, pharmacies, and ultimately patients. 
Many FCM tablets tested had coatings that made sampling of the tablet bulk 
difficult by spectroscopic techniques. To illustrate this point, the spectrometers (except the 
4500a FTIR that cannot scan intact tablets) were used to sample AMK 1000 mg (ACA) 
tablets, both intact and crushed (Figure 4-4). The spectral fingerprint of the outer coating 
of intact tablets, depending on coating composition and thickness, may be insufficient to 
derive the quality of the medicine itself as a whole. Reference library creation could also 
be affected if the operator sampled the coating but attempted to match the spectrum to that 
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of a crushed tablet. We were unable to find evidence on the consequences of different 




Figure 4-4 Intact vs. crushed ACA tablet analysis by Raman and NIR spectrometers. 
Spectral comparisons of a field collected sample of AMK 1000 mg (a co-formulation of 
amoxicillin and clavulanic acid) are shown with the (A) Progeny, (B) Truscan RM, (C) 
MicroPHAZIR RX, (D) NIR-S-G1, and (E) Neospectra 2.5 spectrometers. The spectra in 
blue are scans of an intact tablet of AMK 1000 mg. The spectra in black are scans of the 
powder from a crushed AMK 1000 mg tablet. 
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Optimization of the spectrometers’ software’s pass/fail threshold values in 
performing database matching could boost the instruments’ sensitivities and specificities. 
The ROC curves constructed in Figure 4-5 for SIM with the 4500a, MicroPHAZIR RX, 
Progeny, and TruScan RM spectrometers show that setting a higher threshold improve 
devices sensitivities, but at the cost of reduced specificity. The quantitative devices’ 
precision could also be optimized by adjusting the concentration threshold used for 
pass/fail decisions. Lowering the pass threshold concentrations for the quantitative devices 
(C-Vue, PharmaChk, & QDa) improves their specificities, but at the cost of reduced 
sensitivity. Therefore, the pass/fail threshold values for these instruments must be balanced 
to optimize the reliability of medicine quality classification. In most circumstances public 
health risks suggest that optimizing sensitivity for detecting SF medicines will be more 




Figure 4-5 Receiver operating characteristic (ROC) curves for substandard analysis with 
the spectrometers. ROC curves were created for the (A) 4500a, (B) MicroPHAZIR RX, 
(C) Progeny, and (D) TruScan RM spectrometers.  ROC curves were based only on the 
results for simulated substandard and good quality medicines. Each legend identifies the 
threshold chosen for each point, with the one labelled “Stock” being the threshold used for 
the study. The stock thresholds for the MicroPHAZIR RX’s correlation coefficient, 
Progeny’s correlation coefficient, and TruScan RM’s p-value were the default values set 
by the manufacturer. The 4500a stock threshold was selected for the study since that 
instrument did not output pass/fail results. 
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 Limitations of our study include: the limited number of APIs tested; difficulties 
with reference libraries creation for spectrometers; the limited comparability of reference 
libraries due to the variability of spectrometers; the investigators not being blinded to 
sample identity; the limited optimization of the devices to allow API quantitation; and the 
low power to compare sensitivities and specificities between devices. 
With additional development and optimization, many of these devices may be able 
to perform both quantitative and qualitative analysis. For example, methods could be 
developed for spectrometers to perform quantitative analyses by selecting a spectral feature 
correlated to a specific chemical bond in an API, or by monitoring changes in the entire 
spectrum and correlate those to the differences in API concentration. A key obstacle to 
portable spectrometer quantitation would be instrument calibration per brand because they 
analyze the entire formulation that will vary between different excipient recipes. To ensure 
a reliable calibration at a variety of different API concentrations, the calibrants should be 
chemically similar to the medicine of interest due to potential matrix effects. The QDa 
mass spectrometer could be adapted for qualitative analysis by allowing the instrument to 
record the entire mass spectrum to analyze as many ingredients in the formulation as 
possible. However, analyzing a wider mass range risks less accurate quantitation compared 
to single ion monitoring used in this study.  
Which device is optimal for different positions within the medicine distribution 
system will depend on the question being asked. For example, what type of medicine or 
API is tested, whether qualitative or quantitative assays are required, and what human and 
financial capacity is available. The Minilab, PAD, and RDT require minimal training and 
infrastructure to implement in the field rapidly. However, the PAD and RDT are limited 
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due to narrow range of detected API. The spectrometers have the advantages of being non-
destructive (except the 4500a MIR spectrometer) and can analyze a broader API diversity. 
The spectrometers suffer from issues with tablet coatings, the spectral range of the NIR-S-
G1 spectrometer, and fluorescence issues with the TruScan RM can reduce accuracy for 
some medicines. The smartphone simplicity with the NIR-S-G1 is highly desirable. With 
the increasing global prevalence of smartphone technology, connectivity using cell phone 
networks, and Wi-Fi to constantly update reference libraries, software, and back-up data 
could ensure these devices are performing to the best of their ability with rapid access to 
troubleshooting [27]. The simplicity of the C-Vue liquid chromatographer, the automation 
of the PharmaChk microfluidic system, and the sample variety and accuracy for the QDa 
mass spectrometer are all desirable traits for an optimal portable confirmatory instrument. 
The following devices were selected for field testing described in the field evaluation 
in Laos - third paper of the PLOS NTD’s collection: 4500a, Minilab, MicroPHAZIR RX, 
NIR-S-G1, PAD, Progeny, and TruScan RM. The main reasons were their ease of use, ease 
of training, portability, minimal consumables, and ease of export. The RDT were selected 
as field-suitable but could not be included in the field evaluation because not enough tests 
were available. The quantitative devices were not selected because of the consumables and 
training requirements. In addition, the QDa had high mechanical complexity, making 
export and setup difficult. The quantitative devices are highly capable, but the consumables 
and mechanical complexity make transport difficult and the devices would be more 
appropriate for a laboratory. 
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 ACCELERATED SCREENING FOR THE 
PROTECTION AND EFFICACY OF CELL TREATMENTS 
(ASPECT) VIA MALDI-MS 
5.1 Abstract 
Cellular therapies offer the potential for revolutionary treatments for patients. Due to 
their high demand, illicit manufacturers are capitalizing on expensive and low availability 
cellular therapies by creating poor quality and falsified products. Regulatory agencies need 
rapid and simple tools for pre- and post-market surveillance of cellular therapies. Many 
quality control tools exist for cellular therapy screening such as microscopy, 
immunoassays, genotyping, and flow cytometry; however, these tools can be low 
throughput and have complex consumables. The Accelerated Screening for the Protection 
and Efficacy of Cellular Therapies (ASPECT) workflow was developed to rapidly screen 
the quality of cellular therapies using matrix assisted laser desorption ionization (MALDI) 
mass spectrometry. MALDI has been extensively used in the clinic to rapidly speciate 
bacteria with minimal simple consumables and the spectral libraries can be easily updated 
to include more species. The ASPECT workflow includes scripts to automatically analyze 
the raw data by comparing spectra using correlation coefficient testing with little user input 
and easy to read results. In this preliminary study, untreated mesenchymal stromal cells 
(MSC) were compared with ethanol incubated MSC to simulate egregious manufacturing.  
Lipid, protein, and metabolite profiling were evaluated to distinguish untreated and ethanol 
incubated cells. Lipid profiling proved to be effective at detecting ethanol’s disruption of 
the cellular membrane. Although protein and metabolite profiling could distinguish 
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untreated and ethanol incubated cells, few spectral features distinguished the two 
conditions causing a few false positives and negatives. This preliminary data shows 
ASPECT’s potential as a high throughput tool that uses simple consumables for screening 
cellular therapies.  
5.2 Introduction 
New emerging cellular therapies such as stem cells offer the potential for 
revolutionary treatments for patients in regenerative medicine and chronic disease [1–3]. 
The market for cellular therapies is rapidly expanding. From 2001 to 2019, an average of 
2.5 cellular therapy medical products were approved each year worldwide by regulatory 
agencies [4]. Such high demands for these revolutionary medical products can cause an 
influx of poor quality and unregulated cells to enter the market. For example, traditional 
small molecule pharmaceuticals that have been on the market for decades continue to face 
quality concerns with illicit and poor manufacturing. The World Health Organization 
estimates that 1 in 10 medicines in low to middle income nations are deemed poor quality 
due to inadequate manufacturing practices, environmental degradation, or criminal 
falsification [5]. Poor quality small molecule pharmaceuticals such as antibiotics and 
antimalarials can prevent patients’ treatment, cause microbial resistance to anti-infectives, 
and increase distrust in the health system [6].   
 Cellular therapies are currently suffering from similar quality problems as 
traditional small molecule pharmaceuticals. Unlicensed and illegitimate stem cell  
providers have been reported throughout the United States and worldwide [7, 8]. For 
example, a stem cell clinic in the United States has been charged with the sale of adulterated 
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and misbranded cellular therapies that were not approved by the Food and Drug 
Administration (FDA) [9].  Stem cell tourism in unregulated markets is expanding as 
patients seek cellular therapies that are cheaper or not available elsewhere  [10].  There are 
many reports of complications from poor quality stem cells. A survey of academic 
neurologists regarding complications their patients suffered from stem cell tourist clinics 
include: stroke, infections, sepsis, death, and many others [11].  Multi-organ failure and 
death from an unapproved stem cell tourism therapy has been reported in detail as well 
[12]. Another quality problem with stem cells includes bacterial contamination of an 
approved cellular product reported by the U.S. Centers for Disease Control [13]. Illicit 
manufacturers capitalize on patients’ vulnerabilities such as with the COVID-19 pandemic. 
The pandemic caused an influx of falsified medical products on the market including 
chloroquine, a purported COVID-19 treatment [14, 15]. This includes a Missouri state 
lawmaker selling amnionic fluid as an alleged stem cell treatment for COVID-19 [16].  
To elude regulatory authorities, poor quality and falsified cellular therapies will 
become more difficult to detect. As an example in small molecule pharmaceuticals, illicit 
manufacturers have been known to falsify anti-malarials by: replicating the shape and color 
of genuine good quality tablets, imitating the original medicine’s packaging, adding a non-
therapeutic amount of active ingredient to pass rudimentary chemical tests, and copy the 
complex holographic stickers on the packaging used to confirm the authenticity of the 
medicine. Acetaminophen has also been added to falsified anti-malarials without the 
correct active ingredient to elude patients into thinking they are being treated [17]. 
Regulatory agencies will need various powerful tools for the pre- and post-market 
surveillance of cellular therapies to combat poor or illicit manufacturing.  
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There are many tools used to characterize cellular therapies for quality control [18–
20]. Flow cytometry offers a highly sensitive and multiplexed technique for rapid 
quantitation of cellular targets [21]. Characterizing cells through genotyping can help 
speciate cells and monitor mutations in cell lines [22]. Microscopy is a versatile tool for 
stem cell quality control to monitor cells through label and label-free techniques [23]. The 
advent of mobile phone based microscopy can help create a field deployable tool for stem 
cell clinic inspections [24]. Immunoassays can be used to identify key cellular markers. 
Immunoassays can be combined with flow cytometry to improve speed or microscopy for 
the imaging of key cellular targets [25]. Although these technologies are widely used in 
stem cell quality control, some tools are low throughput, many of these tools can only 
analyze a few targets or features without major consumable changes, and many require 
complex consumables such as antibodies or enzymes for specific markers. 
In this article, we show the first set of results regarding the use of matrix assisted 
laser desorption ionization (MALDI) mass spectrometry for the high throughput quality 
screening of cellular therapies. Regulators need a high throughput screening tool that can 
be easily updated with minimal consumables to detect illicit or poor quality cellular 
therapies. In microbiology, bacterial speciation using mass spectrometry was first 
demonstrated in 1975 [26], with MALDI biotyping being developed for rapid bacterial 
speciation in 1994 through protein profiling [27]. MALDI biotyping has been 
commercialized and is now an FDA approved method to speciate a wide variety of bacteria 
in the clinic [28–30]. The main advantage of MALDI biotyping is the ability to speciate a 
wide variety of bacteria with the same simple MALDI matrix and solvents. New bacteria 
can be easily added to the biotyping database by simply updating the spectral library 
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without the need to change the consumables and protocols. MALDI is entering the cellular 
therapy world as it has been used to profile embryonic stem cell differentiation [31]. To 
accelerate MALDI as an easy to use screening tool for cellular therapies, we have 
developed the Accelerated Screening for the Protection and Efficacy of Cell Technologies 
(ASPECT) workflow to swiftly process samples. At the end of the MALDI experiments 
and with minimal user input, the results are processed automatically and output in an easy 
to read format. Protein profiling traditionally used for MALDI biotyping, metabolite 
profiling, and lipid profiling were explored with ASPECT. Preliminary data was acquired 
comparing ethanol incubated versus untreated cells to evaluate ASPECT.  
5.3 Experimental 
Mesenchymal stromal cells (MSC) from RoosterBio (lot 182, 26 y.o. female; 
Frederick, MD) were utilized. Cells were expanded in a culture flask with culture media 
containing low-glucose Dulbecco’s modified eagle medium, 10 % fetal bovine serum, and 
1x antibiotic/antimycotic. The cell expansion was incubated at 37 °C with 5% CO2. After 
incubation, the media was removed and cells were dislodged using trypLE solution. The 
cells were pelleted at 300 g for 5 minutes and resuspended in fresh media. An aliquot of 
cells was removed, stained with trypan blue, and the cell count measured with a 
hemocytometer. After counting, the stock of unstained cells was diluted with fresh media 
to 2.0*106 cells/mL for testing. To simulate the detection of unaffected cells versus 
egregious poor manufacturing, half the MSC were untreated and the other half were 
incubated in ethanol for 15 minutes. After treatment, the cells were pelleted, supernatant 
media or ethanol removed, the pellet was resuspended in phosphate buffered solution 
(PBS), and frozen at -80°C until MALDI experiments.  
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All chemicals required for MALDI experiments were purchased from Sigma-Aldrich 
(St. Louis, MO) at their highest purity available, unless noted otherwise. Dried droplet 
sample preparation chemicals and MALDI matrices were developed from previously 
reported protocols. Bruker’s (Billerica, MA) Bacterial Test Standard MALDI preparations 
method utilizing the matrix α-cyano-4-hydroxycinnamic acid  was used for protein 
profiling [32]. The method using the matrix 9-aminoacridine from Edwards et al. was used 
for metabolite profiling [33]. Our lipid profiling method was developed using the matrix 
2,5-dihydroxybenzoic acid with modification from Bruker’s Guide to MALDI Sample 
Preparation [34]. Details for MALDI dried droplet sample preparation for each profiling 
method are given in detail in the first third of Table 5-1.   
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Table 5-1 Key sample preparation procedures, MALDI settings, and ASPECT script 
parameters. 
ACN = acetonitrile; MeOH = methanol; TFA = trifluoroacetic acid 
*Solution is supersaturated after sonication. Centrifuge the solution and spot the supernatant. 
Sample Preparation 








MALDI Matrix Solvent 
(v/v) 
50.0 % ACN 
47.5 % H2O 
2.5 % TFA 
Acetone 
90.0 % ACN 
10.0 % H2O 
0.1 % TFA  
Concentration of 
MALDI Matrix in 
Matrix Solvent 
10 mg/mL* 9 mg/mL 20 mg/mL  
Sample Solvent (v/v) 
50.0 % ACN 
47.5 % H2O 
2.5 % TFA 
50 % MeOH 
50 % H2O 
90.0 % ACN 
10.0 % H2O 
0.1 % TFA 
Volume of 
Matrix/Sample spotted 
onto target plate 
1.0 µL 0.7 µL 0.7 µL 
Spotting Protocol 
Spot sample solution 
onto target plate and 
dry. Spot matrix 
solution on top of dried 
sample and dry. 
Mix sample solution 
and matrix solution 
1:1. Spot mixture onto 
target plate and dry. 
Mix sample solution 
and matrix solution 
1:1. Spot mixture onto 
target plate and dry. 
MALDI Settings 
Profiling Method Protein Metabolite  Lipid 
Mode Positive Negative Positive 
Mass Range 2200 to 20000 170 to 2000 m/z 300 to 2000 m/z 
Laser Shots 1000 5000 5000 
Laser 
(Application – Smartbeam – 
Scan Range) 
M5 Thin Layer – M5 
– 50 µm 
Custom – Single –  
50 µm 
Custom – Single –  
50 µm 
Shots at Raster Spot 50 10 10 
Walk on Spot Enabled Enabled Enabled 
Movement on Sample Spot 
Random – Partial 
Sample 
Random – Complete 
Sample 
Random – Complete 
Sample 
Sample Rate 1.25  GS/s 5.00 GS/s 2.50 GS/s 
ASPECT Script Settings 
Profiling Method Protein Metabolite  Lipid 
Mass Range Trim 2250 to 9000 m/z 400 to 670 m/z 650 to 870 m/z 
Data Size Reduction 1.25x 2.00x 1.25x 
Bin Size 25 25 25 
Normalization 
Total Ion Current 
(TIC) 
Total Ion Current 
(TIC) 




0.85 0.95 0.8 
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The prepared frozen cells were thawed at room temperature, pelleted, and the PBS 
supernatant was replaced in equal volume with the appropriate sample solvent necessary. 
All samples were spotted onto a Bruker ground steel MALDI target plate (Part# 8074115). 
In this preliminary data set, 4 spots were prepared with untreated cells and used as the 
reference sample for correlation coefficient (CC) testing for each profiling method. These 
4 reference spots were not considered in sensitivity or specificity calculations on the 
MALDI target plate map. On the same target plate, 24 spots were created from the 
untreated cells and 24 spots were dispensed for the ethanol incubated samples for each 
profiling method. Other spots on the target plate included blanks and external mass 
accuracy calibrants. External mass accuracy calibration for protein profiling was conducted 
with the Bruker Protein Calibration Standard 1. Metabolite and lipid profiling external 
mass accuracy calibration was conducted with poly-alanine as detailed by Gruendling et 
al. [35].   
The Bruker rapifleX MALDI Tissuetyper was utilized for all experiments. Each 
profiling method had their own unique mass spectrometry settings as defined in the second 
third of Table 5-1. The rapifleX’s speed processing spots for MALDI is desirable for high 
throughput screening applications. To demonstrate the rapifleX’s speed, Figure 5-2 plots 
the time to process a fully spotted 384 ground steel target plate with protein profiling in 
less than 40 minutes. 
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Figure 5-1 To demonstrate the rapifleX’s speed, the total ion current for each protein profiling experiment was plotted versus the overall 
time taken to process a fully spotted 384 ground steel target plate. Each peak represents the total ion current of a single spot on the target 
plate. The gaps in time between each target plate row are when the rapifleX is transitioning from one row to the next. Each row contains 
24 spots. 
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Two scripts were written for ASPECT. The first script rapidly converts an entire 
folder of Bruker’s raw spectra file into the common .mzXML file format for data 
processing. After MALDI experiments were complete, FID files were created for the raw 
spectra collected using Bruker’s flex Data Converter software. Then, a custom Python 3.7.3 
script was written to automatically take an entire folder of spectra with the FID files and 
convert them to .mxXML files for later processing.  
The second script processes the .mzXML files for data analysis and was written in 
MathWorks’s (Natick, MA) MATLAB R2020b and outlined in Figure 5-2.  Briefly, spectra 
are first baseline corrected and normalized. Second, the number of data points are reduced 
through binning to minimize noise. Then, the mass range can be trimmed to isolate a key 
spectral region of interest, especially those that are biologically relevant. Third, the 
questioned sample’s spectra are then compared to a reference sample’s spectra through CC 
testing. CC testing is a rapid to perform calculation to compare a questioned sample against 
a reference sample’s spectral pattern. If the calculated CC score is greater than an 
established threshold, the questioned sample passes the test and is considered similar to the 
reference sample.  Finally, a map of the MALDI target plate is created showing which 
samples passed and which ones failed. To assess the sensitivity and specificity of ASPECT, 
the developer can input a file with the known quality of the cells. The target plate map plots 
which samples are true positives, true negatives, false positives, and false negatives. In the 
field of poor quality medicine screening: a true positive indicates a poor quality sample 
was correctly identified. A true negative defines a good quality medicine was correctly 
identified. A false positive indicates a good quality sample was incorrectly identified as 
poor quality. Finally, a false negative defines a poor quality medicine that was incorrectly 
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identified as good quality. The sensitivity and specificity are automatically calculated and 
noted on the bottom of the target plate map. Sensitivity is the ratio of true positives over 
the sum of true positives and false negatives. Specificity is the ratio of true negatives over 
the sum of true negatives and false positives. Receiver operating characteristics (ROC) 
curves are automatically calculated and plotted to best find the appropriate CC threshold 
for the assay.  Key parameters for the ASPECT data processing script are listed in the third 




Figure 5-2 Diagram of the workflow in the second script in ASPECT. (A) After the 
.mzXML spectra have been imported into MATLAB, (B) the spectra are baselined 
corrected and normalized. (C) Then, the spectra are binned to reduce noise and the mass 
range is trimmed to isolate a specific region of interest. This spectral region of interest may 
be more biologically relevant than others. (D) The spectra from the questioned samples are 
then compared to a reference sample through CC testing. A CC score is output that 
measures the relative match in the spectral pattern between the questioned sample and the 
reference. A score of 0 is not a match and a score of 1 is a perfect match. The scores are 
compiled into two MALDI target plate maps. (E) The end user would receive a map 
indicating which samples passed or failed CC testing given the defined threshold for 
passing. (F) If the developer evaluating the assay uploads a file with the known samples’ 
quality, the developer’s view calls attention to which spots did not perform as expected. 
False negatives and false positives are highlighted by being large circles. The sensitivity 
and specificity of the assay is automatically calculated and output in the developer’s view. 
In either the user or developer view, gradient colors can be displayed to visually estimate 
the CC score too. 
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5.4 Results and Discussion 
Ethanol incubation disrupts cellular membranes by solubilizing lipids [36]. As seen 
in the mean lipid profiling spectra in Figures 5-3A & B, there is significant change in the 
profile of phospholipids from untreated to ethanol-incubated cells.  After importing the 
data into the ASPECT processing script, CC testing correctly classified both the untreated 
and ethanol incubated cells as seen in the developer’s MALDI target plate map in Figure 
5-3C. All untreated cell spots in row G were classified as true negatives since they differed 
little from the reference samples. All ethanol incubated cell spots in row H were classified 
as true positives because of the distinct change in the spectra from untreated to ethanol 
incubated cells. The corresponding ROC curve to establish the CC threshold for lipid 
profiling is in Figure 5-3D. Although a threshold of 0.8 was set for the experiment, the 
ethanol incubated cells could be distinguished with a threshold as low as 0.525 on the ROC 
curve to still achieve maximum sensitivity and specificity. The orange and yellow small 
spots in row H show that the ethanol incubated cells’ CC scores do not go beyond 0.5, 
suggesting a poor match with the untreated reference cells. The disruption and extraction 
of the cellular membrane lipids with ethanol caused a dramatic change in the lipid profile 




Figure 5-3 The mean unprocessed lipid profiling spectra (n=24) are plotted for (A) ethanol 
incubated cells and (B) untreated cells. Ethanol incubation shows a dramatic shift in the 
lipid profile. (C) After ASPECT data processing, the developer’s view of the MALDI target 
plate map shows that all samples were correctly classified with a specificity and sensitivity 
of 1 (0.85 to 1, 95% CI). All untreated cells passed with CC scores >0.8 and all ethanol 
incubated cells failed with CC scores <0.5. No false positives or negatives were detected 
since all the spots on the target plate map were small circles (D) The ROC curve shows 
that the CC threshold can be set as low as 0.525 and still have a specificity and sensitivity 
of 1 to detect ethanol incubation via lipid profiling. Increasing the CC threshold beyond 
0.8 increases the false positive rate. 
  
 103 
Protein profiling is the primary method to speciate bacteria using MALDI biotyping 
[28–30].  After ethanol incubation, only one feature was extracted as highlighted by the 
red box in Figures 5-4A and B. CC testing can distinguish the difference with only one 
feature missing as seen in ASPECT’s developer’s view of the MALDI target plate map in 
Figure 5-4C. In row C, 20 true negatives (0.83 specificity; 0.62 to 0.95, 95% CI) and in 
row D, 23 true positives (0.96 sensitivity; 0.78 to 0.99, 95% CI) were measured. 
Establishing the appropriate CC threshold is critical to achieve these high sensitivities and 
specificities. As shown in Figure 5-4D, setting a CC threshold <0.85 causes the sensitivity 
of the assay to lower significantly. Setting the CC threshold >0.85 increases the false 
positive rate of this assay. The four false positive spots at C7, C12, C13, and C23 in the 
MALDI target plate map are the likely cause of poor spotting or the random sampling of 
the laser missing key areas with concentrated analyte or matrix on the dried droplet (Figure 
5-4E). The false negative on spot D19 demonstrates how closely aligned the spectra are 




Figure 5-4 The mean unprocessed protein profiling spectra (n=24) are plotted for (A) 
ethanol-incubated cells and (B) untreated cells. Only one feature from the untreated cells 
is extracted after ethanol incubation highlighted by the red box. (C) After ASPECT data 
processing, the developer’s view of the MALDI target plate map shows a high sensitivity 
of 0.96 (0.78 to 0.99, 95% CI) with only one false negative at spot D19. The specificity is 
slightly reduced to 0.83 (0.62 to 0.95, 95% CI) due to 4 false positives at spots C7, C12, 
C13, and C23. (D) The ROC curve shows that setting the CC threshold below 0.85 causes 
the sensitivity of ASPECT towards ethanol incubation detection to decrease. Increasing the 
CC threshold beyond 0.85 increases the false positive rate. (E) The mean spectra for the 
false positive spots C7, C12, C13, and C23 are plotted. These false positives show poor 
acquisition likely correlated to poor sample preparations or the random sampling laser 
missing key spots with concentrated analytes. (F) The spectra for the false negative at spot 
D19 shows the limited difference between untreated vs. ethanol incubated cells for protein 
profiling. 
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The large change in sensitivity and specificity in the ROC curve for protein profiling 
is caused by how close the CC scores are between untreated (row C) and ethanol incubated 
cells (row D) as seen by their green color (Figure 5-4C). Ethanol incubation likely killed 
the cells quicker than the proteome could react to cause a major change in the protein 
profile mass spectra. Since this preliminary data set is created with a single donor and batch 
of MSC, the proteome is not different enough after an ethanol incubation alone. Heap et 
al. shows the effectiveness of MALDI protein profiling for the phenotyping of 
differentiated mouse embryonic stem cells [31]. Cell differentiation significantly changes 
the proteome to modify the function of the cell. Protein profiling would likely be an 
excellent screening method if illicit manufacturers sell the patient the wrong or none of the 
stem cells. If the cells die too rapidly for the proteome to respond, protein profiling may 
not be optimal.  
 Metabolite profiling was evaluated as many of the analytes in the article by  
Edwards et al. have well defined metabolic pathways [33]. Ethanol incubation caused a 
change in intensities for many of the features compared to the untreated cells as shown in 
Figures 5-5A & B. Although the intensities changed likely due to ethanol extraction, there 
is no significant change in new features appearing or disappearing after ethanol incubation 
compared to lipid profiling. As shown in Figure 5-5C, ASPECT achieved 24 true positives 
in row L (1.00 sensitivity; 0.85 to 1, 95% CI) and 23 true negatives in row K (0.96 
specificity; 0.79 to 0.99, 95% CI). A CC threshold of 0.95 was necessary to achieve the 
high sensitivities and specificities. Any other CC threshold above or below 0.95 would 
have drastically decreased the sensitivity or specificity as shown in the ROC curve in 
Figure 5-5D. Based on the spectra plotted in Figure 5-5E, the false positive spot K23 was 
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likely caused by some baseline noise where the laser may have shot less concentrated areas 
of the sample spot.   
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Figure 5-5 The mean unprocessed metabolite profiling spectra (n=24) are plotted for (A) 
ethanol incubated cells and (B) untreated cells. There are changes in the intensities between 
the untreated versus ethanol incubated cells; however, the features remain the same except 
for a peak or two. (C) After ASPECT data processing, the developer’s view of the MALDI 
target plate map shows a high sensitivity of 1 (0.85 to 1, 95% CI) in row L, and a high 
specificity of 0.96 (0.79 to 0.99, 95% CI) in row K with only one misclassification at spot 
K23. (D) The ROC curve shows that setting the CC threshold below 0.95 causes the 
sensitivity of ASPECT towards ethanol incubation detection to plummet. Increasing the 
CC threshold beyond 0.95 increases the false positive rate for ethanol incubation detection. 
(E) The spectra for the false positive spot at K23 is plotted. The baseline noise for K23 
may be the most contributing factor to the misclassification due to a high CC threshold. 
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The high CC threshold of 0.95 for metabolite profiling is necessary to distinguish 
ethanol incubated from untreated cells because so few new peaks appear or disappear after 
ethanol incubation compared with lipid profiling. As mentioned previously with protein 
profiling, the metabolome likely had little time to change drastically as the lipid cell 
membrane was immediately disrupted by ethanol incubation. The abundance differences 
can be attributed to potential extraction of some of the metabolites in the ethanol after the 
cell membrane was disrupted. Metabolite profiling maybe more sensitive to less intensive 
changes to the cell environment that do not immediately kill the cell. For example, culture 
conditions such as monolayer or aggregate expansion can change the metabolome of  MSC 
[37].  
5.5 Conclusions 
This preliminary data showcases the potential of ASPECT as a rapid screening tool 
for cellular therapies. Disrupting the cellular membrane with ethanol was easily detected 
using lipid profiling. Although protein and metabolite profiling were able to distinguish 
between untreated and ethanol incubated cells, the few differential features between the 
two conditions can cause false positives and false negatives due to similar CC scores. To 
improve ASPECT’s script such as in protein and metabolite profiling, other algorithms 
beyond CC testing may be necessary to better distinguish spectra with so few different 
features. It is likely ASPECT can be used to explore other kinds of quality issues commonly 
found in cellular therapies. Examples include detecting batches of cells with bacterial or 
other chemical contamination, evaluating different culture or storage conditions, and 
exploring if ASPECT can be sensitive enough to detect different donors or cell passage 
numbers. This preliminary study sets the basis for ASPECT being a method with simple 
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consumables that is high throughput and can be easily updated for the pass-fail screening 
of cellular therapies.   
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 CONCLUSIONS AND OUTLOOK 
6.1 Abstract 
This chapter summarizes the conclusions drawn from each major project in this 
thesis. A summary for the major accomplishments constructing new tools using vacuum 
assisted plasma ionization (VaPI) are discussed. The impact of the multiphase project 
evaluating the available tools on the market, performance, cost, and field usability of 
several screening devices for small molecule pharmaceuticals is examined. The initial 
development of matrix assisted laser desorption ionization (MALDI) mass spectrometry 
for cellular therapy screening is assessed. Future work for each major project is also 
discussed. 
6.2 Major Accomplishments 
6.2.1 Vacuum Assisted Plasma Ionization Development 
Chapter 2 describes the development of the aerosol vacuum assisted plasma 
ionization (Aero-VaPI) source coupled to the Waters Synapt G2s mass spectrometer. The 
Aero-VaPI source combines three key technologies. First, a scanning mobility particle sizer 
is coupled in parallel to measure the diameters of the aerosols tested. Second, VaPI boosts 
sensitivity by entraining the analytes into the plasma stream that is directly coupled to the 
ambient pressure interface of the mass spectrometer to minimize fluid dynamic losses of 
the ions. Robust online ionization can be conducted with VaPI and without extensive ion 
activation. Third and after VaPI ionization, the ion mobility mass spectrometer (IM-MS) 
in the Synapt captures orthogonal ion mobility and mass to charge information to separate 
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complex isomers that could be formed in aerosols. IM-MS provides higher peak capacity, 
good mass accuracy, and the additional capabilities of MS/MS can help identify features 
of interest. This new tool gathers simultaneous particle size, ion mobility, and m/z 
information in real time without fragmentation of the organic analytes in the ionization 
source. With this information, Aero-VaPI can lead to more in depth understanding about 
the complex chemistry inside of aerosols. Future studies of new prebiotic aerosol 
chemistries with Aero-VaPI-MS can provide insight into the mechanisms of biopolymer 
formation in these environments. 
Chapter 3 details the construction of pyrolysis VaPI (pyro-VaPI) as a tool to analyze 
insoluble polymers such as nylons. The pyrolysis device was built in house that could reach 
temperatures of up to 900°C.  The pyrolysis unit could controllably heat the sample 
impacting the pyrolyzed species’ volatility. After soft ionization of the pyrolyzed analytes 
with VaPI, ion mobility and m/z data for the pyrolyzed analytes can be gathered in real 
time. With these capabilities, unique isobaric species for nylons 6, 6-6, 6-9, 6-10, and 6-12 
were discovered through ion mobility separations once a certain pyrolysis temperature was 
reached. The added MS/MS capabilities of the Synapt allowed for confirmation that the 
separated isobars in the mobility region were their respective nylons. Both isobaric species 
of the same nylon fragmented differently under the same collision energy, suggesting 
different arrangements that impact the bond strength. This nylon data set shows how new 
potential mechanistic discoveries of pyrolyzed polymer molecular interactions can be 
achieved by combining the information gathered from the pyrolysis device temperature, 
collisional cross sections, and m/z values through pyro-VaPI.  
6.2.2 Rapid Pharmaceutical Quality Screening 
 115 
Chapter 4 evaluated twelve different portable tools for the post-market surveillance 
of small molecule pharmaceuticals in a laboratory setting. These twelve devices ranged 
from a simple single-use disposable colorimetric assay to a complex portable mass 
spectrometer. This overall study guides regulators about the advantages and disadvantages 
of each device from set-up to testing. This includes a performance evaluation in detecting 
poor quality medicines that included simulated and genuine field collected samples. 
Overall, all the devices could detect falsified medicines that contain none or the wrong 
active ingredient. Substandard detection with reduced active ingredient concentrations 
varied the most for all the devices evaluated. The quantitative devices such as the mass 
spectrometer had high sensitivities toward detecting reduced active ingredient 
concentrations; however, their specificity suffered when using pharmacopeial thresholds 
for passing tests.  The laboratory phase in Chapter 4 is part of a multi-phase project outlined 
in Appendix B. As one of the largest studies for field deployable poor quality medicine 
detection devices, regulators will have 5 key publications to reference when deciding which 
devices to purchase. First, regulators will have a detailed review of the literature to see all 
the potential devices on the market. Second, a detailed performance evaluation was 
conducted in the laboratory for 12 devices covering the broadest array of technologies 
selected from the literature review. Third, devices deemed field suitable from the lab phase 
are evaluated in a simulated pharmacy by inspectors to assess their usability and note 
common problems. Fourth, a cost analysis is conducted for the tools deemed field 
deployable. Finally, the fifth article details lessons learnt from the project and 
recommendations for future study. 
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Chapter 5 explores the use of MALDI mass spectrometry as a new tool for the rapid 
quality screening of cellular therapies. The Accelerated Screening for the Protection and 
Efficacy of Cellular Therapies (ASPECT) workflow was developed to rapidly process cells 
with minimal user input. Lipid profiling, metabolite profiling, and protein profiling 
MALDI matrix protocols and mass spectrometer settings were established. Two custom 
scripts were written to rapidly process data with minimal user input. The first script rapidly 
extracts the instrument’s proprietary data file format and converts it to the common format 
.mxXML. After conversion, the second script automatically processes the data with little 
user input and output’s a MALDI target map with samples that passed or failed. The 
preliminary data set compared untreated versus ethanol incubated mesenchymal stromal 
cells to simulate normal versus egregiously manufactured cells. Lipid profiling was the 
most sensitive method towards detecting the disruption of the lipid membrane through 
ethanol incubation than protein or metabolite profiling. This preliminary data set 
demonstrates the underlying workflow for ASPECT that can be used to explore a wider 
array of samples and where room for improvement lies.  ASPECT begins the conversation 
of developing tools like MALDI to combat the illicit manufacturing of poor quality cellular 
therapies on the market.  
6.3 Impact and Future Direction 
This thesis work has built and evaluated various mass spectrometric tools that can be 
used for a wide variety of applications. New tool development such as with VaPI can help 
explore new realms of chemistry inaccessible before. The modularity of the VaPI source 
allows for rapid adoptability for various applications. The coupling of VaPI to ion mobility 
mass spectrometry adds additional peak capacity to a technique previously limited to m/z 
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data alone. In the case of Aero-VaPI, there is a whole world of prebiotic chemistry to 
explore in aerosols as micro reaction vessels [1]. The field of aerosol chemistry is wide and 
Aero-VaPI can provide a new toolset for the identification of polymers in atmospheric 
organic aerosols [2]. 
Pyro-VaPI has many avenues of research to explore. Explaining the nylon isobaric 
species with different fragmentation patterns may be an interesting data set to model. 
Pyrolyzed polyolefins have been characterized through ion mobility mass spectrometry 
before; however, two isobaric species in the mobility region from the same chain length 
polymer have not been seen yet to the best of our knowledge [3]. Modeling of polymer 
pyrolysis products have been reported before, but the two isobaric species of the nylons in 
the mobility region have yet to be explained [4, 5].  Various other polymers can be explored 
to see if isobaric species as seen in nylon exist. Due to VaPI’s modularity, it may be 
possible to combine Pyro-VaPI and Aero-VaPI into a single source known as Pyro-Aero-
VaPI as aerosol characterization of pyrolysis products is a field of study [6, 7]. VaPI offers 
a highly adaptable tool and with the power of coupling the source to ion mobility mass 
spectrometry, new areas of chemistry can be explored. 
The laboratory phase of the portable screening device project for small molecule 
pharmaceuticals evaluated 12 out of the 41 tools found in the literature review. There are 
many other devices to evaluate alongside each other to measure their performance, cost, 
and usability in the field. For example, there are many other portable mass spectrometers 
on the market other than the QDa. These portable mass spectrometers have various 
sampling and ionization platforms that maybe easier and cheaper to utilize than the QDa’s 
flow injection analysis through electrospray ionization [8]. The QDa was the most powerful 
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platform within Chapter 4 at detecting substandard medicines with reduced active 
ingredient concentrations. However, the consumables and mechanical complexity make 
the QDa less attractive to deploy in the field compared to more robust handheld Raman or 
infrared spectrometers with little to no consumables required. These other portable mass 
spectrometers could be evaluated together to assess the most cost-effective, simple to use, 
and highest performance tool for the detection of poor quality medicines. Along with the 
United States Pharmacopeia’s efforts through their technology review program, there is a 
great need to standardize the way these portable screening tools are evaluated with so many 
different devices on the market [9].  Further insight into public health policy regarding 
portable screening devices is necessary to keep pace with the technological advances and 
to be as efficient as possible combating poor quality medicines [10, 11].   
The preliminary data from ASPECT along with the work by Heap et al. shows that 
MALDI can be a valuable tool for combating poor quality cellular therapies [12]. There 
are many avenues to evaluate and improve the ASPECT workflow. Assessing and 
expanding the capabilities of ASPECT can include: detecting bacterially- or chemically- 
contaminated cells, monitoring growing or storage conditions, or evaluating donor, lot 
number, and passage number variation. Evaluating the biological reproducibility of cellular 
therapies in MALDI experiments would be critical to establishing biotyping databases such 
as those used for bacteria. The scripts for ASPECT can also be further optimized. Although 
correlation coefficient testing is a quick and easy calculation, there are likely other more 
powerful algorithms that could be utilized to detect poor quality cellular therapies. 
Homogenizing the coding language and developing a graphical user interface for ASPECT 
data processing would make adoption in the field easier. Many of the same difficulties 
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described previously with screening devices for small molecule pharmaceuticals also 
applies to cellular therapy screening tools.  
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APPENDIX A. MICROPLASMA IONIZATION OF VOLATILE 
ORGANICS FOR IMPROVING AIR/WATER MONITORING 
SYSTEMS ON-BOARD THE INTERNATIONAL SPACE STATION  
Adapted with permission from: 
Bernier, M.C., Alberici, R.M., Keelor, J.D., Dwivedi, P., Zambrzycki, S.C., Wallace, W.T., 
Gazda, D.B., Limero, T.F., Symonds, J.M., Orlando, T.M., Macatangay, A., Fernández, 
F.M.: Microplasma Ionization of Volatile Organics for Improving Air/Water Monitoring 
Systems On-Board the International Space Station. J. Am. Soc. Mass Spectrom. 27, 1203–
1210 (2016). https://doi.org/10.1007/s13361-016-1388-y Copyright 2016 American 
Chemical Society. 
Bernier, M.C., Alberici, R.M. and Keelor, J.D. constructed and tested the microplasma 
source. Dwivedi, P. and Zambrzycki, S.C. conducted experiments with the microplasma 
and DART sources.  
A.1 Abstract 
 Low molecular weight polar organics are commonly observed in spacecraft 
environments. Increasing concentrations of one or more of these contaminants can 
negatively impact Environmental Control and Life Support (ECLS) systems and/or the 
health of crew members, posing potential risks to the success of manned space missions. 
Ambient plasma ionization mass spectrometry (MS) is finding effective use as part of the 
analytical methodologies being tested for next-generation space module environmental 
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analysis. However, ambient ionization methods employing atmospheric plasmas typically 
require relatively high operation voltages and power, thus limiting their applicability in 
combination with fieldable mass spectrometers. In this work, we investigate the use of a 
low power microplasma device in the microhollow cathode discharge (MHCD) 
configuration for the analysis of polar organics encountered in space missions. A metal-
insulator-metal (MIM) structure with molybdenum foil disc electrodes and a mica insulator 
was used to form a 300 μm diameter plasma discharge cavity. We demonstrate the 
application of these MIM microplasmas as part of a versatile miniature ion source for the 
analysis of typical volatile contaminants found in the International Space Station (ISS) 
environment, highlighting their advantages as low cost and simple analytical devices. 
A.2 Introduction 
Current in-flight air monitoring systems provide the necessary information to 
accurately assess air quality in the International Space Station (ISS), but the information 
available regarding water quality is still limited. Cabin air monitors in the ISS have 
typically used gas chromatography, ion and differential mobility spectrometry, and mass 
spectrometry (MS) to monitor part-per-million (ppm) levels of air contaminants [1–4]. For 
water samples, electrochemistry and colorimetric solid-phase extraction/reflectance 
spectroscopy are used to determine total organic carbon and biocide concentrations, 
respectively [5, 6]. These on-board technologies, however, lack specificity or only focus 
on a narrow class of analytes, and are not implemented in a fashion that enables 
simultaneous air and water quality assessment. Therefore, the current environmental 
monitoring strategy still relies on ground analysis of returned water samples for obtaining 
more comprehensive chemical information. This limitation, if not addressed, could 
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seriously limit the scope of future space exploration missions beyond low-Earth orbit. To 
address these shortcomings, more advanced in-flight air and water chemical analyzers are 
needed to reduce crew time, provide real-time data to manage nominal and off-nominal 
scenarios, and help assure mission success. 
Recent work by our team demonstrated a new electrothermal vaporization (ETV) 
sample introduction device coupled to a direct analysis in real-time (DART) ambient 
plasma ion source and a high-resolution time-of-flight mass spectrometer for identifying 
and quantifying a variety of volatile organic compounds of importance to the ISS 
environment [7]. The next logical step in the design of a combined air/water analyzer is the 
miniaturization of the plasma ion source itself by using a microplasma system, with the 
goal of reducing overall instrument size, required gas flow rates, and electrical power 
consumption. 
Microplasmas are sub-millimeter scale non-equilibrium electrical discharges [8] 
that operate with unique geometries [9], and serve as effective sources for emission 
spectroscopy [10, 11], chemical ionization MS [12], and vacuum ultraviolet (VUV) 
photoionization MS [13]. Steady growth in the development of microplasmas and other 
low power plasma for analytical chemistry applications has been seen in the recent 
literature [14, 15], the driving force being the potential for developing small, low power 
devices with reduced operational cost and increased fieldability [16, 17], with many 
focused on coupling to portable low resource MS instrumentation [18–20]. Microplasma-
based miniature ion sources operated under ambient sampling/ionization conditions have 
the additional advantages of high sample throughput and simplicity, enabling direct 
analysis with little or no sample preparation [21, 22]. 
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Here, we report on the performance of a microhollow cathode discharge (MHCD) 
microplasma-based ion source for the mass spectrometric analysis of a series of organic 
analytes of relevance to the ISS environment. The performance of the MHCD is compared 
with a commercial DART ion source. To the best of our knowledge, this is the first attempt 




The target compounds were selected to include those representative of low-
molecular-weight polar organics that are routinely detected in the ISS atmosphere and 
water. Analytes tested included methanol, ethanol, isopropanol, acetone, methyl ethyl 
ketone, and ethyl acetate. These were purchased from Fisher Scientific Inc. (Pittsburgh, 
PA, USA) and Sigma Aldrich (St. Louis, MO, USA) and used as received (>98% purity) 
without further purification. Gases used with both the MHCD and DART ion sources 
included industrial grade nitrogen (99.995%), ultrahigh purity helium (99.999%), and 
ultrahigh purity argon (99.999%) obtained from Airgas (Atlanta, GA, USA). 
A.3.2 MHCD Microplasmas 
The prototype microplasma ion source design and construction are shown in Figure 
A-1. The device’s core consists of two conductive molybdenum foil discs (diameter = 8 
mm, thickness = 100 μm) and an insulating mica disc (diameter = 10 mm, thickness = 100 
μm) in a metal-insulator-metal (MIM) configuration. The cylindrical micro-discharge 
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cavity between the planar electrodes was fabricated by laser etching a 300 μm diameter 
hole through the center of the three discs [(16)]. The discs were aligned and mounted in an 
aluminum and PEEK screw-capsule housing containing a gas feed line and electrical 
contacts connected to a PS350/5000 V–25 W high voltage supply (Stanford Research 
Systems, Inc., Sunnyvale, CA, USA). In DC mode, a continuous potential bias in the range 
of +600–2400 V was applied to the front Mo electrode. The electrode was connected in 
series with a set of resistors totaling 20 MΩ and resulting in a current of 30–120 μA for an 
estimated discharge power of approximately 0.1 W using nitrogen gas (0.100–1.0 L min–
1). Helium and argon were also used as source gases at comparable currents and flow rates 
to investigate the operational parameters for optimal ionization efficiency and conservative 
gas flow. The distance between the MHCD microplasma and the mass spectrometer inlet 
was optimized to 4 mm, where the population of reactant ions consisting mostly of water 
clusters ranging from [H2O + H]
+ to [(H2O)4 + H]





Figure A-1 Schematics and images of the metal-insulator-metal (MIM)-type micro-hollow 
cathode discharge (MHCD) microplasma ion source with (A) details of the components of 
the MHCD assembly, and (B) a side-view and front-view of the device showing the plasma 
discharge in operation using 0.3 L min–1 high purity nitrogen. 
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A.3.3 Direct Analysis in Real-Time 
A detailed description of the commercial DART-SVP ion source (IonSense Inc., 
Saugus, MA, USA) is available elsewhere [23]. Briefly, this ion source consists of a point 
electrode spaced ≤1 mm from a grounded disc electrode. A negative DC potential bias of 
several kV is applied to the point electrode. The effective discharge potentials vary 
depending on source gas type, and were measured using a high voltage probe (Fluke 179 
True RMS multimeter) to be approximately –400 V for helium and argon, and –1850 V for 
nitrogen. Undesired background ions were filtered from the post-discharge plasma gas 
stream by a molybdenum grid electrode (+200 V) positioned at the exit nozzle, ensuring 
that metastable species expelled into the ambient ionization region were the primary 
reactants. The DART source ceramic heater was left powered off for an accurate 
performance comparison with the MHCD microplasma source, based purely on plasma 
characteristics and operating at ambient temperature. The DART exit nozzle was optimized 
at a position 5–8 mm away and centered on axis with the mass spectrometer inlet. DART 
gas flow rates were adjusted from 0.15 L min–1 to 2 L min–1 to evaluate ionization 
efficiency under typical DART settings and settings comparable to those used for the 
MHCD microplasma ion source. 
A.3.4 TOF MS Instrumentation 
Both the DART and MHCD ion sources were coupled to an orthogonal time-of-flight 
(TOF) mass spectrometer (JEOL AccuTOF, Tokyo, Japan). The mass spectrometer was 
operated in positive ion mode. Typical ion optics conditions were as follows: orifice lens 
1 set to 10 V, ring lens at 6 V, and orifice lens 2 at 2 V with the desolvation temperature 
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set to 100 °C. The ion guide reference voltage was set at –29 V and the pusher bias voltage 
was –0.28 V. Data was acquired using the JEOL Mass Center software in the 10–300 m/z 
range. The AccuTOF mass spectrometer provided a mass resolution ranging between 1700 
and 4100 (FWHM) across the 18–121 Da range, corresponding to the target analytes. 
A.4 Results and Discussion 
A.4.1 Optimization and Comparison to DART 
The ability of the compact, miniaturized MHCD microplasma to ionize low-
molecular-weight organic volatiles and to match the performance of a commercial DART-
SVP ion source was first evaluated. The DART heater was left disabled during these 
experiments, as enhanced thermal desorption was unnecessary due to the high vapor 
pressures of the target analytes. Furthermore, the addition of an independent resistive 
element would contribute unfavorably to material/power requirements aboard the ISS. The 
microplasma ion source position and operational parameters were adjusted for maximum 
intensity of plasma-derived reactant ions. Figure A-2 A shows results for both the DART 
(left) and MHCD (right) ion sources, operated with ambient temperature nitrogen as the 
plasma working gas at optimized gas flow rates of 2.2 L min–1 and 0.50 L min–1, 
respectively. The background spectra for the microplasma showed a positive mode reactive 
ion population (RIP) consisting of several protonated water clusters (H2O)nH
+, with the n 
= 2 (m/z = 37) protonated water dimer dominating the spectrum, and clusters observed up 
to n = 4 (m/z = 73). This reactant ion background was very similar to the RIP distribution 





Figure A-2 Mass spectra of select target analytes acquired using DART and microplasma 
ion sources with nitrogen at 2.2 L min–1 and 0.5 L min–1, respectively. The left column 
(DART) and right column (MHCD) with (A) background spectra, (B) methanol, (C) 
ethanol (5% IPA), (D) pure isopropanol, and (E) acetone. Mass spectrometer parameters 
were selected to prevent activation in the transfer ion optics: orifice lens 1 at 10 V, ring 
lens at 6 V, orifice lens 2 at 2 V, bias at 29 V, pusher bias voltage at –0.28 V.  
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Qualitative analysis of each of the four volatiles tested (Figure A-2 B&E) was 
conducted by coating the end of a borosilicate glass melting point capillary with neat 
sample solutions of each and holding the capillary probe approximately 2 mm away from 
the ion source gas outlet. Experimental variability originating from sample capillary 
positioning and the amount of solution deposited on the probe was mitigated by averaging 
peak areas from repeated measurements. All target compounds were observed mainly as 
their protonated monomer [M + H]+ and dimer [2M + H]+ ions, with the dimer ions in a 
majority of cases dominating the spectra. Some additional [M+ NH4]
+ analyte species were 
also observed, but in lower abundances than protonated species. The detection of mostly 
clustered ions is attributed to the low inlet orifice potentials used, the neat solution 
concentrations sampled, and the unheated nitrogen ion source gas. Overall, the total ion 
signal intensity was lower for all analytes using the MHCD (approximately 35% of the 
DART signal on average), but the identities and relative ratios of ionic species for 
methanol, ethanol, or isopropanol did not change significantly between spectra for either 
ion source. For methanol, [M + H]+ ions at m/z = 33, [M + NH4]+ ions at m/z = 50, [2M + 
H]+ ions at m/z = 65, and [3M + H]+ ions at m/z = 97 were observed for both DART (Figure 
A-2 B left) and MHCD (Figure A-2 B right). Likewise, each ethanol spectrum presented 
[2M + H]+ ions at m/z = 93, [M + NH4]
+ ions at m/z = 64, [M + H]+ ions at m/z = 47, and 
[3M + H]+ ions at m/z = 139, in descending order of intensity. The only prominent 
exception to the observed matching ion distributions between DART and MHCD spectra 
was for acetone, where the [M + NH4]+ signal equated to ~90% of the [2M + H]+ signal 
for DART, but only 5% of the [2M + H]+ abundance for the MHCD. It is not at all 
surprising that among these four simple volatile organic compounds, acetone showed the 
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greatest variability between the two ion sources, given the DART’s and MHCD’s 
drastically different flow rates and fluid dynamics. Of all analytes, acetone has the highest 
vapor pressure at 0.53 atm [24], whereas methanol, ethanol, and isopropanol possess vapor 
pressures of 0.07, 0.15, and 0.13 atm, respectively [24]. Likewise, the nature of the 
functional groups in each case (alcohol versus ketone) may offer very distinct stabilization 
of NH4+ adducts and different protonation sites, which would clearly have an influence on 
the relative spectral abundances. Such behavior could be useful in deciphering volatiles 
based on their fingerprint spectra (i.e., [M + H]+ versus [M + NH4]
+ versus [2M + H]+) 
when low resolution mass analyzers are employed. The differences in sensitivity between 
the MHCD and DART ion sources seen in Figure A-2 are a consequence of differences in 
parameters such as gas flow rate and plasma current. The higher predicted gas velocity 
through the reduced dimensions of the MHCD disc electrode (i.d. = 300 μm) could also be 
a factor affecting ion transport under these conditions. The plasma generation conditions 
for each ionization source may also play a role in terms of differences in metastable 
abundances. However, the DART plasma operates in the corona-to-glow transition mode 
[25, 26], which is relatively similar to the MHCD glow mode, so in the absence of direct 
spectroscopic measurements, a solid conclusion cannot be drawn. Nevertheless, it appears 
that the limited scale and lower current of the MHCD are the primary reasons for a lower 
ion signal compared to the DART source, at least when the comparison is performed under 
gas flow regimes where DART is typically operated [26, 27]. 
To fully implement a system utilizing MHCD into the ISS, the ionization source must 
be characterized for limits of detection and ability for quantitation. Using the same 
capillary introduction system and using nitrogen plasma gas at a flow rate of 0.100 L min-
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1, estimated LODs were defined as the minimum amount of material on the borosilicate 
capillary placed between the MHCD source and MS inlet that could be detected with high 
confidence. The values were found to be 3000 pmol (100 ppm) for methanol, 2000 pmol 
(100 ppm) for ethanol, 170 pmol (10 ppm) for isopropanol, and 430 pmol (25 ppm) for 
acetone. For MEK and ethyl acetate, LODs of 350 and 110 pmol (25 and 10 ppm) were 
achieved, respectively. These two compounds compare very well to previous work using 
our ETV source, which achieved quantitative limits of detection of 194 pmol for MEK and 
2000 pmol for ethyl acetate injected into the sampling system [7]. For the three organic 
compounds with Spacecraft Water Exposure Guideline (SWEG) values, methanol, 
acetone, and MEK, 100-day allowable exposures were found to be 40, 150, and 54 ppm, 
respectively [28, 29]. While the methanol detection limit is 2.5 times higher with the 
current MHCD set-up than SWEG values, we believe much of the sample is being lost 
when placing the borosilicate capillary in an open pathway between the source and MS 
inlet. MEK and acetone detection limits, however, were lower than the recommended 
values stated in the exposure guidelines. Using a modified introduction method where 
sample loss is minimized through more efficient ion/neutral collection, focusing, and 
mixing of the plasma gas, LODs could be lowered dramatically enabling quantitation, as 
previously demonstrated using the ETV set-up coupled to DART [7]. 
A.4.2 Optimization and Comparison to DART 
To fully qualify the viability of using MHCD microplasma devices as practical 
environmental sensing components aboard the ISS, it is critical that the operational 
parameter space be fully explored, including gas type and flow rate. Although nitrogen is 
an abundant and cost-effective option for sustaining MHCD plasmas, the power 
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requirements for stable plasma operation are still substantially larger than those needed for 
helium or argon-sustained discharges, even with the miniature cavity dimensions used. 
Figure A-3 showcases spectral differences observed for several analytes when operating 
the MHCD ion source with nitrogen, argon, or helium. Spectra of methanol (Figure A-3 
A), ethanol (Figure A-3 B), isopropanol (Figure A-3 C), and acetone (Figure A-3 D) were 
acquired with low energy transfer ion optics settings in order to preserve the nature of the 
ion population without the influence of in-source declustering. Throughout these 
experiments, the plasma DC potential was held at a value necessary to achieve a plasma 





Figure A-3. Microplasma mass spectra for select target analytes acquired using N2, Ar, 
and He as the plasma gases at optimized flow rates of 1.0, 0.3, and 0.5 L min–1, 
respectively and currents of 0.050 mA for all three. Compounds shown include (A) 
methanol, (B) ethanol, (C) isopropanol, and (D) acetone and show the positions and relative 
intensities of the [M + H]+ (black triangles), [M + NH4]
+ (black stars), and [2 M + H]+ 
(black circles). Operation parameters set to same low-activation settings as in Figure A-2: 
orifice lens 1 at 10 V, ring lens at 6 V, orifice lens 2 at 2 V, bias at 29 V, pusher bias voltage 
at –0.28 V. Spectra are an average of three trials collected from one total ion chromatogram 
taken over multiple capillary introductions of the volatile sample. 
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Regardless of the plasma gas chosen, all microplasma spectra showed mainly [2M 
+ H]+ proton-bound dimers, as was the case in Figure A-2. It is clear for all test volatiles 
that the most intense [M + H]+ and [2M + H]+ signals were achieved with helium while 
sensitivity for argon and nitrogen remained essentially equal for each analyte. In the case 
of methanol (Figure A-3 A), ethanol (Figure A-3 B), and isopropanol (Figure A-3 C), the 
dimer intensity was about 3–5 times higher using helium than when using argon and 
nitrogen. For acetone, the signals for [2M + H]+ with nitrogen and argon source gas were 
significantly greater, at approximately 50% and 75% of the dimer intensity detected using 
helium, respectively. Given the higher vapor pressure of acetone mentioned before, the 
higher acetone dimer ion abundances observed are reasonable. The much larger ion signal 
observed for helium was expected, since its higher thermal conductivity and metastable 
energy result in greater signal than is possible for either nitrogen or argon. Furthermore, it 
is of note that in order to achieve the highest intensity spectra for helium, an optimized 
flow rate of 1.0 L min–1 was used whereas for argon and nitrogen optimal signal was 
achieved at flow rates of 0.30 and 0.50 L min–1, respectively. For higher density plasma 
gases such as Ar and N2, higher flow rates appeared to destabilize the discharge, requiring 
the flow rates where maximum signal was achieved to be about 30%–50% of the optimized 
flow rates for helium. 
We next considered the fundamental difference in flow rates needed for effective 
DART and MHCD operation and its effect on ionization efficiency. Figure A-4 compares 
the performance of the various plasma gases for both the MHCD and DART as a function 
of gas flow rate for the dimer [2M + H]+ species. When operating the MHCD at helium 
flow rates of 0.05, 0.15, 0.30, and 0.50 L min–1, analyte average peak areas were on par 
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with those seen for DART helium flow rates between 1.4 to 2.2 L min–1. For nitrogen-
based discharges, DART ion abundances appeared to generally increase across 1.0–2.3 L 
min–1, with the exception of acetone. In this particular case, the nitrogen MHCD signal 
changed less across all flow rates tested, and dimer intensity remained 30% to 50% of the 
DART signal at flow rates above 1.4 L min–1. 
The formation of [M + NH4]
+ adducts for each of the volatile analytes of interest 
was much more pronounced with DART than with the MHCD ion source at all flow rates 
tested, and with all plasma gases. Typically, MHCD [M + NH4]+ ion signals averaged 
0.1%–5.0% of those produced by helium DART. Given the lower ionization potential of 
ammonia (10.02 eV) versus that of water (12.62 eV), and the respective proton affinities 
of ~850 kJ mol–1 for ammonia and ~690 kJ mol–1 for water, the probability of ammonia 
protonation over water is greater, and ammonia adduction with an analyte may be preferred 
in instances where the analyte proton affinity is lower than that of ammonia [30, 31]. 
As seen in Figure A-4, regardless of the plasma gas used or analyte measured, the 
DART signals decreased drastically if gas flow rates fell below 1.0 L min–1. Although 
decreasing the DART-inlet distance could improve ion transmission at lower flow rates, 
for gases such as helium the increased gas load on the mass spectrometer vacuum system 
could have short- and long-term detrimental effects. Additionally, it is suspected that for 
nitrogen plasma gas, the longer path length between the DART discharge chamber and 
sampling region may contribute to depletion (or relaxation) of metastable excited-state 
species in the plasma afterglow prior to interaction with the analyte, comparatively 
reducing ion signal intensity. Regardless, the nitrogen MHCD does perform well at a 
fraction of the flow rate needed for DART, as it also does with argon and helium. For this 
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reason, MHCD microplasmas are an attractive alternative when considering the limited 




Figure A-4 Peak areas for the [2M + H]+ species for (A) methanol, (B) ethanol, (C) 
isopropanol, and (D) acetone using argon gas (first - purple), helium gas (second - orange), 
and nitrogen gas (third - green) for microplasma (left) and DART (right) at a series flow 
rates (L min–1). Flow rates for each gas were set to 0.05, 0.15, 0.3, 0.5, and 1.0 L min–1 for 
MHCD and 0.15, 0.3, 0.5, 1.0, 1.4, 1.8, and 2.2 L min–1 for DART. Error bars are derived 
from the standard deviation of three experiments. 
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A.4.3 Power and Lifetime Characterization 
The durability of MCHD microplasmas is an important factor to evaluate prior to 
implementation for dependable routine use aboard ISS or any other space mission. A 
relevant consideration is device lifetime, as it was observed that the microplasma ion 
source elements could be prone to degradation and decrease in performance with 
continuous and prolonged use. Microplasma cavity durability is directly related to the 
sputtering rates induced by the specific plasma conditions chosen, largely determined by 
the choice of electrode material, plasma gas, and I/V regime. Figure A-5 describes the 
threshold plasma formation conditions for the MHCD and compares the power usage for 
the three plasma gases mentioned above.  
The device power consumption depended on the discharge gas, as different applied 
voltages were required in each case to sustain an equivalent current. The power curves for 
each gas (Figure A-5) strongly indicate there is a clear difference in the power profile and 
the wattage used for nitrogen gas compared with argon and helium gases, as expected. In 
addition, it was observed that when using nitrogen and argon, the lifetime of the electrode 
at higher currents was significantly longer compared with helium. For this gas, lifetimes at 
powers above 0.120 mA were approximately 2–4 hours, with evident signs of electrode 
deterioration along the edges of the bored cavity, resulting in performance loss. Operation 
with nitrogen and argon was more robust and consistent even at these higher currents, with 
the ability to operate at over 24 h of constant use. Furthermore, operation at lower powers 
(<50 uA) increased lifetimes to over 100 h of operation for all plasma gas types examined. 
It is speculated that the rate of device degradation using helium is caused by the higher 
metastable energies [32] and higher plasma gas temperature because of the superior heat 
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capacity, thermal conductivity, and excited state distributions of helium versus nitrogen 
and argon. Driving MHCD devices with AC waveforms rather than a DC bias could further 
reduce electrode sputtering and prolong lifetime [33]. However, if operated with currents 
in the order of 0.050 mA, and equipped with molybdenum electrodes (E1 and E2, Figure 
A-1), we expect MHCDs could provide reliable operation for months if powered 




Figure A-5 Microplasma power consumption by plasma gas type at a constant flow rate 
of 0.100 L min–1 with nitrogen highlighted in green (diamonds), argon highlighted in purple 
(squares), and helium gas in orange (triangles). 
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MHCD operation using nitrogen provided an ideal balance of low power 
consumption and gas cost while affording adequate sensitivity and device longevity. As a 
possible alternative to nitrogen, argon microplasmas showed a lower onset discharge 
potential than helium (Figure A-5), and provided a similar sensitivity to nitrogen for 
volatile analysis at low gas flow rates (Figure A-3). 
A.5 Conclusion 
  This study demonstrated the performance capabilities of a MHCD microplasma ion 
source for detection of organic volatiles important in environmental monitoring 
applications. The low power consumption and compact design make this type of plasma 
device a promising alternative ion source for miniature and field mass spectrometers. Both 
the DART and microplasma ion sources produced similar reactant ion populations and 
relative distributions of analyte ions, with higher-order ion clusters detected in abundance 
in both cases, given the relatively “soft” mass spectrometer transfer optics settings used. 
Analytes were observed as protonated neutrals and ammoniated adducts in most cases, with 
protonated dimers being the most common. Comparison experiments with various plasma 
gases provided significant evidence that the source of ammonia was ambient and that 
between nitrogen, argon, and helium at equivalent power use, there was a clear advantage 
for helium use in terms of sensitivity, but not power consumption or device durability. 
In practice, nitrogen usage as the plasma gas would provide the most practical 
approach for implementing MHCD ionization aboard the ISS. It is available in large 
quantities and given the low flow rate required, should not make a significant impact on 
existing resources. It has been previously used for the volatile organic analyzer (VOA) [4] 
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and despite the power and signal performance observed for nitrogen operation, it would be 
a promising avenue for further development in designing a better water and air analysis 
platform. However, additional research is needed to enable the detection and quantitation 
of lower levels of analytes in these environments. Future studies will be aimed at improving 
ion transfer from the AP ionization region into the mass spectrometer. Other pursuits 
include device operation in AC versus DC power modes to assess device lifetime and 
sampling efficiency, and investigation of more complex molecular systems using flow-
through sample introduction schemes for practical use aboard a manned space vessel, such 
as the ISS. 
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APPENDIX B. A MULTI-PHASE EVALUATION OF PORTABLE 
SCREENING DEVICES TO ASSESS MEDICINES QUALITY FOR 
NATIONAL MEDICINES REGULATORY AUTHORITIES 
B.1 Introduction 
Adapted with permission from: 
Caillet, C., Vickers, S., Zambrzycki, S., Luangasanatip, N., Vidhamaly, V., Boutsamay, 
K., Boupha, P., Lubell, Y., Fernández, F.M., Newton, P.N. “A multi-phase evaluation of 
portable screening devices to assess medicines quality for national Medicines Regulatory 
Authorities – Introduction” PLOS Negl. Trop. Dis. Accepted April 2021. 
 In this PLOS Collection, “A multiphase evaluation of portable screening devices to 
assess medicines quality for national Medicines Regulatory Authorities,” we describe the 
results of the multiphase collaborative study conducted between 2016 and 2018 that was 
part of the Results for Malaria Elimination and Communicable Diseases Control (RECAP) 
under the Regional Malaria and Communicable Disease Trust Fund (RMTF) at the Asian 
Development Bank. The study aimed to evaluate the accuracy, utility, usability, and cost-
effectiveness of different portable devices to identify SF medicines across a variety of 
essential anti-infective medicines commonly used in the Greater Mekong Sub-region 
(GMS) to treat malaria and bacterial infections. 
As far as we are aware, this multiphase study is the first collaborative independent 
investigation listing the advantages and disadvantages from diverse chemical, economical, 
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and regulatory points of view. The overall study assesses and compares device accuracy, 
describes potential barriers, and evaluates the costs versus the benefits of the 
implementation of a wide diversity of portable medicine quality screening devices in a 
public health perspective. The series also highlights the difficulties and barriers to perform 
screening devices research and the important remaining gaps of scientific evidence. 
B.2 Literature Review 
Adapted with permission from: 
Vickers, S., Bernier, M., Zambrzycki, S., Fernandez, F.M., Newton, P.N., Caillet, C.: Field 
detection devices for screening the quality of medicines: a systematic review. BMJ Glob. 
Heal. 3, e000725 (2018). https://doi.org/10.1136/bmjgh-2018-000725   
B.2.1 Background 
Poor quality medicines have devastating consequences. A plethora of innovative 
portable devices to screen for poor quality medicines has become available, leading to hope 
that they could empower medicine inspectors and enhance surveillance. However, 
information comparing these new technologies is woefully scarce. 
B.2.2 Methods 
We undertook a systematic review of Embase, PubMed, Web of Science and 
SciFinder databases up to 30 April 2018. Scientific studies evaluating the 
performances/abilities of portable devices to assess any aspect of the quality of 
pharmaceutical products were included. 
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B.2.3 Results 
Forty-one devices, from small benchtop spectrometers to ‘lab-on-a-chip’ single-use 
devices, with prices ranging from <US$10 to >US$20 000, were included. Only six devices 
had been field-tested (GPHF-Minilab, CD3/CD3+, TruScan RM, lateral flow dipstick 
immunoassay, CBEx and Speedy Breedy). The median (range) number of active 
pharmaceutical ingredients (APIs) assessed per device was only 2 (1–20). The majority of 
devices showed promise to distinguish genuine from falsified medicines. Devices with the 
potential to assay API (semi)-quantitatively required consumables and were destructive 
(GPHF-Minilab, PharmaChk, PADs, lateral flow immunoassay dipsticks, paper-based 
microfluidic strip and capillary electrophoresis), except for spectroscopic devices. 
However, the 10 spectroscopic devices tested for their abilities to quantitate APIs required 
processing complex API-specific calibration models. Scientific evidence of the ability of 
the devices to accurately test liquid, capsule or topical formulations, or to distinguish 
between chiral molecules, was limited. There was no comment on cost-effectiveness and 
little information on where in the pharmaceutical supply chain these devices could be best 
deployed. 
B.2.4 Conclusion 
Although a diverse range of portable field detection devices for medicines quality 
screening is available, there is a vitally important lack of independent evaluation of the 
majority of devices, particularly in field settings. Intensive research is needed in order to 
inform national medicines regulatory authorities of the optimal choice of device(s) to 
combat poor quality medicines. 
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B.3 Field Evaluation 
Adapted with permission from: 
Caillet, C., Vickers, S., Zambrzycki, S., Fernandez, F.M., Vidhamaly, V., Boutsamay, K., 
Boupha, P., Mukaka,M., Newton, P.N. “A comparative field evaluation of six medicine 
quality screening devices in Laos.” PLOS Negl. Trop. Dis. Compiling Revisions May 
2021. 
B.3.1 Background 
Medicine quality screening devices hold great promise for post-market surveillance 
(PMS). However, there is little independent evidence on their field utility and usability to 
inform policy decisions. This pilot study in the Lao PDR tested six devices’ utility and 
usability in detecting substandard and falsified medicines (SF). 
B.3.2 Methodology/Principal findings 
Observational time and motion studies of the inspections by 16 Lao medicine 
inspectors of 1) the stock of an Evaluation Pharmacy (EP), constructed to resemble a Lao 
pharmacy and 2) a sample set of medicines (SSM); were conducted without and with six 
devices: four handheld spectrometers (two infrared: MicroPHAZIR, NIR-S-G1 & two 
Raman: Progeny, Truscan); one portable infrared spectrometer (4500a), and single-use 
paper analytical devices (PAD). User experience was documented by interviews and focus 
group discussions.  
Significantly more samples were wrongly categorized as pass/fail with the PAD compared 
to the other devices in EP inspections (p<0.05). The numbers of samples wrongly classified 
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in EP inspections were significantly lower than in initial visual inspections without devices 
for 3/6 devices (NIR-S-G1, MicroPHAZIR, 4500a). The NIR-S-G1 had the fastest time per 
sample (median 93.5 sec, p<0.001). The time spent on EP visual inspection was 
significantly shorter when using a device than for inspections without devices, except with 
the 4500a, risking missing visual clues of SF presence. The main user errors were the 
selection of wrong spectrometer reference libraries and wrong user interpretation of PAD 
results. Limitations included repeated inspections of the EP by the same inspectors with 
different devices and limited availability of SF medicines. 
B.3.3 Conclusions/Significance 
This pilot study suggests policy makers wishing to implement portable screening 
devices in PMS should be aware that overconfidence in devices may cause harm by 
reducing inspectors’ investment in visual inspection. It also provides insight into the 
advantages/limitations of diverse screening devices in the hands of end-users. 
B.4 Cost Effectiveness 
Adapted with permission from: 
Luangasanatip, N., Khonputsa, P., Caillet, C., Vickers, S., Zambrzycki, S., Fernandez, 
F.M., Newton, P.N., Lubell, Y. “Cost-effectiveness of six medicine quality screening 
devices in post-market surveillance of antimalarial treatments in Laos”. PLOS Negl. Trop. 
Dis. Compiling Revisions May 2021. 
B.4.1 Background  
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Substandard and falsified (SF) antimalarials have devastating consequences 
including increased morbidity, mortality and economic losses. Portable medicine quality 
screening devices are increasingly available, but whether their use for the detection of SF 
antimalarials is cost-effective is not known. We evaluated the cost-effectiveness of 
implementing such devices in medicine inspections in pharmacies in Laos PDR, 
conservatively focusing on their benefit in detecting SF artemisinin-based combination 
therapies (ACTs).  
B.4.2 Methods and findings  
We used a decision tree model to simulate the deployment of six portable screening 
devices: two handheld near-infrared [MicroPHAZIR RX, NIR-S-G1], two handheld 
Raman spectrometers [Progeny, TruScan RM]; one portable mid-infrared device [4500a 
FTIR], and single-use disposable paper analytical devices [PADs]. We considered two 
scenarios with varying prevalence of SF ACTs. In Scenario 1, 20% of ACTs were assumed 
to be substandard and 20% falsified. In Scenario 2, 10% were assumed to be substandard 
and 5% falsified. Different sampling strategies in which medicine inspectors would test 1, 
2, or 3 sample(s) of each brand of ACT were evaluated. Incremental cost-effectiveness 
ratios were estimated for each device compared with a baseline of visual inspections alone. 
A multiway head-to-head comparison of all devices and sampling strategies was carried 
out by ranking the net monetary benefit of all options. In Scenario 1, all devices were cost-
effective with a 1-sample strategy. In Scenario 2, only four devices (the MicroPHAZIR 
RX, 4500a FTIR, NIR-S-G1, and PADs) were cost-effective with a 1-sample strategy. In 
the multi-way comparative analysis, in both scenarios the NIR-S-G1 testing 2 samples was 
the most cost-effective option. 
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B.4.3 Conclusions:  
Routine inspection of ACT quality using portable screening devices is likely to be 
cost-effective in the hypothetical Laos context. This work should encourage policy-makers 
or regulators to further investigate investment in portable screening devices to detect SF 
medicines and reduce their associated undesired health and economic burdens. 
B.5 Recommendations and Next Steps 
Adapted with permission from: 
Caillet, C., Vickers, S., Vidhamaly, V., Boutsamay, K., Boupha, P., Zambrzycki, S., 
Luangasanatip, N., Fernandez, F.M., Lubell, Y., Newton, P.N. “Evaluation of portable 
devices for medicine quality screening: lessons learnt and next steps.” PLOS Med. 
Compiling Revisions May 2021. 
 We assessed the performances, usability/utility and cost-effectiveness of 
implementation of devices that can assist in the detection of substandard and falsified 
medicines from different viewpoints. We conclude that, even if current technology does 
not enable one device to effectively monitor the quality of all medicines, there is great 
promise for portable devices to empower regulatory authorities in their key function to 
improve national and global public health. The devices assessed in our work have 
capabilities useful in specific contexts and needs. However, one should also be aware of 
their limits and difficulties that may arise for their implementation. With the current state 
of knowledge, for the devices to fully realize their promise, more than technological 
advances embedded in these devices will be required to ensure that their use has the 
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intended impact in mitigating the devastating effects of substandard and falsified medicines 
on global health. A strong regulatory framework, selecting the right device for the right 
job, cost & logistic considerations, standardized device protocols, and the need for more 
evidence is necessary for effective portable device implementation.  
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APPENDIX C. ATMOSPHERIC PRESSURE DRIFT TUBE ION 
MOBILITY–ORBITRAP MASS SPECTROMETRY: INITIAL 
PERFORMANCE CHARACTERIZATION. 
Adapted with permission from: 
Keelor, J.D., Zambrzycki, S., Li, A., Clowers, B.H., Fernández, F.M.: Atmospheric 
Pressure Drift Tube Ion Mobility–Orbitrap Mass Spectrometry: Initial Performance 
Characterization. Anal. Chem. 89, 11301–11309 (2017). 
https://doi.org/10.1021/acs.analchem.7b01866. Copyright 2017 American Chemical 
Society. 
Keeler J.D. setup and optimized the drift tube. Zambrzycki S. performed replicated 
experiments, troubleshooting, and maintenance for the drift tube. 
C.1 Abstract 
Atmospheric pressure drift tube ion mobility spectrometry (AP-DTIMS) was 
coupled with Fourier transform Orbitrap mass spectrometry. The performance capabilities 
of this versatile new arrangement were demonstrated for different DTIMS ion gating 
operation modes and Orbitrap mass spectrometer parameters with regard to sensitivity and 
resolving power. Showcasing the optimized AP-DTIMS-Orbitrap MS system, isobaric 
peptide and sugar isomers were successfully resolved and the identities of separated species 
validated by high-energy collision dissociation experiments.  
C.2 Introduction 
 156 
Ion mobility (IM) spectrometry provides an additional analytical separation 
dimension when combined with mass spectrometry (MS) as well as the ability for ion 
selection and filtering based on size-to-charge ratios, ultimately enabling increases in 
instrument specificity, peak capacity, and dynamic range. By expanding spectral coverage 
across two or more dimensions (e.g., drift time and m/z), IM–MS analysis facilitates 
spectral interpretation by lessening spectral congestion [1] for different compounds with 
distinct structural motifs, e.g. lipids, carbohydrates, peptides, etc., mapping each to unique 
molecular trend lines [2]. Data extracted from this type of multidimensional space have 
immensely enriched chemical classification and molecular identification in various 
“omics” research fields. Further expansion of the IM–MS approach in time-nested liquid 
chromatography (LC)–IM–MS or IM–IM–MS systems further increases peak capacity, 
recovering more of the IM–MS dimensional space obscured by the pseudo-orthogonal 
dependence between ion mobility (K) and m/z, and also removing ambiguity in regions of 
CCS-m/z overlap [3, 4]. Such nested IM–MS platforms are capable of providing greater 
information density all the while reducing spectral complexity without a significant cost to 
analysis time. 
Currently, the most successful commercial implementations of IMS paired with MS 
employ time-dispersive drift tube (DTIMS) or traveling wave (TWIMS) mobility 
techniques. These particular techniques, for which ion-neutral collision cross-section 
(CCS) determination is relatively straightforward, have proven exceptionally useful in the 
burgeoning fields of proteomics, metabolomics, and structural MS. The majority of 
traveling wave or drift tube IM–MS arrangements, best exemplified by the Waters Synapt 
G2-S or Agilent 6560 instruments, respectively, feature mobility cells embedded within 
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the MS system that are thereby restricted to operation at reduced pressures by the vacuum 
constraints of the mass analyzer [2, 5]. All IMS separations rely on ion/gas interactions that 
scale with pressure, and such reduced-pressure configurations inevitably limit the 
achievable mobility resolving power as levels of ion diffusion are more appreciable than 
at atmosphere. Ion trapping approaches, however, can partially or completely offset this 
limitation. Enhancements to resolution and sensitivity have also been made in reduced 
pressure systems by exploiting different gas polarizabilities [1, 6], or by applying 
additional electrodynamic RF field focusing to reduce diffusional broadening [7, 8], or 
electrostatic lens implementations that can restore IMS operation at atmospheric pressure 
[9]. In this pressure regime, the resolving power of DTIMS is maximized as diffusion is 
reduced, yielding peak capacities that may even surpass LC separation efficiencies [10, 
11]. An additional benefit of atmospheric pressure operation is the assurance that the ion 
mobilities measured are from fully thermalized ions interacting with a neutral gas under 
the low field limit [12, 13]. However, very few implementations of atmospheric pressure 
(AP)-DTIMS–MS are commercially developed, with the TOFWERK IMS-TOF system 
recognized as the prime example [14]. 
Traditionally, time-dispersive ion mobility has been paired with quadrupole ion traps 
[15] and time-of-flight (TOF) analyzers [16], with modern TOF technology now providing 
mass resolutions and scan speeds ideally suited for time-nested analysis. Contemporary 
commercial IM-Q-TOF MS instruments are designed to maximize sensitivity and 
commonly incorporate ion trapping and transfer stages to alleviate the intrinsically low IM 
duty cycles [16–18]. Spatial and temporal DTIMS–MS multiplexing approaches, which 
encompass either arrays of mobility analyzers coupled to a single detector or time-
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multiplexing of multiple ion injection pulses per IM acquisition, have also been used to 
improve IM duty cycle [19–21]. Hadamard transform and pseudorandom sequence 
multiplexing methods have enabled favorable increases in signal-to-noise ratios and 
sensitivity while also retaining the higher theoretical resolving powers, enhancing 
instrument efficiency for more practical applications of AP-DTIMS [22, 23]. Recent 
advances in coupling atmospheric pressure ion mobility with FT ion cyclotron resonance 
(ICR) mass spectrometry are pushing the boundaries of achievable peak capacity [24]. 
Initial cost, however, still prevents FT-ICR instrumentation from becoming mainstream. 
Presented in this work is the combination of atmospheric pressure DTIMS with 
Orbitrap FT–MS, aimed at both increasing drift tube IMS separation power and providing 
higher mass accuracy and stability for better annotation of unknowns. One of the 
challenges with combining DTIMS with Orbitrap is that the analyzer scan times are rather 
long in comparison with those of TOF, with only a single report on a custom ion mobility 
drift cell paired with a modified Orbitrap MS currently in the literature [25]. In contrast, 
we here present the coupling of an unmodified Thermo Q-Exactive Orbitrap mass 
spectrometer to a commercially developed, fully modular EXCELLIMS MA3100 
atmospheric pressure drift tube ion mobility spectrometer. The DTIMS module is equipped 
with dual ion gates, which not only serve to define the boundaries of the drift region but 
also enable several different modes of mobility selection and filtering, accommodating the 
Orbitrap scan speeds. Several key mobility parameters, including drift tube temperature, 
drift gas flow rate, and electric field strength in both positive and negative ion modes were 
optimized. The effect of DTIMS gate pulse width on IM–MS resolving power, together 
with the impact of fixed-gate versus scanned-gate acquisition modes on system sensitivity, 
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was also explored. Primary consideration was given to understanding Orbitrap variables 
that determine maximum detector scan rate such as injection time (IT) and automatic gain 
control (AGC) settings while investigating system limits of detection. Envisioned 
applications for this system include rapid screening of complex combinatorial libraries and 
rapid metabolomics phenotyping. 
C.3 Experimental 
C.3.1 Chemicals and Materials 
Positive mode ion mobility calibration standards, including 2,6-ditertbutylpyridine 
(≥97%), nicotinamide (≥99.5%), trihexylamine (≥96%), and negative mode standard citric 
acid (≥99.5%), were purchased from Sigma-Aldrich (St. Louis, MO). Positive mode 
standards were mixed in a 1:1:1 ratio in 80:20 methanol:water at 25 ppm w/v (i.e., 130, 
204, and 93 pmol μL–1 of 2,6-ditertbutylpyridine, nicotinamide, and trihexylamine, 
respectively). A concentration series of negative mode citric acid standard, ranging from 
100 ppb to 100 ppm w/v (∼0.52–520 pmol μL–1), was prepared by serial dilution of a 1000 
ppm w/v stock solution dissolved in 80:20 methanol:water. Solutions containing isomeric 
Gly-Asp-Gly-Arg-Ser and Ser-Arg-Gly-Asp-Gly peptide sequences were prepared in 
50:50 acetonitrile:water with 0.1% formic acid to 1 mg mL–1 following the protocol 
provided with the Waters reverse peptide kit (P#700005089) obtained from Waters 
Corporation (Milford, MA) and then mixed and diluted to 100 ppm w/v (204 pmol μL–1). 
Sugar analytes d-(+)-raffinose pentahydrate (≥98%), d-(+)-melezitose hydrate (≥99%), and 
d-(+)-melibiose (≥98%) were also procured from Sigma-Aldrich and dissolved in 80:20 
methanol:water as a 100 ppm w/v mixture (∼168 pmol μL–1 for d-(+)-raffinose and d-(+)-
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melezitose hydrates, and 292 pmol μL–1 for d-(+)-melebiose) with ≥2.5 molar excess of 
NaCl. HPLC grade methanol or acetonitrile organic solvents (Sigma-Aldrich) and 
ultrapure 18.2 MΩ cm deionized water (Barnstead Nanopure Diamond, Van Nuys, CA) 
were used for all analyte solutions. High-purity nitrogen (99.998%) and ultrazero grade 
compressed air (99.998%) were acquired from Airgas Inc. (Atlanta, GA) and used as 
DTIMS buffer gases. 
C.3.2 Instrument and System Parameters 
The EXCELLIMS MA3100 drift tube ion mobility spectrometer uses a traditional 
stacked-ring electrode construction with the cell body divided into a desolvation and a drift 
segment, 6.25 and 10.55 cm long, respectively. For reference, the electrodes are thin steel 
bands (width: ∼4.5 mm, spacing: ∼1 mm), all resistively coupled to one another via printed 
circuit board connections and secured to a rectangular ceramic support (50 × 25 mm). The 
insulated ceramic block is temperature-regulated (≤250 °C) using resistive heating 
elements positioned along the cell body and at the drift gas inlet. Operation potentials up 
to ±10 000 V were applied to the desolvation cell inlet, resulting in a maximum linear 
electric field gradient of ∼570 V cm–1 across the entire drift space. 
Attached in front of the desolvation chamber is a source enclosure housing a 
sheathless (i.e., without nebulizing gas) electrospray tip (50 μm ID) adjustable to a 
maximum potential of ±5000 V relative to the IMS inlet bias. The MA3100 design features 
two Bradbury–Nielsen ion shutters situated at the entrance and the exit of the drift cell. The 
first and second ion gates are floated at ∼62.9 and ∼7.7% of the operation potential, 
respectively. The first ion gate is pulsed with a tunable symmetric potential of ±70 V during 
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conventional drift mode operation. At the end of the drift region and positioned directly 
behind the second ion gate/aperture grid is a Faraday anode disk with a 6.4 mm diameter 
opening allowing partial ion transmission to the entrance of the Orbitrap’s ion transfer 
capillary. Compressed air or nitrogen drift gas (≤3.0 L min–1) is delivered through a heated 
input line at the drift cell terminus, passed as a symmetric sheath-flow across the anode 
and pumped out (≤3.5 L min-1) through an exhaust port located at the front of the 
desolvation cell via a diaphragm pump. Gas feed lines, high voltage electronics, and 
multifunction data acquisition DAQ hardware are contained in the MA3100 peripheral 
controller box connected to the DTIMS and Orbitrap computer system. Controller box 
commands were issued using the EXCELLIMS VisIon software (version 1.2.0.31). Known 
drift tube dimensions and experimentally determined optimal settings for key mobility 




Table C-1 Summary of key system parameters 
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The MA3100 module was mounted to the atmospheric pressure interface of a 
Thermo Fisher Q-Exactive Orbitrap mass spectrometer. A schematic of the system 
configuration is depicted in Figure C-1. Ion transport past the DTIMS Faraday detector 
was governed by the combined effect of the vacuum pull within the interface preceding the 
mass spectrometer inlet and the electrostatic fields applied. The Q-Exactive MS Tune 
source voltages and sheath gas flows were assigned “0” values (switched off), and the S-
Lens RF level was held at 50 V. The ion transfer capillary temperature was set to match 
the drift tube temperature (60–240 °C). Parameter space experiments focused on the 
Orbitrap detector automatic gain control (AGC), injection time (IT), and resolution settings 
that influenced the effective analytical cycle time. Unless otherwise specified, the mass 
resolution was set at 17500 to afford the fastest possible analyzer scan rate (∼12 Hz). 
During IM–MS analysis, AGC threshold was tuned to a minimum of 2.0 × 104 ion counts 
or a maximum of 5.0 × 106 ion counts, while IT was varied from 100 to 2000 ms. The 
number of microscans setting was left at 1, and the mass range was typically set between 
50 and 500 Da. For fragmentation studies with peptides using the high-energy collision 
dissociation (HCD) cell, the normalized collision energy (NCE) was 20–45 V for an all ion 
fragmentation (AIF) range centered at m/z = 400 Da. Orbitrap analysis was conducted using 
Thermo Xcalibur 2.6 software. ProteinProspector software version 5.17.1 (University of 
California, San Francisco, CA) was used for assignment of peptide ion fragments. The most 




Figure C-1 Illustration of the AP-DTIMS-Orbitrap MS instrument configuration. 
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C.3.3 DTIMS Ion Gating Schemes 
The MA3100 is equipped to perform several analysis modes based on various trigger 
configurations of the dual ion shutters. For Faraday mode acquisitions, the second ion gate 
was held open at a set potential, thereby serving as an open aperture grid, while the first 
ion gate was pulsed open/closed once per sweep scan, and signal current was recorded at 
the DTIMS anode. When operating with MS detection, the second ion gate was also 
utilized to select (or filter) target ions using several distinct modes (Figure C-2, Table C-
1). In gated mode, the second ion gate was pulsed open following a delay after the first 
gate pulse, and signal for ions transmitted through the fixed-gate time window was 
measured by the Orbitrap MS detector. Using the alternative scan mode, the second gate 
pulse was scanned in sequential time bins across the defined drift period to generate a 




Figure C-2 Illustration of the DTIMS dual-gate modes of operation for ion selection and 
filtering. The corresponding MS TIC traces for gate #2 operations using gated mode and 
scan mode IM-MS acquisition schemes are shown. 
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The gate pulse widths for each ion shutter ranged from 30 μs to the full mobility 
acquisition period (≤50 ms). The first gate pulse width in all experiments was varied 
between 50 and 600 μs; larger pulse widths resulted in a total loss of spectral resolution. In 
gated mode, the second ion gate was typically pulsed open for a narrow 1–2 ms over the 
selected drift time interval or mobility peak of interest. Scan mode functions required 
definition of the drift time interval or scan duration, the second ion gate pulse width, and 
the step size of the scanned second gate. Unless otherwise specified, the scan time window 
was set within a range of 4–16 ms over the standard 20.3 ms mobility acquisition period, 
following a short delay (≤1 ms) from the first ion gate trigger pulse (the period was defined 
as an uneven value to reduce periodic anode noise). DTIMS dwell time was set to 1015 
ms, which equated to 50 Faraday acquisitions per gate scan step for the set 20.3 ms scan 
period. Except during specific characterization experiments, the first and second gate pulse 
widths were set equal to one another. The second gate was stepped at time intervals 1/2 to 
1/4 the pulse width over the defined scan window to effectively oversample, rendering 
scan-step-to-pulse-width ratios of 2:1 or 4:1. VisIon Faraday spectra were generated from 
20 s summations of full-period mobility scans, and mass spectra were produced from total 
scan time averages of the Orbitrap TIC spectra. When ion mobility separations were not 
desired, the DTIMS unit functioned as a passive guide for ion transmission simply by 
floating both ion gates open at voltages defined by the drift cell potential gradient (e.g., 
open mode). 
C.4 Results and Discussion 
C.4.1 AP-DTIMS Basic Performance Optimization  
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Performance of the AP-DTIMS unit was first characterized for key physical 
parameters affecting ion mobility separation, namely drift electric field strength, drift gas 
temperature, and drift gas flow rate. A systematic exploration of these parameters on 
attributes such as sensitivity and resolution was conducted with optimum parameters 
presented in Table 1. In positive ion mode, the greatest resolving power (Rp ≥ 70) and 
signal intensities were achieved using the highest programmable operating potentials 
(9000–10000 V). This resolving power is comparable to some existing low-pressure drift 
tube instruments (i.e., Agilent 6560) but with a short, compact drift tube. Maximum signal 
in negative mode was achieved at a slightly reduced DTIMS operating potential (−7000 to 
−8000 V) to avoid signal distortion from electron currents on the Faraday detector 
originating from ion source discharges. These distortions could also be mitigated by 
decreasing the electrospray potential (−2200 V) relative to the positive mode value (2600 
V). Higher DTIMS temperatures (180–220 °C) assisted droplet desolvation while retaining 
resolving power, but temperatures in excess of 240 °C induced currents in the Faraday plate 
detector and an artificial elevation of the spectral baseline by ∼3 V. Drift gas flow rate, in 
combination with DTIMS temperature, had the most influence on drift gas uniformity and 
signal fidelity. Balancing a higher drift gas input (2.0–3.0 L min–1) with a lower exhaust 
pumping rate (≤1.5 L min–1) had an optimal effect on signal, facilitating ion declustering 
and stabilizing gas flow for ion transmission. High exhaust pump rates were prone to 
disrupt the electrospray stability. 
C.4.2 DTIMS Gate Pulse Width Scan Step Functions 
The contribution of various gate pulse widths on DTIMS-Orbitrap MS sensitivity 
and resolving power was investigated to better understand the effect of scanning gate 
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operation parameters. Analysis of a citric acid standard was performed in negative ion 
mode using different gate 1 and gate 2 pulse width ratios and different scan step increments 
to control over- or undersampling. Figure C-3 A shows the Faraday responses for 4 ppm 
w/v (∼21 pmol μL–1) citric acid with gradually increasing gate #1 pulse widths. The 
mobility peaks showed increasing abundances with near linearity until a gate #1 pulse 
width of approximately 300 μs. Beyond this value, the peaks plateaued and broadened, 
further diminishing mobility resolving power. In practice, increasing the gate #1 pulse 
width also extends the drift time by a commensurate amount on the falling edge of the 
widening peak so the peaks in Figure C-3 were aligned to a centroid by subtracting 1/2 
pulse width from the drift time. For Faraday mode, gate #1 pulse widths of 75–150 μs were 
determined to provide the best balance between sensitivity and resolving power.  
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Figure C-3 (A) Faraday response for 4 ppm w/v citric acid in 80:20 methanol/water 
for increasing DTIMS gate #1 pulse widths. (B) MS signal for 10 ppm w/v citric 
acid for increasing DTIMS gate #2 pulse widths over a 2.5 ms scan window. The 
gate #1 pulse width was 100 µs and the scan step was 25 µs. (C) MS signal for 10 
ppm w/v citric acid for increasing DTIMS gate #2 scan step ratios over a 2.5 ms 
scan window. Gate #1 and #2 pulse widths were set equal at 100 µs. The number 
of data points per peak is plotted with each curve trace. For (A-C), DTIMS 
operation potential was -7000 V, drift gas temperature was 200 ˚C, and drift gas 
flow rate and exhaust pump rate were 2.0 L min-1 and 0.5 L min-1, respectively. 
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The effect of gate #2 pulse operations relative to that of gate #1 was evaluated in 
scan mode. Orbitrap parameters, further discussed in the next section, were set as follows: 
resolution = 17500 [12 Hz], AGC= 5.0 × 106, IT = 1000 ms. The gate #1 pulse width was 
set to 100 μs, while gate #2 pulse widths were varied from 25 to 400 μs over a drift time 
scan window of 2.5 ms centered on the citric acid drift time (Figure C-3 B). For the shortest 
gate #2 pulse width (25 μs), no signal was detected because the programmed pulse width 
was below the rated cutoff of the ion shutter. Peak area was observed to increase with gate 
#2 width, while resolution decreased for gates wider than 100 μs, but resolving powers 
remained comparable to those observed from the Faraday detector response (gate #1 and 
#2 at 100 μs: Rp ∼ 60–70). For alignment, the citric acid peaks were corrected for gate 
pulse width by subtracting 1/2 of the first gate pulse width and adding 1/2 of the second 
gate pulse width. Improved timing correction for instances where the pulse width of gate 
#2 was larger than gate #1 required addition of an extra adjustment factor equal to (1/16) 
of gate#2, which is related to the scan step. As expected, shorter gate #2 pulse widths 
relative to gate #1 resulted in lower intensity MS signals due to gate shutter “clipping” of 
ion packets with modest or no improvement to resolving power. 
The impact of the scan step duration on signal was investigated independently while 
setting gate #1 and gate #2 pulse widths equal (100 μs). Gate scan steps were varied from 
12.5 μs up to 200 μs for an IMS dwell time of 1015 ms, equating to 50 DTIMS acquisitions 
per scan step over the 20.3 ms drift period. Orbitrap parameters were set as before 
(resolution: 17500 [12 Hz], AGC: 5.0 × 106, IT: 1000 ms). Figure C-3 C shows the citric 
acid MS signal using these various scan steps, which corresponded to oversampling ratios 
of 8:1 (12.5 μs), 4:1 (25 μs), and 2:1 (50 μs), a matched sampling ratio of 1:1 (100 μs), and 
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an undersampled ratio of 1:2.5 (250 μs). There was a minor drift time variance across peak 
apexes for the different scan steps, which may be correlated with minute fluctuations in 
measured ion intensity over the different mobility times. As expected, undersampling 
resulted in a dramatic loss of resolving power, with oversampling being critical to refine 
peak shape when using gate #1 widths of 100 μs or larger. An oversampling of 4:1 (25 μs) 
was observed to provide the best balance between adequate sampling and overall speed of 
analysis. 
C.4.3 Effect of Orbitrap Automatic Gain Control and Injection Time 
Apart from DTIMS gate pulsing schemes, the Orbitrap MS detector settings were 
the other principal determinants of performance, as they potentially had a substantial 
influence on sensitivity, resolution, and analytical cycle time. Analyzer resolution, 
injection time, and automatic gain control were examined while assessing DTIMS 
performance in both fixed-gate and scan modes. The lowest available analyzer resolution 
(17500) was chosen for all characterization experiments to permit the fastest allowable 
acquisition rate (∼12 Hz) for the selected mass range (m/z = 50–500). The automatic gain 
control, which defined the threshold for the target ion number, was set initially to the 
highest available value (5.0 × 106) in order to fix injection time. The maximum injection 
time, or the nominal duration of ion accumulation and the rate-limiting cycle step 
governing sensitivity, was adjusted between 100 and 2000 ms, values that allowed for 
adequate analyte detection. 
C.4.4 DTIMS-Orbitrap MS Applications 
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Several test analyte sets were investigated to explore system performance in 
applications involving isomer separation and identification. Figure C-4 A shows the 
Faraday response and associated mass spectrum for a 100 ppm w/v mixture of two reverse 
peptides (Ser-Asp-Gly-Arg-Gly and Gly-Arg-Gly-Asp-Ser) collected using optimized 
mobility parameters and scan mode acquisition (gate #1 and #2 pulse width: 150 μs, scan 
step: 50 μs, scan window: 5–15 ms). Three species were detected in the Faraday trace, 
representing the singly charged peptide monomers (m/z = 491.221) overlapping at td = 
12.25 ms and the doubly protonated monomers (m/z = 246.114) of GRGDS and SDGRG 
at td = 7.12 and 7.45 ms, respectively. The [M + 2H]2+ peptide species, having reported 
collision cross-section areas of Ω = 222.7 Å2 and Ω = 211.7 Å2 at 250 °C in N2 [26], were 
clearly resolved to baseline by AP-DTIMS (Rp ∼ 72) with roughly double the resolving 
power possible for these ions using TWIMS (Rp > 36). Isomer identities were verified by 
drift time measurements for single-component peptide standards and further confirmed by 
high-energy collision dissociation (HCD) MS/MS experiments of the mobility-resolved 
sequence isomers. Figures C-4 B&C shows the characteristic HCD MS/MS spectra for the 




Figure C-4 Scan mode averaged mass spectrum and Faraday response (inset) for 100 
ppm w/v of mixture of [Ser-Asp-Gly-Arg-Gly] and [Gly-Arg-Gly-Asp-Ser] peptide 
sequence isomers in 50:50 acetonitrile/water with 0.1% formic acid (A). All ion 
fragmentation HCD of the separated peptide isomers using a normalized collision 
energy of 20 V, where individual [M+2H]+ species were isolated by ion mobility before 
fragmentation (B and C). Asterisks (*) denote identified sidechain fragments of serine, 
aspartic acid, and arginine. (DTIMS operation potential: 10,000 V, drift gas 
temperature: 220 ˚C, drift gas flow rate: 3.0 L min-1, exhaust pump rate: 1.5 L min-1; 
gate #1 and #2 pulse width: 150 µs; scan step: 50 µs). 
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In addition to the reverse peptide sequences, a simple carbohydrate mixture of sugar 
isomers and structural homologues was examined. Analyte solutions were concentrated at 
100 ppm w/v with a 2.5× excess of NaCl salt to facilitate positive mode ionization via 
sodium adduct formation. Figures C-5 A–D depict VisIon spectral data for both Faraday 
and MS detectors obtained using a DTIMS scan mode over a 4 ms scan acquisition window. 
The 200 μs gate pulse widths used resulted in a small reduction in Rp to benefit sensitivity 
and a large solvent signal recorded in the Faraday channel. Within the drift time zone of 
9–13 ms, four distinct signals were observed. In order of increasing td, the carbohydrate 
peaks were assigned to [M + Na]+ for the disaccharide d-(+)-melibiose (m/z = 365.105) at 
td = 9.94 ms, and the trisaccharide isomers d-(+)-melezitose (m/z = 527.158) and d-(+)-
raffinose (m/z = 527.158) at td = 11.70 ms and td = 12.19 ms, respectively. The peak order 
was consistent with mobility distribution reports from the literature [15, 27] and was 
verified by injecting single-component solutions of the standards. The one peak not 
assigned to a sugar at td = 10.70 ms is a suspected contaminant tentatively identified as the 
sodiated adduct of decamethylcyclopentasiloxane (m/z = 393.082), a common ESI 
background ion. The m/z vs drift time plot conveyed an additional approach to visualize 
the data, portraying the nested IM–MS distribution and precursor ion trendlines. The 
ellipses drawn on the plot mark peaks for the carbohydrates and contaminant ion while 
filtering any other background signal overlapping in the same mass/mobility region. This 
data show the power of AP-DTIMS-Orbitrap MS for discriminating isobaric analytes in 




Figure C-5 AP-DTIMS-Orbitrap MS analysis for 100 ppm solution (w/v in 50:50 
methanol/water) of 3 saccharides: D-(+)-melibiose, D-(+)-melezitose, and D-(+)-
raffinose. Panels show the extracted mass spectra for each mixture component (A), the 
corresponding Faraday response (B), a map of the chemical space with m/z plotted as a 
function of drift time (C), and the extracted MS total ion chronograms (D). (gate #1 & 
#2: 200 µs, scan step: 50 µs; AGC: 5.0E+06, IT: 1000 ms, Resolution: 35,000). 
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C.5 Conclusion 
This work involved characterization of a dual-gate AP-DTIMS-Orbitrap system, 
showcasing its performance capabilities to date. The DTIMS unit afforded the greatest 
separation efficiency near the maximum operation potential of 10000 V while using gas 
temperatures ≥200 °C and high drift gas flow rates of 2.0–3.0 L min–1 balanced with lower 
exhaust pump rates of 0.5–1.5 L min–1. The effects of different ion mobility gating schemes 
on sensitivity and resolving power were thoroughly investigated. It was found that 
resolving power (Rp ≤ 70) was mostly determined by the initial DTIMS gate pulse width 
(50–150 μs), and during scan mode analysis, the scan step bin width for the second ion gate 
if pulse width was set equal to the first gate. Likewise, sensitivity and throughput were 
primarily dictated by DTIMS gate pulse width, while Orbitrap parameters governing 
analytical cycle had a subtler and more complex influence. Orbitrap variable injection 
times did not appear to significantly alter intensity levels at high gain settings but had a 
more pronounced impact on average signal intensity at the lowest gain settings and higher 
analyte concentrations. The optimized AP-DTIMS-Orbitrap MS parameter settings were 
used to successfully resolve simple mixtures of peptide and sugar isomers, and HCD 
MS/MS was performed to further confirm peptide identities based on characteristic 
fragmentation spectra. Future experiments will include collision cross section 
measurements and peak capacity estimations for the IM–MS platform, with the ultimate 
outlook for this system involving implementation of multiplexed sampling approaches. 
Further improvements in resolving power through the use of longer drift tubes, more 
effective ion gating, and higher drift voltages are also envisioned. 
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APPENDIX D. ROBOTIC SURFACE ANALYSIS MASS 
SPECTROMETRY (ROSA-MS) OF THREE-DIMENSIONAL 
OBJECTS. 
Adapted with permission from: 
Li, A., Paine, M.R.L., Zambrzycki, S., Stryffeler, R.B., Wu, J., Bouza, M., Huckaby, J., 
Chang, C.-Y., Kumar, M., Mukhija, P., Fernández, F.M.: Robotic Surface Analysis Mass 
Spectrometry (RoSA-MS) of Three-Dimensional Objects. Anal. Chem. 90, 3981–3986 
(2018). https://doi.org/10.1021/acs.analchem.7b04980 Copyright 2018 American 
Chemical Society 
Li, A. and Paine, M.R.L. engineered the initial robot and performed experiments. 
Zambrzycki, S. assisted in construction of the robot, evaluation or robotic arm precision, 
and screening of falsified medicines.  
D.1 Abstract 
Many technologies currently exist that are capable of analyzing the surface of solid 
samples under ambient or vacuum conditions, but they are typically limited to smooth, 
planar surfaces. Those few that can be applied to nonplanar surfaces, however, require 
manual sampling and a high degree of human intervention. Herein, we describe a new 
platform, Robotic Surface Analysis Mass Spectrometry (RoSA-MS), for direct surface 
sampling of three-dimensional (3D) objects. In RoSA-MS, a sampling probe is attached 
to a robotic arm that has 360° rotation through 6 individual joints. A 3D laser scanner, 
also attached to the robotic arm, generates a digital map of the sample surface that is used 
to direct a probe to specific (x, y, z) locations. The sampling probe consists of a spring-
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loaded needle that briefly contacts the object surface, collecting trace amounts of 
material. The probe is then directed at an open port liquid sampling interface coupled to 
the electrospray ion source of a mass spectrometer. Material on the probe tip is dissolved 
by the solvent flow in the liquid interface and mass analyzed with high mass resolution 
and accuracy. The surface of bulky, nonplanar objects can thus be probed to produce 
chemical maps at the molecular level. Applications demonstrated herein include the 
examination of food sample surfaces, lifestyle chemistry, and chemical reactions on 
curved substrates. The modular design of this system also allows for modifications to the 
sampling probe and the ionization source, thereby expanding the potential of RoSA-MS 
for a great diversity of applications. 
D.2 Introduction 
Over past decades, tools for surface analysis by mass spectrometry (MS) have rapidly 
progressed [1]. The ability to probe solid samples by MS directly has enabled correlation 
of analyte abundances with their spatial distribution. This is most notably exemplified by 
MS imaging (MSI) of biological tissues, where mapping of analytes across different 
features has revealed biological information that would otherwise be lost if only analyzing 
the corresponding sample homogenate [2, 3].  
Matrix-assisted laser desorption/ionization (MALDI) [4] and secondary ion mass 
spectrometry (SIMS) [5] are two of the first methods developed for MSI of solid surfaces 
in vacuum. Ambient ionization methods, such as desorption electrospray ionization 
(DESI), [6] liquid microjunction surface sampling probe (LMJ-SSP), [7] liquid extraction 
surface analysis (LESA), [8] nanospray desorption electrospray ionization, [9] matrix-
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assisted laser desorption electrospray ionization (MALDESI), [10] and laser ablation-
electrospray ionization (LAESI) [11] have also been used for MSI, but with the additional 
advantage of keeping samples in a state closer to their native form. Despite their usefulness, 
however, these ambient techniques were not necessarily conceived for probing large, 
bulky, curved, three-dimensional (3D) objects. For this purpose, other approaches such as 
probe electrospray ionization, [12, 13] and swab procedures [14–16] have been used with 
success, but still requiring a high-degree of human intervention. 
Robotic arms coupled with various techniques, such as laser-induced breakdown 
spectroscopy, have been previously implemented for the analysis of 3D surfaces with 
success [17, 18]. In previous work, we combined remote sampling and plasma ionization 
with a 3-dimensional (3D) IR camera [19]. This proof-of-principle work demonstrated that 
point cloud output data from that 3D camera could be used to direct a robotic arm to the 
samples’ surface for ambient MS analysis. However, the range of analytes amenable to 
plasma ionization was limited to those of significant volatility due to the use of the heated 
desorption gas plume of a direct analysis in real time (DART) ion source, and resolution 
was limited to 3 mm spots due to imprecisions in surface digitization. Moreover, the 
industrial robotic arm employed required very specific measures for its safe operation in 
the laboratory environment. 
Here, we report on a new generation of instrument and methods for 3D surface 
chemical analysis, named robotic surface analysis mass spectrometry (RoSA-MS). In 
RoSA-MS, surface topography digitization is accomplished at higher accuracy by a 
custom-built laser scanner mounted on a safe, force-sensing robotic arm via a 3D-printed 
adapter. The point cloud data generated by the scanner is used by scripts in a custom 
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graphical user interface (GUI) to direct a spring-loaded semiblunt needle probe that is also 
mounted on the arm. This probe is used to touch points of interest in the surface of 
irregularly shaped, nonplanar objects. Following surface sampling, the robot control scripts 
direct the arm to place the needle probe into an open port sampling interface (OPSI) [20, 
21]  feeding into an electrospray ion for MS and MS/MS analysis. MS data acquisition is 
performed in parallel with robot motion and probe insertion. Molecular cartography [15] 
plots for a wide range of object types and target analytes are then generated by combining 
peak-picked MS data, the coordinates for the sampled points of interest, and the mesh 
surface created from the laser scan. 
D.3 Experimental 
D.3.1 RoSA System 
A UR5-Cb2 (gen 2) robotic arm (Universal Robots, Odense, Denmark) with 360° 
rotation and force-sensing capabilities through six individual joints was used for all 
experiments. A control framework, “Actin-MS”, was coded in the Actin software 
environment (Energid, Cambridge, MA) and used to control the robot as well as other 
system components. A 3D line laser scanner was attached to the robotic arm’s “wrist” with 
a custom 3D-printed mount. The Actin GUI guided the robot movement so that the probe 
can approach the digitized (x, y, z) coordinates selected by the user. The major objects 
(bench, mass spectrometer, etc.) in the laboratory environment were built into the GUI 
(Figure D-1 A) so that collision avoidance boundaries could be incorporated into the Actin 




Figure D-1 (A) The robot and laboratory environment integrated into the Actin GUI. The 
digitized object surface contour following the laser scan was also included (shown in red). 
(B) Laser scan start and end waypoints being programmed in Actin-MS to define the length 
of the scan. (C) A bell pepper being scanned by the laser. A block of foam was placed on 
the actual workbench to define a safety buffer zone. The scanned object contour appears to 




A line laser (532 nm, 50 mW, class I, BES532-L, Apinex, Montreal, Canada) and 
a Ximea camera (MQ013CG-E2, Ximea Corp. Lakewood, CO) were used to build the laser 
scanner and were attached to the robot’s end-effector. The laser scanner control and data 
collection were integrated in the Actin-MS GUI, allowing to set parameters such as scan 
waypoints and direction, scan speed, exposure, and height threshold (Figure D-1 B). To 
digitize an object’s topography, a laser line was projected across such object, and moved 
by the robotic arm in a direction perpendicular to the laser line along the y-direction, while 
maintaining the x and z coordinates identical at a speed of 3 cm s–1. The laser line reflection 
on the object was captured by the camera at a rate of 30 frames per second (Figure D-1 C). 
Using computer vision techniques, the video frames captured with laser projections were 
used to construct the point cloud data that formed the object’s surface contours in 3D. This 
data showed a resolution of 0.2 mm in the x-direction, 1.0 mm in the y-direction, and 0.6 
mm in the z-direction. The Actin-MS GUI created a mesh file with this data, representing 
the surface of the sample object. The laser scanner/camera system worked well for most 
types of surfaces, except those highly reflective (e.g., mirrors) that did not produce 
sufficient diffuse radiation. 
By clicking on the mesh surface displayed in the GUI, the coordinates of the clicked 
point were immediately obtained, designating the sampling point for the probe to be 
directed at. The RoSA-MS probe was guided by Actin-MS to contact the surface at this set 
of coordinates. The needle probe was constructed by securing a round stainless-steel tip 
(0.2 mm diameter) on a compression spring (1/8 in. OD × 0.093 ID × 0.75 in. length, 5.27 
lbs in–1, McMaster Carr). This spring provided extra travel for the needle following contact 
with the surface, avoiding any possible damage by the probe. To ensure adequate pressure 
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for analyte transfer during probe-surface contact, the z-axis of the robot was offset in the 
control software by −1 mm. 
D.3.2 Mass Spectrometric Analysis 
A sampling interface was used to couple RoSA with the atmospheric pressure inlet 
of mass spectrometers without modifying existing source parameters. Both a Thermo Q 
Exactive Plus Orbitrap and a Waters Synapt G2-S quadrupole-time-of-flight were tested. 
This interface featured a flow system similar to the OPSI reported by Van Berkel [20] with 
the difference that it was sealed by the needle probe when the robot-arm docked. As shown 
in Figure D-2 A, a coaxial tubing configuration was adopted to enable solvent delivery to 
the OPSI through the annulus, and solvent delivery to the ESI ion source via a center 
capillary. A PTFE outer tube (1/16 in. OD × 0.03 in. ID × 20 mm length; IDEX, Oak 
Harbor, WA) and a fused silica center capillary (361 μm OD × 254 μm ID × ∼300 mm 
length; Polymicro Technologies, Phoenix, AZ) were used for constructing the interface. 
The inner capillary had a dead volume of 15 μL. A PEEK tee (IDEX, Oak Harbor, WA) 
was used to secure the OPSI assembly. Solvent delivery to the OPSI was controlled by a 
syringe pump, while a continuous solvent flow to the ESI ion source was ensured by sealing 
the annulus tubing with the needle probe (Figure D-2 B). A methanol–water solvent 
mixture (1:1) was used in all experiments. Flow rates ranging from 5 to 50 μL min–1 could 
be chosen on demand by controlling the syringe pump and were independent from the ion 
source settings. At flow rates lower than 5 μL min–1, stable ion signals were difficult to 
maintain and leaking was observed at flow rates higher than 50 μL min–1. In the majority 
of cases, a flow rate of 20 μL min–1 was used, resulting in a 45 s wash-through time. The 
OSPI assembly was tilted 45° from vertical for easier access by the robotic arm. Using this 
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setup, typical times for RoSA-MS operations were as follows: 10 s for the laser scan, 8 s 
for sampling one surface point starting from the robot’s home position, and 42 s for 
orienting and introducing the needle probe into the OPSI. Following these events, the 




Figure D-2 (A) During RoSA-MS analysis, the robot docks the needle probe into an open 
port sampling interface (OPSI). (B) Schematic of the needle probe docked in the OPSI. 
Pressure from the spring-loaded probe against the annulus tubing maintains a sealed 
junction. The solvent flow between the annulus and the center capillary dissolves the 




The Orbitrap mass spectrometer was used to conduct most experiments. A heated 
electrospray ionization (HESI) ion source attached to the Ion Max housing was used 
without modification. Ion source parameters were as follows: sheath gas flow rate 15–25 
arb. units, aux. gas flow rate 2 arb. units; sweep gas flow rate 0 arb. units, heater (aux.) 
temperature 80 °C, spray voltage: ± 2.5 kV, capillary voltage 0 V, capillary temperature 
200 °C; S-lens RF level 50 arb. units. Unless noted otherwise, the Orbitrap was operated 
in either positive- or negative-ion modes at a mass resolution of 17 500 at m/z 200. The 
automatic gain control target was set to 1 × 106 ions, and the maximum ion injection time 
was set to 65 ms. The Xcalibur software was used to process and export MS data into a.csv 
format file. 
A Waters Synapt G2-S HDMS mass spectrometer was also easily coupled with the 
RoSA robot. MS data was obtained using its built-in ESI ion source operated with the 
following parameters: capillary voltage ±2.5 kV, sampling cone 12 V, source offset 30 V; 
source temperature 200 °C, desolvation temperature 100 °C; cone gas flow 2 L h–1, 
desolvation gas flow 300 L h–1, nebulizer gas pressure 5.8–6.2 bar. Unless noted otherwise, 
this mass spectrometer was operated in positive- or negative-ion, time-of-flight resolution 
mode. 
D.3.3 RoSA Data Processing and Fusion 
Meshlab (version 2016.12) [22], an open source software, was used to process the 
raw point cloud data from the laser scan. Poisson parameters (12, 1.5, 4) were used to 
achieve a good balance between smoothing noise and preserving surface details in the mesh 
generation process [23]. Topological artifacts in the generated mesh were manually 
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removed, if needed. The curated 3D surface mesh data was converted to a .stl file format 
for fusion with MS data. Integrated abundance areas were listed in a .csv file together with 
the sampled 3D coordinates and the peaks’ m/z values [15, 24]. Spot sizes of 1–5 mm were 
used for visualizing sampled spots on objects of different sizes. 
Visualization was achieved by loading the .stl surface mesh file and the .csv file into 
the ili software [24–26]. Unless indicated otherwise, the following ili visualization 
parameters were used: spot opacity 1, border opacity 0.1, size factor 1, mapping: scale 
linear or logarithmic, color map jet; hotspot quantile 1. All molecular cartography data is 
available at the following link: 
https://ww2.chemistry.gatech.edu/fernandez/supplementary-material 
D.4 Results and Discussion 
D.4.1 Sampling Precision and Resolution 
The UR-5 robot controls its position coordinates with an accuracy of 0.01 mm, and 
the Actin GUI reserves position accuracy of 0.0001 mm for robot simulation and control. 
However, due to control system integration and the added custom-built probe, the precision 
of the system was expected to be lower. For this reason, the sampling precision was 
evaluated by repeatedly piercing a paper sheet using a 0.125 mm-diameter solid needle at 
the same nominal location following random arm movement through various waypoints 
(Figure D-3). As shown in Figure D-3 A&B, the Actin-UR-5 system was observed to 




Figure D-3 (A) To evaluate the precision of the robot controlled by Actin, a 0.125 mm OD 
needle was programed to pierce the same location on a piece of paper after a random 3-
waypoint arm movement. (B) For the first twenty cycles of piercing, the needle went 
through the paper creating a single hole 200 μm in diameter. From these measurements, 
the estimated deviation was calculated to be in the order of 200 μm -125 μm =75 μm, for 
an overall precision of 75 μm/2=37.5 μm (~40 μm). Following this experiment, the RoSA 
system was restarted to test experiment-to-experiment positioning robustness. The system 
was programmed to pierce the same location as in the previous experiment for an additional 
20 cycles. In this case, it was observed that the system showed a offset that created a new 
hole ~300 μm away from the original location. (C) Several objects scanned by the laser 
scanner, (D) the obtained point cloud data revealing the laser scanner’s precision in the x, 
y, z directions. 
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The laser scanner’s contribution to sampling precision was also investigated. Point 
cloud data for a series of objects placed on a flat surface were collected (Figure D-3 C&D). 
Investigation of the generated point cloud data showed a spacing of 0.2 mm in the x-
direction and 1.0 mm in the y-direction. Standard deviations in the z-values of 100 identical 
points scanned from a flat surface revealed a precision of ±0.6 mm along that coordinate. 
Considering the observed z-direction precision, a sampling position tolerance of 1.0 mm 
was built-in the probe design by means of a compression spring, and a 1 mm z-direction 
offset in the robotic sampling GUI operation. In all performed experiments, the sampling 
probe always came into contact with the selected surface points, suggesting an overall 
spatial resolution of approximately 1 mm, an improvement over the ∼3 mm obtained in 
previous work [19]. The spring loaded tip had the additional advantage of providing a softer 
touch that did not pierce surfaces of more delicate samples. 
D.4.2 Characterization of OPSI Performance 
Prior to examining 3D objects, the operation of the OSP interface was tested by 
analyzing model analytes on relatively flat surfaces. First, the RoSA probe was directed to 
contact for 1 s an area where 1 μL of a 100 μM neat caffeine solution had been allowed to 
dry on a cotton swab. Following sampling, the robot docked the tip of the needle probe into 
the OPSI while the mass spectrometer was being operated continuously in positive-ion 
mode. A signal at m/z 217 corresponding to the [M + Na]+ ion of caffeine was readily 
observed in the real-time mass spectrum, ∼45 s after the probe docking event, at a solvent 
flow rate of 20 μL min–1. The extracted ion chronogram (EIC) showed a peak of 
approximately 18 s FWHM. Although shorter wash through times and sharper peaks could 
be obtained by using a shorter center capillary [20], the OPSI configuration chosen in these 
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experiments provided the extra clearance needed between the robotic arm and the mass 
spectrometer. The signal at m/z 217 returned to background levels ∼45 s after it was first 
detected, with negligible carryover. 
The detection limit and dynamic range achievable with the RoSA-MS system were 
evaluated by pipetting neat cocaine samples of increasing concentrations directly onto the 
probe needle. The samples were applied in the form of 1 μL solution and allowed to dry. 
The lowest detectable level of cocaine with the current system using parallel reaction 
monitoring (PRM) mode of the m/z 182.12 fragment ion was 1 pg (1 ppb). A dynamic 
range of 4 orders of magnitude was achieved until the EIC started to broaden at a 
concentration level of 10 ng (10 ppm). These experiments indicated the potential of this 
system for direct, automated, surface semiquantitative experiments. 
D.4.3 Molecular Cartography RoSA-MS Applications 
One driver for implementing robotics for MS sampling purposes is to replace error-
prone, labor-intensive human operations. Both commercial systems such as LESA [27] and 
laboratory-built systems [28] can perform automated sample screening either on flat 
surfaces, or after appropriate sample preparation. With RoSA-MS, sample objects can be 
directly scanned in their native form and shape, coregistering the chemical analysis data, 
the 3D contour of the sample object, and the sample collection coordinates. We therefore 
tested RoSA on several model samples, obtaining both full survey and tandem mass spectra 
for each point sampled. 
In the first test, a plastic coffee cup cover with a dried coffee stain was probed by 
RoSA-MS, as a simulation of a sample of potential forensic interest. Mesh coordinates 
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were selected so as to guide the probe to touch the stain on the cup (Figure D-4 A&B). The 
needle probe was then docked in the OPSI to subject the detached material to ESI-MS 
analysis. As expected, the MS data confirmed the presence of caffeine on this spot at m/z 
217 (Figure D-4 C). 
   
 196 
 
Figure D-4 (A) Digitized surface mesh for a coffee cup. The red dot indicates the selected 
sampling point. (B) Photo showing the needle probe contacting the sample surface. (C) 
Mass spectrum obtained for the material detached by the probe and injected into the OPSI. 
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The rapid screening of medicine quality is another potential application of RoSA-MS. 
Falsified medicines (in particular anti-infectives and antimalarials) have become a 
significant worldwide problem, requiring constant surveillance [29]. Genuine and falsified 
artemether/lumefantrine antimalarial tablets [30] in their original blister packs, were 
screened by RoSA-MS (Figure D-5). The needle probe was used to pierce through the 
aluminum foil seal, touching the tablet surface. For a genuine tablet, intense peaks at m/z 
321 and 619, corresponding to the [M + Na]+ and [2M+Na]+ ions of artemether were 
observed. For a fake tablet, peaks at m/z 203, 205, and 365, corresponding to the [M + 
Na]+ ions of glucose, mannitol, and sucrose, respectively, were detected (Figure D-5), 




Figure D-5 (A) Genuine artemether/lumefantrine antimalarial combination medicine 
blister pack being laser scanned. The relative abundances for artemether (m/z = 321, 619) 
(B) and various sugar-like compounds (m/z = 203, 205, and 365) (C) are plotted on the 
mesh surface. (D) Falsified antimalarial combination medicine blister pack being laser 
scanned, (E) and (F) show intensities for artemether (m/z = 321, 619) and various sugar 
ions (m/z = 203, 205, and 365) ions. The corresponding survey mass spectra are shown in 
(G) and (H). 
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In another example, a rubber football which had been touched by a person who 
used N,N-diethyl-meta-toluamide (DEET) to fight off mosquitoes was subjected to RoSA-
MS. Spots in the area that had been touched by the hand showed significantly higher 
abundances for ions at m/z 192 and 214, corresponding to the [M + H]+ and [M + 
Na]+ species of DEET (Figure D-6). Most of the other regions, however, did not produce 
DEET signals much higher than the background level, agreeing with the fact that this 




Figure D-6 (A) A hand that was sprayed with DEET holding a football. (B) Several 
locations on this football were analyzed by RoSA-MS. The summed peak area (m/z 192 + 
214) for DEET ions was converted to a pseudo color scale for the specific coordinates 
sampled. The dashed lines indicate the approximate boundary of the fingers when touching 
the football surface. (C) Full scan mass spectrum obtained from the coordinates where the 
thumb contacted the surface. 
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A useful application of RoSA-MS is that of monitoring products of chemical 
reactions on 3D surfaces as a means of understanding the role that these surfaces play in 
facilitating (or hampering) chemical reactivity. As an example, we studied the 
condensation polymerization reaction of amino acids and alpha hydroxy acids, following 
an ester–amide exchange mechanism leading to depsipeptides—a plausible prebiotic route 
to modern peptides [31–33]. Thus, far, these reactions have been carried out in bulk with 
the role of heterogeneous surfaces still yet to be determined. To test the applicability of 
using RoSA-MS for studying this system, a simulated condensation experiment was 
performed on a laboratory spot plate. A roughened 6-well spot plate (Figure D-7 A) was 
used to carry out a dry down reaction with 600 μL of an aqueous solution of glycolic acid 
(120 mM, “g′”), alanine (40 mM, “A”), glycine (40 mM, “G”), and leucine (40 mM, “L”), 
at 80 °C. The spotted solution initially occupied approximately half the volume of each of 
the wells. After an overnight dry down in the oven to favor condensation polymerization 
followed by cooling of the plate at room temperature, a darker region at half the well height 
was observed due to the “coffee ring effect”. The solid residue was found to have climbed 
up the well wall toward the rim, and against gravity during the drying process. RoSA-MS 
was then used to visualize the distribution of reagents and products along the wall. After 
generating the corresponding mesh surface by a laser scan, seven points located at places 
ranging from the bottom of the well to the rim were probed. The full scan MS intensities 
were normalized against the leucine abundance to eliminate any variability in sample 
collection amount. Figure D-7 B shows the distribution of the g′GAg′ depsipeptide reaction 
product. Its observed abundance changed over 2 orders of magnitude across the well wall, 
with a maximum at the center of the scanned transect line, corresponding to the darker 
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“coffee ring” regions in the photo. In comparison, leucine only showed a difference of 1 
order of magnitude in abundance.   
 203 
 
Figure D-7 (A) A spot plate following a dry down condensation reaction involving amino 
acids and hydroxy acids to form mixed amide/ester-linked oligomers, known as 
depsipeptides. The surface of the wells was analyzed by RoSA-MS to detect product 
formation. The dashed line in the inset indicates the sampled transect. (B) Seven 
independent surface points were probed, and the abundances of the g′GAg′ depsipeptide, 
one of the reaction products, mapped on the mesh representation of the surface. (g′, glycolic 
acid; G, glycine; A, alanine.) (C) Surface abundance for leucine, one of the starting 




A new platform for robotic surface analysis coupled with 3D surface sampling that 
incorporates surface contour digitization, robotic sampling, and 3D surface molecular 
cartography has been developed. With a 1 mm spatial resolution afforded by the line laser 
scanning technique, RoSA-MS is well suited to discrete sampling analyses for a variety of 
applications within the food industry, forensics, chemical reaction monitoring, and many 
others yet to be explored. In the present configuration, a spring-loaded semiblunt needle 
was used to collect sample from various surfaces. However, due to the modular nature of 
the system, the sampling probe could be easily tailored to different applications. For 
example, replacing the metal needle with a cotton swab would allow for more delicate 
sample-probe interactions. A sealed open sampling port interface effectively extracted 
analytes from the tip of the probe and was easily coupled to high resolution mass 
spectrometers. It is expected that the open and modular nature of RoSA-MS will enable 
further developments in automated, 3D computer vision-based MS analysis, further 
harnessing ongoing advances in robotics. 
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